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Abstract 
Substantial progress is being made in molecular psychiatry. Psychiatric genetic 
counselling (PGC), which may address how our knowledge from genetic studies is 
delivered to patients, is likely to become more routinely available as our aetiological 
understanding of psychiatric illness increases. The present study explores, using 
mixed-methods, potential consumers’ understanding and beliefs about the aetiology 
and pathology of psychiatric illness; their awareness of genetic counselling and 
perceptions of the purpose of the service, and their attitudes towards receiving 
PGC. Results indicate that there is an interest and keenness in receiving PGC, 
however also highlights potential issues that may arise through the provision of 
genetic counselling for psychiatric conditions, including that awareness of the 
service is low and misconceptions exist regarding its purpose; as well as concerns 
amongst respondents that it may cause psychological distress and also that it may 
be associated with eugenic-type values and practices which raises considerations of 
an ethical nature. The study overall highlights a need for further exploration of the 
findings presented and their wider implications in regards to future efforts to 
implement PGC within the UK. 
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1. Psychiatric Genetic Counselling within the UK – An 
Introduction 
 
Following advances in psychiatric genetics we are now starting to elucidate the 
genetic architecture of psychiatric disorders including schizophrenia (SCZ), bipolar 
disorder (BPD) and major depressive disorder (MDD). Researchers and clinicians 
now face the challenge of how to translate genetic findings to improve the lives of 
patients and families. The potential genetic counselling (GC) holds in addressing 
this has been discussed for many years; however there is a lack of consensus on 
the best way forward in delivering this service. Exploring future UK service user’s 
beliefs and perceptions about aetiology and familial risk, and their attitudes 
regarding the service, may be helpful in providing insight into how this may be best 
achieved to guide future delivery of psychiatric genetic counselling (PGC) within the 
UK. 
This research study uses a mixed-methods approach to examine beliefs about 
aetiology and familial risk and awareness and perceptions of the UK public with 
regard to PGC, to explore its implementation within the UK specifically. It will focus 
on UK individuals only as proper consideration of individuals from other countries 
and thus healthcare systems is beyond the scope of this research project. 
This chapter begins by exploring the background literature supporting the rationale 
behind PGC, followed by a review of the current literature specifically regarding 
PGC. It concludes with the aims and objectives that this study intends to address. 
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1.1 Defining mental illness 
 
Mental disorders are extremely common across the world (Ormel et al. 1994, Steel 
et al. 2014). There are many different types of mental disorders with different 
presentations (Insel et al. 2010, WHO 2014). The World Health Organization’s 
International Classification of Diseases (ICD) is the official world classification 
system for psychiatric disorders (WHO 1993, WHO 2010, Tyrer 2014), and is the 
system used in the UK for diagnosis. ICD-10 groups mental disorders into blocks on 
the basis of a common aetiology or similar presentation of symptoms (American 
Psychiatric Association 2000, WHO 2010, see figure 1). 
In comparison, the Diagnostic and Statistical Manual of Mental Disorders (DSM) is 
the standard classification of mental disorders used by mental health professionals 
in the United States, however the main groups of psychiatric disorder are diagnosed 
similarly by the two classification systems (Tyrer 2014). 
This literature review will focus on mood disorders and psychoses as these account 
for a substantial proportion of psychiatric disorders globally (Wittchen and Jacobi 
2005, Wittchen et al. 2011). 
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Figure 1: ICD-10 classification of mental and behavioural disorders  
(Figure from World Health Organization 2015) 
Disorders that are symptomatically similar are classified into blocks. The ICD-10 is the 
standard classification of mental disorders used by clinicians in the UK. This review focuses 
on psychoses (F20-F29) and mood disorders (F30-F39).  
 
 
 
 
 
 
 
(Fig. 1) 
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1.1.2 Mood disorders 
 
According to ICD-10 ‘mood disorders’ encompasses characteristics affecting either 
depression or elation (Arnow et al. 2015) and is usually associated with a secondary 
change in the patient’s overall physical activity (Emerson and Williams 2015).This 
includes bipolar affective disorder, recurrent depressive disorder, mania, and 
persistent mood disorders (WHO 2015). Mood disorders are often recurrent, with 
individual episodes typically related to stressful events or periods (WHO 2015).  
 
 
Depressive disorder, recurrent (Major depressive disorder) 
 
Major depressive disorder (MDD) is the most common mood disorder and is 
characterised by persistent sad or low mood, and/or anhedonia (NICE 2011). Other 
symptoms include fatigue, insomnia or hypersomnia, reduction in energy and 
inability to concentrate (Kendler and Gardener 1998, Arnow et al. 2015). 
MDD can include recurrent episodes of depressive reaction, recurrent episodes of 
major depression, and seasonal depressive disorder (WHO 2015). There is no 
history of mania, defined as independent episodes of mood elation and increase in 
energy, although the individual may experience brief episodes of mild mood elation 
and overactivity following a depressive episode; if the individual experiences an 
episode of mania, the ICD-10 states the diagnosis should be changed to bipolar 
disorder (BPD) (WHO 2015, see figure 2). 
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Figure 2: Key Differentiating symptoms between MDD and depressive symptoms in 
BPD. 
(Figure from Culpepper 2014) 
The overlap between clinical symptoms can be problematic for diagnosis and can result in 
deterioration of symptoms and increase treatment costs.  
 
 
 
 
 
 
 
 
 
(Fig. 2) 
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Bipolar disorder (BPD) 
BPD is episodic disorder characterised by recurrent, periodic episodes of 
depression and mania (Cosgrove and Suppes 2013, Culpepper 2014). Subtypes of 
BPD include BPD type I (depressive and manic episodes); BPD type II (depressive 
and hypomanic episodes); and cyclothymic disorder (hypomanic and depressive 
symptoms that do not meet criteria for depressive episodes) (Phillips and Kupfer 
2013, Culpepper 2014). Depressive symptoms are usually more common and 
longer-lasting than symptoms of elation and contribute to most overall morbidity, 
predominantly due to suicidality (Anderson 2012). Additionally, around 50% of 
manic episodes also contain psychotic elements (Cosgrove and Suppes 2014, see 
figure 3). 
The diverse presentation of symptoms in BPD can make diagnosis a challenge and 
misdiagnosis - often of MDD - is a clinical problem (see figure 2) that often results in 
inappropriate treatment, typically involving overuse of antidepressants and 
underuse of more effective treatment options, ultimately resulting in deterioration of 
symptoms for patients and significantly increasing direct treatment costs (Matza et 
al. 2005, Culpepper 2014). 
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1.1.3 Psychosis 
 
The term ‘psychosis’ describes a group of disorders in which a person’s mood, 
thoughts, perceptions and behaviour are significantly altered (Yung and McGorry 
1996, Austin and Honer 2008, NICE 2014, see figure 3). Psychosis can include 
schizophrenia (SCZ), schizoaffective disorder (SCZAD) and severe depression, and 
is also often experienced during the manic phase of BPD (Mental Health Foundation 
2007, Cosgrove and Suppes 2013).  
The overlap in symptomology between diagnostic boundaries can be clinically 
problematic (Malhi et al. 2008, Cosgrove and Suppes 2013, Wilson et al. 2014, see 
figure 3) as evidence-based outcomes have shown that early and appropriate 
treatment interventions can be critical in the effective management of psychotic 
disorders (Birchwood et al. 1998, McGorry 2005), including reducing suicide rates, 
shorter duration of hospitalisations, and longer employment periods (Chan et al. 
2015).  
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Figure 3: Typical features of BPD, SCZ and SCZAD.  
(Figure from Cosgrove and Suppes 2013, p.2) 
Whilst hallucinations and delusions are typically considered the hallmark symptom of SCZ 
and mood fluctuations of BPD; psychosis may be present in both. SCZAD, has been 
proposed to represent a mid-point on the phenotypic spectrum between BPD and SCZ. In 
clinical practice, symptomatic overlap between diagnostic boundaries presents clinical 
problems.  
 
 
 
 
 
 
 
(Fig. 3) 
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Psychosis – symptoms  
The two major symptoms of psychosis are hallucinations and delusions (see figures 
4 and 5, following pages); other common pathophysiological phenomena in 
psychosis include thought disorder, negative symptoms and cognitive impairment. 
Symptoms of psychosis vary in nature and severity across patients and the course 
of the illness; and each affected individual will develop their own unique combination 
of symptoms and experiences that often change over course of the illness and are 
dependent on their personal circumstances and life experiences (Tandon et al. 
2009, Schmitt et al. 2014, NICE 2014).  
 
Definitions of hallucinations and delusions in psychosis, along with examples, are 
provided in the figures in the following pages. 
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Figure 4: Hallucinations in psychosis 
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Definitions in the literature 
 
 “Persistent delusions… that are culturally inappropriate and completely impossible” 
(World Health Organization 1993, chapter F20) 
 
 “Fixed, false beliefs that are not shared by an individual’s cultural/religious group” 
(Austin 2005, p.329) 
 
 “Markedly unusual or bizarre ideas” (NICE 2014, p.102) 
 
Common types of delusions in psychosis 
 
 Grandiose:  
e.g. “Thinking that one has superhuman powers… …(believing that one is) able to 
control the weather, or… in communication with aliens from another world (World 
Health Organization 1993 chapter F20); 
e.g. Thinking one is Jesus Christ” (Mueser and McGurk 2004, p.2064);  
 
 Persecutory (paranoid): “Abnormal attention to threat related-stimuli” (Bentall et 
al. 1994, p.331) 
e.g. “An evil spirit is out to kill me” (Freeman and Garety 2014, p. 1179). 
 
 Erotic: 
e.g. The false belief that another person (often of higher status, a stranger, or 
somebody famous) has fallen in love with the affected individual and is making 
“amorous advances towards him/her” (Kennedy et al. 2002, p.1) 
 
 Control: The belief that others can interfere with the affected individuals thoughts 
and/or actions (Mueser and McGurk 2004, p.2064) 
 
 Somatic: involves an “irrational preoccupation” with one’s health or body (Kamara 
et al. 2009, p.1-2), however this belief is “false” or untrue, and that there is 
sufficient contradictory evidence to prove as such (Maher and Ross 1984, p.383) 
 
 
 
Figure 5: Delusions in psychosis 
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Schizophrenia 
 
Schizophrenia (SCZ) affects around 1% of the population (Mueser and McGurk 
2004, National Institute for Mental Health 2015). In addition to positive symptoms 
(psychosis) affected individuals experience negative symptoms including blunted 
affect (lack of emotional reactivity), alogia (lack of speech) and anhedonia (lacked 
capacity to experience pleasure) (Rector et al. 2005, WHO 2015, Tsapakis et al. 
2015); and cognitive impairments including deficits in working memory, attention 
and processing (Mikell et al. 2009, Tsapakis et al. 2015, see figure 6). 
SCZ is the ‘flagship’ disorder of the Psychiatric GWAS (Genome Wide Association 
Studies) Consortium and resultantly its genetic dissection is more advanced than 
other psychiatric disorders (Gratten et al. 2014), which have much smaller sample 
sizes. This review therefore gives particular attention to the aetiology of SCZ, as 
described in section 1.3.1 
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Figure. 6: The three major symptom domains of SCZ 
(Adapted from Mikell et al. 2009, p.257) 
The three major symptom domains of SCZ are positive symptoms, negative symptoms, and 
cognitive impairments. Hypotheses regarding proposed pathophysiology underlying 
impairment have guided suggested pharmacological treatment pathways, as shown on the 
diagram. The efficacy of pharmacological treatments in psychiatry are poor and very few 
drugs of proven efficacy have been developed; the therapeutic stagnation is largely due to 
limited aetiological understanding.  
(Fig. 6) 
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1.2 Significance of mental disorders 
 
1.2.1 Global and national Significance 
 
A WHO report in 2001 estimated that 450 million people worldwide suffer from 
mental health problems (WHO 2001, Mental Health Foundation 2007) placing 
mental disorders amongst the leading causes of illness and disability globally. This 
is now believed to have reached almost 500 million (Tawar et al. 2014) and is 
projected to rise exponentially as the population continues to grow; life expectancy 
increases; as well as additional contributory socioeconomic factors including 
increased immigration and warfare (Mawani 2014) and growing global poverty 
(Tilleczek et al. 2014). These figures are likely to be underestimations due to many 
affected individuals with mental health problems not seeking professional help 
and/or not receiving a proper psychiatric diagnosis. 
 
The growing global burden of mental health disorders has major social, economic 
and human rights consequences across the world (WHO 2014). All mental disorders 
can be chronic, lifelong conditions that can cause significant long-term functional 
impairment and disability (NICE 2011) meaning that, in addition to medical 
treatments (e.g. medication, therapy), affected individuals with mental illness often 
require social care and support within the community such as finding housing and 
employment and accessing education (WHO 2014). It has thus been urged that 
mental disorders should be made a public health priority (Whiteford et al. 2013); this 
could have both quality of life and economic benefits for hundreds of thousands, 
potentially millions, of people world-wide (Collins et al. 2011). 
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In Britain specifically, one in four adults will experience mental health problems in 
any year (Singleton et al. 2001, Mental Health Foundation 2014). Direct costs of 
mental health in England are over £22.5 billion a year and are projected to continue 
growing as prevalence increases (McCrone et al. 2008, see table 1). Despite this, 
mental health services in the UK are facing increasing funding cuts (see figure 7). 
This period of austerity makes efficiency in mental health services imperative; 
evidence-based prevention and early intervention and treatment for mental 
disorders are becoming increasingly important in ensuring maximum efficacy of 
mental health services in the UK, and overall optimal patient outcomes (McDaid and 
Knapp 2010). 
 
 
Table 1 Number of UK affected individuals with specific disorders and current and 
projected costs 
(From McCrone et al. 2008, p.18) 
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Figure 7: Guardian article featuring Mark Winstanley 
(Source: O’Hara 2015). 
Chief executive of Rethink mental illness charity, warning of the impact of spending cuts in 
the UK. Despite the growing prevalence of psychiatric conditions, services are facing huge 
cuts with major implications on care and support.  
 
 
 
 
 
 
 
 
 
(Fig. 7) 
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1.2.2 Morbidity and mortality in mental disorders 
 
Individuals with mental health problems have shorter life expectancy, especially 
those with more serious psychiatric disorders (Dickey et al. 2004). Individuals with 
SCZ, for example, have a lifetime expectancy that is 20% shorter than that of the 
general population (Newman and Bland 1991, Hennekens et al. 2005, Munitz 2010). 
 
The mortality gap is largely explained by natural causes owing to morbidity with 
other, non-psychiatric medical diseases (Gardner-Sood et al. 2015), including 
higher prevalence of metabolic diseases such as hypertension, diabetes and 
hyperglycaemia (Koran et al. 1989, Briskman et al. 2012, Gardner-Sood et al. 
2015); HIV and infectious hepatitis (Rosenburg et al. 2001, Goff 2005) and poorer 
dental health (Mirza et al. 2001, Kisely et al. 2015). Under-diagnosis and under-
treatment of hospitalised psychiatric patients in comparison to non-psychiatric 
patients (Briskman et al. 2012); less effective self-care; adverse health behaviours 
such as smoking (Naylor et al. 2012) or alcohol abuse, potentially to self-medicate 
symptoms (Duffy et al. 2007); and poorer quality of life (Naylor et al. 2012) have 
been proposed as confounding factors. Additionally, cardiac distress in psychosis is 
also believed to act as a specific potential cardiovascular risk factor (Rasul et al. 
2005). 
 
Furthermore, psychiatric comorbidity, whereby an individual meets the diagnostic 
criteria for two or more psychiatric conditions, is also common with studies reporting 
that over 50% of affected individuals diagnosed with a common mental disorder also 
meet diagnostic criteria for at least one more psychiatric condition (Andrews et al. 
2002, Maj 2005, NHS information Centre for Health and Social Care 2009). 
Psychiatric comorbidity is associated with increased severity of symptoms, longer 
duration of illness, greater functional disability, poor adherence to self-care 
regimens and increased use of public health services (NHS information Centre for 
Health and Social Care 2009, Katon et al. 2011). 
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Higher rates of suicide and suicidal tendencies also account for the excess mortality 
in affected individuals with psychiatric disorders. Suicide is strongly associated with 
psychiatric conditions (Cheng 1995, Duffy 2014). For example, for affected 
individuals with SCZ there is a lifetime suicide risk exceeding 10% (Becker 1988, 
Inskip et al. 1998, Enger et al. 2004, Giusti-Rodríguez and Sullivan 2013); and 
suicide is the leading cause of premature death (Kwon et al. 2013). Additionally of 
all psychiatric disorders, mood disorders account for the greatest proportion of 
suicides (Pritchard et al. 2005). 
 
 
 
Figure 8 : Suicide rates per 100,000 in the UK in 2012. 
(Figure from Scowcroft 2014, p.8). 
Suicide rates per 100,000 in the UK in 2012. British men are three times higher to die by 
suicide than British women. The so-called gender paradox in suicide is largely attributed to 
social factors, especially that pressures to fit the traditional image of male masculinity may 
promote maladaptive coping strategies including substance abuse, emotional 
inexpressiveness and increased reluctance to seek medical help.  
 
 
 
 
(Fig. 8) 
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In the UK specifically, in 2012, more than 5,900 people died by suicide, and British 
men are over three times more likely to die by suicide than British women 
(Scowcroft 2014, see figure 8). The UK also has one of the highest rates of self-
harm in Europe, at 400 per 100,000 (Singleton et al. 2001, Mental Health 
Foundation 2007).  Furthermore, prevalence of suicidal phenomena is actually 
much higher than indicated from such data, as the number of affected individuals 
with psychiatric disorders that experience suicidal thoughts, and even attempt 
suicide, will be far greater than those who successfully commit suicide. 
 
The high morbidity and mortality rates seen in psychiatric patients thus emphasise 
the urgent need to improve both psychological and physical care provision to 
affected individuals with psychiatric conditions. 
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1.2.3 Psychosocial aspects of mental disorders – stigma 
 
Stigma is defined as a mark, label or attribute that usually links a person to 
undesirable characteristic (Goffman 1963, Jones et al. 1984, Link and Phelan 2001, 
Thornicroft et al. 2007) and sets a person apart from the rest of society (Austin and 
Honer 2005, Steel et al. 2014). Affected individuals with mental illness are amongst 
the most stigmatised in society; indeed the association between stigma and 
psychiatric illness has been explored many groups (see e.g. Phelan et al. 1998, 
Thara and Srinivasan 2000, Corrigan et al. 2001, Byrne 2001, Link et al. 2004, Steel 
et al. 2014). 
Typical negative connotations associated with mental illness that induce 
stigmatising attitudes and prejudice include beliefs and assumptions that affected 
individuals can be violent, weak, lacking intelligence and dirty (Olmsted and Durham 
1976, Phelan 2002, Schulze and Angermeyer 2003, Steel et al. 2014). 
 
Stigma can manifest as open-discrimination in areas such as employment and 
housing (Corrigan et al. 2003, Thornicroft et al. 2007, Brohan et al. 2010) to more 
subtle expressions such as the negative portrayal of characters with mental illness 
in television series (Phelan 2002). Stigma can also be a major barrier to help-
seeking behaviours in mental health, such as medication adherence, help-seeking 
at time of onset, and following medical advice, which results in deterioration of 
symptoms and poorer management of the condition (Schulze and Angermeyer 
2003, Steel et al. 2014, Mental Health Commission of Canada 2015). 
Stigma thus has a direct impact on an individual’s self-esteem and psychological 
well-being (Link et al. 1991, Link 2001, Link and Phelan 2001, Austin and Honer 
2005, Steel et al. 2014, Government of Western Australia Mental Health 
Commission 2014); their economic and physical well-being through reducing life 
and employment opportunities and health-related quality of life (Schulze and 
Angermeyer 2003, Corrigan et al. 2003). Indeed, for many affected individuals the 
effects of stigma can be more debilitating than the mental illness itself (Schulze and 
Angermeyer 2003, Thornicroft et al. 2007). 
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Equally family members of affected individuals with mental illness can also be 
affected by stigma (Goffman 1963, Phelan 2002, Corrigan and Miller 2004). 
Common examples include family members being blamed for causing their 
relative’s illness or relapse (Phelan 2002, Corrigan and Miller 2004, Larson and 
Corrigan 2008, Girma et al. 2014); being rejected or avoided out of fear of 
contamination of the mental illness (Corrigan and Miller 2004); or having their own 
mental health questioned (Phelan 2002, Austin and Honer 2005). These prejudices 
can result in feelings of shame, guilt, fear and isolation from society amongst family 
members (Thara and Srinivasan 2000, Austin and Honer 2005), may reduce the 
support network, make them less able to be proactive in their loved one’s care 
(Major and O’Brien 2005); and may cause psychological distress (Ostman and 
Kjellin 2002). 
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1.2.4 Psychosocial aspects of mental illness - Shame and guilt 
 
Although used synonymously, shame is defined as a negative judgement of oneself 
in response to failing to meet personal or social standards; whilst feelings of guilt 
result from negative evaluations of a specific behaviour (Averill et al. 2002). 
Affected individuals affected by mental illness and their relatives often experience 
profound feelings of guilt and shame (Miller and Mason 2005, Austin and Honer 
2005); this has been reported across different cultures and nations including the UK 
(Gilbert et al. 1994), Americans (Morrison 1985), Indians (Thara and Srinivasan 
2000), American Asians (Chow et al. 2003) and Hispanic Americans (Strug and 
Mason 2002). These feelings can be intense and remain even after successful 
treatment or management of the symptoms of the mental illness (Miller and Mason 
2005). 
Although multiple factors can contribute to feelings of guilt and shame, it is well 
established that oversimplified ideas and misconceptions about the causes of 
mental illness, often when there is a lack comprehensive understanding and in 
place affected individuals develop their own explanations (Meiser et al. 2005, Austin 
and Honer 2005, Austin and Honer 2007, Jaremo et al. 2011, Inglis et al. 2014, 
Costain et al. 2014a, Costain et al. 2014b), commonly induce feelings these feelings 
amongst families. This may include extensive attribution of the mental illness to 
environmental factors and life experiences such as events that occurred during 
childhood that the mental illness is later attributed to (Meiser et al. 2005, Austin and 
Honer 2005, Hill and Sahaar 2006, Finn and Smoller 2006, Austin and Honer 2007, 
Peay et al. 2008, Inglis et al. 2014); and also oversimplified ideas about genetic 
contributions to mental illness; for example, parents may feel responsible for 
‘passing on’ the condition to their children (Austin 2005, Austin and Honer 2007, 
Austin and Honer 2008). 
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Experiencing guilt and shame can have a direct effect on self-esteem (Lewis 1987), 
such as feelings of humiliation, disgrace, or failure in fulfilling one’s responsibilities 
(Miller and Mason 2005). Shame and guilt can also have important treatment 
implications as they may act as a barrier to help-seeking behaviours such as 
accessing professional mental health services (Thara and Srinivasan 2000, Miller 
and Mason 2005), for example out of fear of a label or diagnosis that carries such a 
negative stereotype (Miller and Mason 2005), or, amongst relatives, fear of being 
blamed for causing their or their loved one’s illness (Austin and Honer 2005). 
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1.3 Aetiology of Psychiatric disorders 
 
1.3.1 Psychiatric Genetics 
Epidemiological studies 
 
Family, adoption and twin studies have indicated a significant genetic contribution to 
psychiatric disorders (Gottesman and Shields 1966, Cardno et al. 1999, Shih et al. 
2004). Familial aggregation has been consistently demonstrated for psychiatric 
disorders including SCZ, SAD and BPD (Kendler 1988, Tsuang 2000, Shih et al. 
2004, Laursen et al. 2005). The percentage risk for these psychiatric disorders is 
correlated to the degree of relatedness of the affected individuals in the family 
(Craddock and Jones 1999, Tsuang 2000, see figures 9 and10), and despite the 
fact that a substantial majority of affected individuals diagnosed with SCZ, SAD or 
BPD have no family history of the disorder, having a positive family history remains 
the single greatest risk factor for developing mental illness (Merikangas and Risch 
2003, Laursen et al. 2005, Austin 2005, Finn and Smoller 2006, Hunter et al. 2010, 
Craddock and Sklar 2013, Meiser et al. 2013, see figures 9 and 10).  
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The percentage risk for these psychiatric disorders is correlated to the degree of 
relatedness of the affected individuals in the family.  
 
 
 
Figure 9: Estimated lifetime risks for SCZ. 
(Figure from Hill and Sahaar 2006, p.508). 
 
 
 
 
Figure 10: Empirical risks of developing SCZ for relatives of an individual with SCZ. 
(Figure from Austin 2005, p. 331, adapted from data from Gottesman 1991). 
 
 
Empirical risk estimates are derived from over 2 decades of standardised, family-
based studies that have resulted in relatively comprehensive risk data.  
(Fig. 9) 
(Fig. 10) 
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Heritability of psychiatric disorders 
 
Twin studies have consistently reported substantial and similar heritability estimates 
for psychiatric disorders, with estimates typically ranging from 60-85% (Cardno et al. 
1999, Wray and Gottesman 2012, see table 2, following page), indicating that 
around 80% of vulnerability is determined by genetics (Nature 2010). 
Notably the heritability for psychiatric illnesses including BPD and SCZ is 
substantially higher than for other complex medical including breast cancer, 
diabetes and heart disease - diseases widely recognised by the public as having a 
genetic component (Plomin et al. 1994, Austin 2005). 
Despite this whilst affected individuals with or at risk of breast cancer, diabetes and 
heart disease are routinely referred for GC this is not currently the case in 
psychiatry (see table 2), indicating current provision of genetic information for 
psychiatric disorders lags behind that for physical disorders. 
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Table 2: Heritability estimates of multifactorial diseases including SCZ, 
BPD and MDD 
Disease Heritability 
estimate 
Reference 
Schizophrenia 60-85% Cardno et al. 1999, Wray and 
Gottesman 2012 
BPD 60-85% McGuffin et al. 2003, Wray and 
Gottesman 2012 
MDD 30-50% Hamet and Tremblay 
2005,Lohoff 2010,Wray and 
Gottesman 2012 
Asthma 70-80% Thomsen et al. 2010 
Diabetes* 26-70% Poulsen et al. 1999, Almgrem et 
al. 2011 
Spina Bifida* 60-70% Copp et al. 2015 
Age-related 
macular 
degeneration* 
50-70% Klaver et al. 1998 
Breast 
Cancer* 
25-55% Schildkraut et al. 1989, Czene et 
al. 2002, Cancer Research 
2015. 
Coronary 
heart 
disease* 
35-50% Katzmarzyck et al. 2000 
 
Note: * denotes GC is available in the UK for affected individuals with/at risk 
of having specified condition. 
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Genetic studies in psychiatric genetics 
 
Despite evidence from family studies, progress in psychiatric genetics had until 
recently been slow with early attempts to identify risk loci proving disappointing. 
Linkage studies, for instance, which attempt to identify large segments of 
chromosomes that are inherited with disease, were a major focus of early 
psychiatric genetic studies. Although some psychiatric genetic linkage study groups 
reported positive linkages in regions, some of which achieved replication by other 
study groups, including 22q11-12 for SCZ (Coon et al. 1994, DeLisi et al. 2002), and 
13q32 for BPD (Stine et al. 1997, Detera-Wadleigh et al. 1999) and SCZ 
(Brzustowicz et al. 1999, Mulle et al. 2005, Gadelha et al. 2012), most studies 
neither achieved ‘genome-wide’ levels of significance nor replicated pre-existing 
findings (Owen et al. 2004, Owen et al. 2005, Craddock and Sklar 2013).  
Similarly, findings of candidate gene studies, which have also traditionally 
dominated psychiatric genetic approaches (Varga et al. 2011) with over 1000 
studies of SCZ (Allen et al. 2008) and hundreds of studies of BPD (Craddock and 
Sklar 2013), have been inconsistent, with initial positive findings also lacking 
replication in subsequent, independent studies (Tabor et al. 2002, Collins et al. 
2012). 
 However these approaches were not an overt failure as they provided insight into 
the inheritance pattern of common psychiatric which finally enabled settlement of 
the longstanding the “rare” Vs. “common” variant debate in psychiatric genetics 
(Collins and Sullivan 2013). Providing strong evidence that Mendelian-like mutations 
(i.e. highly penetrant) could be ruled out in psychiatric pathogenesis, the insight 
gained through these early genetic studies helped guide researchers in designing 
studies that are adequately powered to detect the common, low-penetrance loci 
involved in conferring susceptibility to psychiatric disorders. This resulted in the 
transition to genome-wide association studies (GWAS), which compare frequencies 
of genetic variants between cases and controls for a large set of genetic markers 
distributed across the genome (Collins and Sullivan 2013). 
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At the time of writing this thesis, genome-wide association studies (GWAS) have 
identified 108 independent loci for SCZ (Psychiatric Genomics Consortium SCZ 
Working Group 2013, see figure 11 next page) and eight loci for BPD (Charney et 
al. 2013 cited Gratten et al. 2014) that reach genome-wide significance. Crucial to 
the success of psychiatric GWAS has been the adoption of rigorous statistical 
standards (Pe’er et al. 2008, Sullivan 2010, Panagiotou and Ioannidis 2011), 
meaning that the biology of a gene plays no role in establishing its association  and 
the studies are thus unbiased in their approach (Sullivan 2010, Collins and Sullivan 
2013), and also international collaborations between study groups which has 
resulted in the accrual of historically massive sample sizes and resultantly increased 
the power of detection of modest-effect size alleles (Wellcome Trust Case Control 
Consortium 2007, Ferreira et al. 2008).  
Conversely no association achieving genome-wide significance for MDD has been 
made to date (Cohen-Woods et al. 2013, Major Depressive Disorder Working Group 
of the Psychiatric GWAS Consortium  2013, Flint and Kendler 2014). As a higher-
prevalence, low heritability disorder, the most likely explanation for the lack of 
success is that GWAS studies have been underpowered to detect loci (Wray et al. 
2012, Major Depressive Disorder Working Group of the Psychiatric GWAS 
Consortium  2013, Flint and Kendler 2014). Similarly, for obsessive compulsive 
disorder (OCD), anorexia nervosa and Tourette’s, published data are sparse and 
GWAS sample sizes are small by current standards (Collins and Sullivan 2013). It is 
anticipated that as sample size increases power of detection will increase and loci 
will be identified for such common, lower heritability psychiatric conditions. 
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Figure 11:  Figure showing i) Proportion of variance in liability (SNP-based 
heritability) and ii) proportion of covariance in liability between disorder (SNP-based 
coheritability) for five major psychiatric conditions. 
(Figure from Cross-disorder group of the Psychiatric Genomics Consortium 2013, p.23). 
Common genetic variation accounted for up to 30% of the variance in liability. Among pairs 
of disorders (light green), SCZ and BPD shared ~16% of the same common genetic 
variation (‘coheritabilities’). 
 
 
 
 
 
 
 
(Fig. 11) 
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GWAS has thus finally provided insight into the genetic architecture of psychiatric 
disorders. Psychiatric disorders are now understood to be highly polygenic, with 
many different genetic loci conferring risk - estimates suggest that variation at 
around 8,300 independent loci will ultimately be found to account for up to 50% of 
the genetic risk to SCZ (Ripke et al. 2013) and it is predicted that this is likely true 
for most psychiatric disorders (Gratten et al. 2014). Additionally it is now understood 
that risk is dominated by smaller-effect,  common variants (Ripke et al. 2013, 
Gratten et al. 2014) with statistical analyses on GWAS data (described in Ripke et 
al. 2013) indicating that common variants of small effect (i.e. 0.05% or less) account 
for a substantial proportion of heritability (between one third to half) for SCZ 
(Gratten et al. 2014, see figure 10), and that this is likely to be the case for other 
psychiatric disorders including for BPD and MDD (Lee et al. 2013) and OCD and TS 
(Davis et al. 2013). 
Thus, heritability for psychiatric disorders is not “missing” – a concept that has 
attracted much coverage in the media (Hirsch 1999, Wade 2010), and online blogs 
and articles (Latham and Wilson 2010, Joseph 2013) - but rather “hidden” by 
inadequately powered studies (Gershon et al. 2011, Giusti-Rodríguez and Sullivan 
2013, Gratten et al. 2014).  
Furthermore, GWAS has revealed that some genes associated with psychiatric 
disorders are non-specific, having associations across the diagnostic boundaries 
including SCZ, BPD, intellectual disability, and autism (Rudan 2010, Gratten et al. 
2014, see figure 10). Cross-disorder GWAS meta-analyses has identified three loci 
for a shared SCZ-BPD phenotype (SCZ Psychiatric Genome-Wide Association 
Study (GWAS) Consortium et al. 2011) and four loci for a broader psychiatric 
genotype spanning ASD, ADHD, BPD, MDD and SCZ (Cross-Disorder Group of the 
Psychiatric Genomics Consortium 2013). 
This finding of shared genetic risk factors across traditional psychiatric diagnoses is 
consistent with overlapping clinical presentations and it is hoped this insight may 
help develop a more effective classification system based on underlying biological 
causes rather than symptomology-based diagnoses in psychiatry today (Cross-
disorder group of the Psychiatric Genomics Consortium 2013). 
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Biological insights from GWAS 
 
As well as providing glimpses into the genetic architecture of psychiatric conditions, 
GWAS findings also enable insights into the biological underpinnings of psychiatric 
disorders. Such understanding is valuable as it is hoped it will enable development 
of better management of psychiatric conditions (e.g. medication and treatment 
options), better prevention measures for those deemed ‘at-risk,’, and more accurate 
diagnosis. 
A key theme to emerge for example is the implication of calcium signalling in SCZ 
and BPD pathogenesis. A recent GWAS associated the gene encoding the α1c  
subunit of L-type, voltage-dependent calcium channels, CACNA1C at the intronic 
SNP rs 1006737 with SCZ (Ripke et al. 2013), replicating previous associations that 
did not reach the threshold of genome-wide significance, for both schizophrenia 
(Green et al. 2010) and BPD (Ferreira et al. 2008). Notably, this provides genetic 
molecular evidence of shared aetiology between BPD and SCZ (Cross-disorder 
group of the Psychiatric Genetics Consortium 2013).  
Additionally one of the most statistically robust findings for SCZ GWAS involves 
genetic variation within the major histocompatibility complex (MHC) region (Shi et al. 
2009, Stefansson et al. 2009, Collins et al. 2012). Although the MHC encodes over 
400 genes involved in immunity (McAllister 2014), it has traditionally been a major 
focus of early genetic studies, largely driven by epidemiological findings that have 
reported increased prevalence of autoimmune and inflammatory diseases, including 
caeliac disease and rheumatoid arthritis, in SCZ affected individuals and their 
relatives (Eaton et al. 2006) as well as reports of immune dysregulation in affected 
individuals including CNS inflammation in SCZ post-mortem brain tissues (Smyth 
and Lawrie 2013), and abnormal cytokine levels in tissues in SCZ affected 
individuals (Watanabe et al. 2010, Di Nicola et al. 2013. The implication of MHC by 
GWAS thus raises the possibility of an aetiological role for an immune, autoimmune, 
or infection process in psychiatric pathogenesis (Sullivan 2010). Mechanistically, it 
has been hypothesised that epigenetic interactions may be involved in mediating 
vulnerability to SCZ conferred by MHC risk variants (see 1.3.2). Interestingly, this 
thus highlights how GWAS findings may be helping explain epidemiological puzzles, 
such as increased rates of immune disorders amongst psychiatric patients (Gratten 
et al. 2014).  
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1.3.2 Environmental (non-genetic) factors in psychiatric pathogenesis 
 
Epidemiological data 
 
Family studies have also demonstrated an environmental (non-genetic) contribution 
to pathogenesis of mental illness. 
Despite high heritability, concordance rates for psychiatric illness amongst 
monozygotic twins is substantially less than 100% (see table 3). In SCZ for 
example, although heritability is estimated to be 60-85% (Cardno et al. 1999, Wray 
and Gottesmann 2012), concordance in monozygotic twins is only 40-48% 
(Gottesman and Wolfgram 1991). This indicates environmental factors play a critical 
role in mediating susceptibility to illness onset (Tsuang 2000, Hill and Sahhar 2006). 
From a clinical perspective this knowledge is especially valuable as it may help 
identify factors which i) protect mental health or ii) increase risk, to facilitate 
strategies to better manage and protect mental health for those with or at risk of 
developing psychiatric conditions. 
 
Table 3: Concordance rates (%) for schizophrenia in monozygotic (MZ) and dizygotic 
(DZ) twin studies. 
(from Tsuang 2000, p.211, adapted from data from Gottesman 1991). 
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Identifying environmental factors involved in psychiatric pathogenesis 
 
Identification of environmental factors is notoriously complex. Sophisticated studies 
addressing genetic confounding by controlling for genetic risk have been conducted 
along with extensive meta-analyses in order to comprehensively aid identification. 
To this degree, some notable progress has been made over the past two decades. 
What is now understood that factors or events that occur both pre- and peri-natally 
mediate environmental risk (Mueser and McGurk 2004, Maric and Svrakic 2012), 
and that these risk factors may be biological, physical and/or psychosocial (Vilain et 
al. 2013). 
Indeed some environmental factors have now been consistently associated with 
increasing risk of psychosis (Mueser and McGurk 2004, Uher 2009, van Os et al. 
2010, Maric and Svrakic 2012) including being born in spring (Barry and Barry 1961, 
McDonald and Murray 2000), increased paternal age (Dalman and Allebeck 2002, 
Crow 2003, Rees et al. 2011, Goreily et al. 2013), growing up in an urban 
environment (Frissen et al. 2015) cannabis use (Semple et al. 2005, Parakh and 
Buso 2013), minority group position (van Os et al. 2010, Suvisaari et al. 2014), 
obstetric complications (Lewis and Murray 1987, Cannon et al. 2002, Ballon et al. 
2008), and childhood trauma (Rutter 1965, Janssen et al. 2004, Schäfer and Fisher 
2011, Dvir et al. 2013). Additionally, early trauma or stress- including separation, 
bereavement, family problems, neglect and child abuse (Ford and Kidd 1998, 
Kendler et al. 2004, Mandelli et al. 2015); occupational stress (Cohen and Wills 
1985, Stansfeld et al. 2012, Theorell et al. 2015) and social isolation or reduced 
social support (Cohen and Wills 1985, Nordentoft 2007, Voisin et al. 2015) have 
been consistently associated with MDD and suicidal behaviour (Paykel 1976, 
Mandelli and Serretti 2013). 
Focus has now switched to attempts to elucidate the biological underpinnings of 
putative gene/environmental interactions in psychiatric pathogenesis (see figure 7). 
These investigations typically involve studies that attempt to identify the influence 
environmental factors have on gene expression and activity (i.e. epigenetic 
interactions) in order to elucidate the underlying molecular mechanism(s) that may 
confer susceptibility (Marik and Svrakic 2012, Mandelli and Serretti 2013 for 
reviews). 
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The consistent association of psychiatric illness with increased paternal age, for 
example, has been attributed to accumulation of de novo mutation with age in the 
male germline which are subsequently passed on to offspring (Dalman and Allebeck 
2002, Crow 2003,Uher 2009, Rees et al. 2012, Fromer et al. 2014, Milekic et al. 
2015). It has been hypothesised that the mutations alter biological mechanisms, 
such as methylation (Jenkins et al. 2014, Milekic et al. 2015), to influence “risk 
pathways” and result in neurodevelopmental alterations that ultimately increase risk 
to neuropsychiatric illness (Malaspina et al. 2015). Interestingly these de novo 
mutations are believed to increase risk across a spectrum of neurodevelopmental 
disorders, providing further evidence of shared aetiology between traditional 
diagnostic boundaries (van Os et al. 2010). 
Additionally, inflammatory imbalance - potentially mediated by both genetic 
contributions, such as MHC risk variants (as discussed in 1.1.3.1.2) and 
environmental contributions such as maternal infection - have been proposed as a 
biological mechanism conferring vulnerability to onset of psychosis (McAllister 
2014). A leading hypothesis is that the resulting chronic changes in immune 
molecules in the brain may affect neurodevelopmental processes later in life, such 
as nerve cell maturation, signalling, differentiation, proliferation, and survival, 
ultimately resulting in the neurological defects associated with SCZ and/or 
psychosis (Smyth and Lawrie 2013). 
Gene-environment interactions have also been proposed to explain the association 
between cannabis use and psychosis (Henquet et al. 2008). Available evidence 
indicates that genetic variation may influence sensitivity to the psychosis-inducing 
effects of cannabis (Decoster et al. 2012). For example, the polymorphism 
Val158Met in the gene encoding catechol-O-methyl transferase (COMT) - one of the 
most studied hypothesis-driven candidate genes (Collins et al. 2012)- results in 
respectively in high and low-activity forms of the enzyme, which degrades dopamine 
(Al-Asmary et al. 2014). Studies have reported that carriers of the COMT Val 
homozygous alleles have a rapid dopamine metabolism and subsequently low 
cortical and high midbrain dopamine levels (Sagud et al. 2010) and have been 
found to be at increased risk of psychosis if they use cannabis during adolescence 
(Caspi et al. 2002, Caspi et al. 2005, Maric and Svrakic 2012). Cannabis is known 
to cause a significant decrease in cortical dopamine and increase in midbrain 
dopamine, and it has therefore been proposed that pre-existing heritable dopamine 
dysfunction may be amplified by cannabis to ultimately induce psychosis (Maric and 
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Svrakic 2012). Other candidate variants hypothesised to influence cannabis-induced 
risk are NRG1 (Pelayo-Téran et al. 2012, Long et al. 2013, Suárez-Pinilla et al. 
2015) and AKT1 (van Winkel et al. 2011, Decoster et al. 2012, Radhakrishnan et al. 
2014). Notably, it has been proposed that other environmental factors such as 
childhood trauma or urbanicity may also influence differential dopamine 
sensitisation effects, to have a synergistic effect with cannabis and further increase 
risk of psychosis (Pelayo-Téran et al. 2012, Radhakrishnan et al. 2014).  
Thus, current understanding is that genetic vulnerability to psychiatric illness is 
partially mediated by differential sensitivity to numerous risk factors which affect 
brain functioning and/or influence brain development (van Os et al. 2010). It is 
hoped that longitudinal studies alongside the adoption of multidisciplinary 
translational approaches will enable deeper exploration of gene-environment 
interactions and help identify the underlying mechanisms (van Os and Kapur 2009, 
Nature 2010, van Os et al. 2010) which may in turn help increase biological 
understanding of psychiatric illness and thus advance clinical management and 
treatment strategies (van Os et al. 2010, Schmitt et al. 2014). 
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1.3.3 Current aetiological understanding of psychiatric conditions: 
Implications for clinical practice 
 
What is currently understood about the aetiology of psychiatric disorders raises the 
clinical question of how this information can effectively delivered to patients and 
their families.  
The aetiological information regarding the relative contributions of genetic and 
environmental factors, and protective factors in mental health, is especially complex 
and surrounded by uncertainty with much yet to be understood, and this needs to be 
effectively managed and counselled around by the clinician (Peay et al. 2008, 
Hippman 2013). 
Genetic counsellors, whom are specially trained to convey complex information and 
in the provision of supportive counselling, have been proposed to be ideally placed 
to deliver such information (Austin and Honer 2005, Austin and Honer 2008, Peay et 
al. 2008) This is discussed further in sections 1.5.1 and 1.5.2 
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1.4 Genetic counselling 
 
1.4.1 Genetic counselling – A growing profession 
 Genetic counsellors today are qualified healthcare professionals that have specific 
expertise in identifying and educating patients at risk for inherited conditions (AGNC 
2015). They are specially trained to personalise, interpret, and communicate 
complex science into information that is helpful for the patient (Mester et al. 2012). 
 As our understanding of the human genome continues to unfold and we gain more 
insight is gained into the genetic underpinnings of disease and health, genetic 
counsellors are becoming an increasingly important part of the healthcare team. 
Over recent decades GC has evolved to embrace an increasing number of fields in 
clinical medicine (Resta et al. 2006, Guttmacher et al. 2007, Skirton et al. 2015, see 
table 2) including oncology, cardiology, and endocrinology; with the skillset of 
genetic counsellors continuing to expand in response to the increasing complexity 
and diversity of the issues of their presenting patients (Kasparian et al. 2007, Mester 
et al. 2012). 
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1.4.2 Genetic counselling - Definition of practice 
The NSGC’s most recent definition of practice of genetic counselling describes it as: 
“The process of helping affected individuals adapt to the medical, 
psychological and familial implications of genetic contributions to disease” 
(Resta et al. 2006, p. 77) 
Under this definition of practice, the process should integrate the following: 
 “Interpretation of family and medical histories to assess the chance of disease 
occurrence or recurrence. 
 Education about inheritance, testing, management, prevention, resources and 
research 
 Counseling to promote informed choices and adaptation to the risk or 
condition” 
(Resta et al. 2006, p.77) 
 
However the goals of and approaches to genetic counselling have undergone 
significant changes since early practice, and to this day, whilst there has been 
overall agreement in the general tasks encapsulated in the process of genetic 
counselling, as described in the NSGC’s definition of practice, there remains a lack 
of consensus regarding the process itself. Indeed, the development of a consistent 
model of practice is a topic has engaged much recent discussions (see for example, 
Biesecker 2001, McCarthy Veach et al. 2006, McCarthy Veach et al. 2007, 
Hartmann et al. 2013). 
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1.4.3 Genetic counselling – A brief history 
Origins, Sheldon Reed, and associations with eugenics 
 
The term ‘genetic counselling’ was originally coined by Sheldon Reed in 1947, who 
described it as the provision of 
“supportive counselling and genetic information about inheritance patterns 
and recurrence risks” (Reed 1947, cited Reynolds and Benkendorf 1999 
p.375).  
 
Early genetic counselling was of a social rather than medical nature, and Reed 
himself described it primarily as a form of “social work without eugenic connotations” 
(Reed 1975, p.335). For example, the single most common purpose of early genetic 
counselling enquiries was to evaluate a newborn for adoptive placement (Stern 
2012), which typically related to matters of race or ancestry, e.g. to determine a 
child’s skin colour or to obtain an evaluation for other racial characteristics (Resta 
2006, see figure 12). Other purposes for early enquiries included obtaining 
recurrence risk for conditions including epilepsy, intellectual disability, and SCZ 
(Resta 2006, Stern 2012) as well as questions relating to consanguinity and mate-
choice (Resta 2006, Stern 2012).  
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Figure 12: Extract detailing an early genetic counselling enquiry from the Dight 
Records, Dight Institute Inquiries, August 30, 1948.  
(Cited Resta 2006, p.270). 
Enquiries regarding skin colour, such as the above, were common lines of enquiry in early 
GC practice.  
  
Thus, the early era of genetic counselling had a predominantly “public health-
centered approach”(Resta et al. 2006, p.270), often with the wide aim of bettering 
the well-being of society rather than that of benefitting the individual patient. It has 
been reflected that, in reality, it was sometimes difficult to disentangle early practice 
with the eugenics movement of the early 20th Century (Resta 2006). This will be 
reviewed in greater detail in section 1.5.5  
In the 1980s there was a general shift from a ‘public-health’ approach towards 
preventative medicine in regards to provision and practice of GC. Whilst the overall 
goal of genetic counselling still focussed on preventing genetic defects, there was 
increasing support for an information model that facilitated client-informed decision-
making, and had a more person-centered approach (Biesecker 2001).  
In contemporary practice, non-directiveness is a guiding principle, with the 
counsellor promoting autonomy of the individual patient and helping them make 
decisions which are in line with their own personal, social and cultural beliefs and 
practices (Biesecker 2001, Resta 2006, McCarthy Veach et al. 2007). This has been 
proposed, at its most basic level, as the counterpoint to a eugenic approach (Maio 
et al. 2013). 
 
“Letter from Miss (…), Bureau of Child Welfare, 
regarding adoption of (a boy), a ‘near white’ by a 
white mother. Usual question as to whether his 
children could show prominent Negroid 
characteristics.” 
(Fig. 12) 
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1.4.4 Genetic counselling - Models of practice 
 
Traditionally there have been, two major schools of thought in regards to 
approaches to genetic counselling - education, and counselling (Kessler 1997). 
These are captivated by the two prominent models used to conceptualise genetic 
counselling - the ‘teaching’ model, common to healthcare, and the ‘counselling’ 
model, common to psychology (Hartmann et al. 2013). These models are distinctive 
in both their approach and goals (Kessler 1997, Roter et al. 2005, McCarthy and 
McCarthy Veach et al. 2006, see fig. 13, following page). 
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Figure 13: A comparison of the teaching model and counselling model of genetic 
counselling. 
(Figure from McCarthy Veach et al. 2006, p.30-31). 
Historically, the two traditional approaches to GC have been the teaching model, and the 
counselling model. These models are distinctive in their approach and goals. 
(Fig. 13) 
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The teaching model of genetic counselling 
The teaching model centres on the transmission of information between counsellor 
and client. It aims to facilitate understanding of the occurrence, probable course, 
and available management of the condition (Berkenstadt et al. 1999, Davey et al. 
2005), with the overall goal of educating the patient. Consequently genetic 
counselling under the teaching model has been described as health education 
rather than counselling (Kessler 1997). The central tenet underlying this model is 
that patients seek genetic counselling in order to obtain genetic information, and so 
it has an educational purpose (McCarthy Veach et al. 2007).  
In support, to an extent, of the teaching model of practice, studies have found that 
delivery of factual information is the most frequent interaction between client and 
counsellor (Michie et al. 1997, Roter et al. 2005, Austin et al. 2014). Indeed, 
traditionally many research studies evaluating effectiveness of genetic counselling 
sessions have focused on client knowledge gain (Kasparian et al. 1997, Davey et al. 
2005, Roter et al. 2005, Austin et al. 2014). 
 
The counselling model of genetic counselling 
The counselling model of genetic counselling, on the other hand, rests upon the 
assertion that the relationship between the client and the counsellor is 
psychotherapeutic in its nature, with the psychological well-being of the patient 
being the integral aspect of the exchange (Biesecker 2001). The central tenet to this 
model is that there are diverse reasons for which people seek genetic counselling, 
and these will be individual to each patient (McCarthy Veach et al. 2007); and that 
the most effective genetic counselling will involve recognition, and subsequent 
addressing, of these needs. 
Historically, although counselling based-approaches are largely accredited to Joan 
Marks, director of the first Genetic Counseling Program at the Sarah Lawrence 
College in 1969, and the counselling theories of Carol Rogers, a leading 
psychologist who devised ‘client-centered’ counselling (Resta 2006 p.271, NICE 
2014), the psychotherapeutic aspects of genetic counselling had been discussed by 
early practitioners of genetic counselling some decades previous (Resta 2006). 
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Under the counselling model of GC, key goals would be: understand the patient’s 
needs and concerns, help the client to personalise the genetic information and use it 
in a way that is personally meaningful to them (Biesecker 2001), increase their 
perceived sense of control and self-efficacy, reduce or minimise psychological 
distress, provision of support, help the patient with autonomous decision-making 
(McCarthy Veach et al. book, Biesecker 2001, Biesecker and Peters 2001), and, 
ultimately, to enhance the patients’ ability to adapt to the condition, or risk of the 
condition, over time (Resta 2006). Thus, the key underlying philosophy of this model 
is that education is not considered an end in itself, unlike under the teaching model, 
but rather a means to facilitating other, psychological, goals and outcomes for 
patients (Kessler 1997). 
Specifically, the counselling model recognises that communicating about genetic 
information, and especially about risk, can have a major emotional impact for 
patients. For example, obtaining this information can often be a stressful or 
‘threatening’ event  for patients (Davey et al. 2005, p.198) and can induce diverse 
negative psychological feelings and emotions including shame, guilt, anxiety, 
feelings of loss of personal control, bereavement, reduced self-esteem, social 
isolation, and stigmatisation (Biesecker 2001). The counselling model advocates 
that a counsellor should deliver information in such a way that not only minimises 
the potential negative impact of such information, but also reduces psychological 
distress (Biesecker 2001, Resta et al. 2006). This may be achieved, for example, 
through being aware of the client’s emotions – their hopes, fears and 
rationalisations; and building a supportive relationship through which these feelings 
may be discussed and addressed (Bernhardt et al. 2000, McCarthy Veach et al. 
2007). 
Furthermore, the counselling model recognises that scientific explanations are only 
one way to explain risk. In practice, individuals think in varied, complex and abstract 
ways which can be influenced by numerous factors (Sivell et al. 2008). This can 
allowing for personal interpretation and meaning of genetic information, and the 
overriding of what may be considered ‘logical’ by the client’s emotions (Biesecker 
2001). Under the counselling model, the clinician should have an awareness of 
these psychological and psychosocial complexities, and be able to effectively 
counsel around them, to ultimately facilitate better comprehension amongst the 
patient (Biesecker and Peters 2001). 
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In order for genetic counselling training courses to be accredited by the 
Accreditation Council for Genetic Counseling (ACGC) there is the requirement for 
the curricula to incorporate psychotherapeutic skills and competencies in regards to 
genetic counselling (Resta 2006, ACGC 2013 cited Semaka et al. 2014). Thus, 
theoretically, counselling approaches are integral to current day practice. 
In spite of this, there is some evidence indicating that a teaching model is more 
prevalent than a counselling model in regards to practice (Kessler 1997, Biesecker 
and Peters 2001, McCarthy Veach et al. 2007, Roter et al. 2005). Additionally it has 
been proposed that in the current so-called ‘genomic era,’ with increasingly 
sophistic genomic technologies, increasing genetic testing options and surging 
interest of the public in genetics in regards to health, genetic counselling is shifting 
more towards being a form of health education and thus teaching-based 
approaches (Biesecker 2001, Austin et al. 2014). 
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1.4.5 Genetic counselling – Contemporary practice 
 
There has been growing awareness of the need to develop a consensus, 
international model of practice of GC. This is due to a number of factors including, 
and not limited to, growing understanding of the role of genetic contributions in 
common diseases and consequently a bigger scope of genetic counselling; 
increased public interest and awareness in genetics research in relation to health; 
increasing sophistication of genomic technologies; and growing support for the 
importance of evidence-based practice in healthcare interventions (Bisecker 2001). 
Resultantly program directors and special task forces have met over the past 
decade to discuss models of practice to try and achieve more, international, 
agreement in regards to the practice of GC (see for example Biesecker 2001, Roter 
et al. 2005, McCarthy Veach 2007, Hartmann et al. 2013). 
Lack of consensus on a model of practice has been partially put down to 
inconsistencies in regards to measuring outcomes of interventions and lack of 
validated outcome measures, largely due to lack of clarity in regards to the best 
outcomes to measure (McAllister et al. 2011). 
 
 
Model of empowerment and GCOS-24 
 
In an attempt to address the existing gap in consensus of GC practice, McAllister et 
al. (2011) developed and validated the Model of Empowerment. 
Under the model of empowerment, the key goal of GC would be to increase 
empowerment, defined as: 
“A set of beliefs that enable a person from a family affected by a genetic 
condition to feel that they have some control over and hope for the future” 
(McAllister et al. 2011, p. 125). 
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Key outcomes would be that, following the intervention, the patient: 
 Can make informed life decisions (‘decisional control’). 
 Has adequete information and understanding about the genetic condition, e.g. 
familial risk to self and relatives; treatment, management and prevention options 
available; support that is available to them (‘cognitive control’). 
 Can make effective use of the health and social care systems for both self and 
relatives (‘behavioural control’). 
 Can manage one's feelings about having a genetic condition in the family 
(‘emotional regulation’). 
 Has hope for the future incuding in terms of fulfilling family life, for oneself and 
living and future descendants (‘hope’). 
 
(adapted from McAllister et al. 2011, McAllister 2015, pers comms, 15 February 
2015). 
 
Thus, at its most basic level, the model of empowerment embraces both ‘teaching’ 
aspects and ‘counselling’ aspects of traditional genetic counselling approaches.  
The model of empowerment was the key construct for the development of the 
Genetic Counselling Outcomes Scale, a validated 24-question self-reported patient 
reported Outcomes Measure (PROM).  GCOS-24 has been translated or is currently 
undergoing translation into Dutch, Danish, Urdu, Arabic and Japanese, and is being 
used to evaluate service evaluations for routine clinical practice and patient benefits 
from new interventions in research, including novel PGC interventions (Inglis et al. 
2014). It is the outcomes measurement supported by the National Society of 
Genetic Counselors (NSGC 2016). 
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1.5 Genetic counselling for psychiatric disorders - A review of the 
literature 
 
A review of the literature regarding PGC was undertaken in order to formulate a 
research question and guide study design. This review process is described in more 
detail in chapter 2, materials and method: Literature review. 
 
Genetic counselling for psychiatric conditions – An introduction 
PGC is a novel but currently minor sub-specialism of genetic counselling that is as 
yet largely untested, predominantly because PGC is not routinely provided for 
psychiatric conditions. 
Despite this, there has in fact been long-standing interest in the application of GC 
for affected individuals with psychiatric disorders, with supporting literature spanning 
over 5 decades (Heston 1966, Kessler 1980, Schulz et al. 1982, Moldin and 
Gottesman 1997, Rutter et al. 1997, Hodgkinson et al. 2001, Collier et al. 2009, 
Inglis et al. 2014). 
These groups have generally advocated GC may be valuable clinical tool in 
delivering genetic information about psychiatric conditions to patients and providing 
supportive counselling around related concepts. Genomic advances in psychiatry, 
which have provided insights into the aetiology of psychiatric disorders, has seen 
renewed interest in the potential application of GC in psychiatry over the past 
decade (Hodgkinson et al. 2001, (Austin and Honer 2007, Austin and Honer 2008, 
Meiser et al. 2013, Austin et al. 2014). 
Additionally, whilst focus has typically centered on providing GC for SCZ and BPD, 
as more is understood about the genetic architectures and aetiology of other mental 
illnesses there is growing consensus that GC may have a wider application and be 
provided for other, more common, mental disorders including OCD and MDD 
(Meiser et al. 2013, Austin et al. 2014). 
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1.5.1 Goals of PGC 
There has been general consensus in currently available literature in regards to 
goals of PGC interventions. Identified potential outcomes include increasing 
aetiological understanding, identifying protective factors and influencing health-
related behaviours, increasing understanding of familial recurrence risks, providing 
information, support, and facilitating decision-making around genetic testing, 
reducing stigma, and psychotherapeutic aspects including reducing shame, guilt 
and blame.  
However these discussions remain largely hypothetical, as there is to date little 
available outcomes data assessing actual practice of PGC interventions, meaning it 
remains a largely untested sub-specialism of GC. Clinical research groups are 
putting greater emphasis on assessing interventions to enable development of an 
evidence-base (Costain et al. 2014a, Costain et al. 2014b, Austin 2015, pers 
comms, 15 February 2015). 
 
 
Goals of PGC: Increasing aetiological understanding  
A consistently identified major goal of PGC is to increase understanding about the 
causes (genetic and environmental) of mental illness amongst affected individuals 
and their relatives (Austin and Honer 2005, Finn and Smoller 2006, Hill and Sahaar 
2006, Austin and Honer 2007, Lyus 2007, Austin and Honer 2008, Costain et al. 
2014a, Costain et al. 2014b, Inglis et al. 2014). 
Specifically, PGC should increase understanding of multifactorial models of 
inheritance and comprehension of gene X environment interactions. These 
concepts are often explained using pictorial aids (Austin and Honer 2007, Austin 
and Honer 2008, see figures 14 and 15) to enhance understanding. Incorporating 
the individual’s family history of mental illness may also facilitate understanding of 
complex concepts, .e.g.  explaining why some affected individuals develop 
psychiatric disorders and others do not, or why some affected individuals develop 
one psychiatric condition and their relatives develop a different condition (i.e. 
genetic overlap between psychiatric diagnostic boundaries) (Austin and Honer 
2007, see figure 14); and may also help affected individuals contextualise the 
information, e.g. understanding why periods of stress may have influenced their 
illness onset or worsened their symptoms (Peay et al. 2008).  
65 
 
 
Figures 14a and 14b: Quantitative trait models used in PGC sessions 
(Morris 2015, pers comm., 13 January. Figures © J. Austin, 2015). 
Yellow balls represent genetic factors and orange triangles represent environmental factors.  
These diagrams can help explain concepts such as i) relative contributions of factors 
involved in pathogenesis (figure 14a) and ii) why some affected individuals may never 
develop mental illness (figure 14b).  
 
 
 
 
 
 
(Fig. 14a) 
(Fig. 14b) 
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Studies that have researched attribution perceptions for mental illness amongst the 
general public have reported that, although consistent with medical models of 
practice, affected individuals and relatives commonly attribute a multifactorial 
models of causation for mental illness (Gamm et al. 2004, Meiser et al. 2005, 
Meiser et al. 2007, Peay et al. 2008, Baines and Wittkowski 2013) there have been 
indications that comprehensive understanding of pathophysiology is lacking and 
uncertainty still exists regarding causal explanations (Hodgkinson et al. 2001, 
Holzinger et al. 2003, Austin and Honer 2005, Costain and Bassett 2012, Costain et 
al. 2014a). 
In support of these findings, studies exploring public understanding of genetics more 
widely have shown that knowledge of genetic concepts related to health and 
disease is limited and that common misconceptions exist (Lanie et al. 2004, Molster 
et al. 2009, Potokar et al. 2012). For example, the terms ‘genetic’ and ‘hereditary’ 
are commonly thought of as synonymous, indicating potentially lack of full 
understanding of the implications of genetic contributions to disease (Costain et al. 
2014b). 
Thus, it has been proposed that there is a potential need regarding the provision of 
aetiological and genetic information amongst this population (Austin and Honer 
2005, Finn and Smoller 2006, Hill and Sahaar 2006, Austin and Honer 2007, Lyus 
2007, Austin and Honer 2008, Costain et al. 2014a, Costain et al. 2014b, Inglis et al. 
2014).  
Providing further supporting for the case of providing aetiological information for 
affected individuals and their families, and therefore it has been proposed, for the 
provision of PGC, groups exploring potential impact of PGC (e.g. Hodgkinson et al. 
2001, Austin and Honer 2005, Finn and Smoller 2006, Lyus 2007, Austin and Honer 
2007, Peay et al. 2008, Austin and Honer 2008, Inglis et al. 2014) have advocated 
that research from health psychology has indicated increased aetiological 
understanding can be a critical factor in facilitating psychological adaptation to the 
disease (e.g. Skirton and Eiser 2003, Walter et al. 2004, Husson et al. 2011, 
Johannson et al. 2014).  
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Furthermore it has been asserted that this may be particularly useful in psychiatry 
due to the incomplete understanding regarding aetiology of psychiatric disorders; 
uncertainty regarding familial risk; and psychotherapeutic aspects of mental illness 
associated to causation including shame, guilt, and stigma (Hodgkinson et al. 2001, 
Austin and Honer 2005, Finn and Smoller 2006, Lyus 2007, Austin and Honer 2007, 
Peay et al. 2008, Austin and Honer 2008, Inglis et al. 2014). 
 
PGC thus potentially provides the opportunity to explore the patient’s existing 
perceptions of cause, address misconceptions, explore emotional implications of 
misconceptions, and redevelop more positive attitudes towards the mental illness on 
a basis of an improved aetiological understanding (Austin and Honer 2007, Peay et 
al. 2008, Inglis et al. 2014), which may have important outcomes such as 
decreasing perceived burden of the illness, increasing coping ability and health-
related quality of life, reducing family-based conflict; to ultimately facilitate better 
adaptation to the mental illness (Austin and Honer 2007). 
The hypothesis that PGC is helpful in facilitating better understanding of aetiology is 
now some supported with some data from GC outcomes studies. For example, in a 
pilot study, 92% of participants (n=12) reported they had learned new information 
about the causes of mental illness, and 78% (n=7) of participants reported that GC 
had decreased confusion regarding causes of mental illness (Austin and Honer 
2008). Costain and colleagues (2012, 2014) reported significant and lasting 
improvements in knowledge and perceived knowledge of aetiology for patients with 
schizophrenia (Costain et al. 2014a) and relatives of affected individuals with 
schizophrenia (Costain et al. 2014b) following PGC. Further, Costain et al. (2014a) 
reported PGC reduced self-blame alongside increasing perceived and objective 
aetiological knowledge amongst affected individuals with SCZ as well as general 
reduction in anxiety. No other relevant outcome data is currently available, however. 
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Goals of PGC: Identifying protective factors and influencing health-related 
behaviours 
 
Studies have identified that PGC may facilitate better management of (/risk of) 
mental illness by identifying protective factors and influencing health-related 
behaviours of affected individuals and their relatives. 
Practically, it has been identified that PGC provides a useful forum to presenting 
and discussing what is currently knows with affected individuals and relatives known 
from research about risk contributors to psychiatric illness such as smoking 
cannabis or methamphetamine use (Austin and Honer 2005, Austin and Peay 2006, 
Austin et al. 2007, Austin and Honer 2008, Inglis et al. 2014). 
It has also been postulated that PGC provides an environment for patients to 
identify effective research-informed ‘protective factors’, such as coping strategies for 
dealing with stress (e.g. adequate sleep, regular exercise)((Austin and Honer 2005, 
Austin et al. 2008), again often explained using pictorial aids (see figures 15a and 
15b). This may enable patients to be better informed in making decisions that may 
help prevent relapse or development of psychiatric illness (Austin and Honer 2005, 
Austin et al. 2008). 
In GC these discussions often incorporate the patients’ personal experiences of 
mental illness or stress (Austin and Honer 2005, Inglis et al. 2014) for example, life 
events that occurred around the time of onset of illness; environmental factors that 
may be personal ‘triggers’ to onset or relapse, such as smoking marijuana; or life 
events occurring around periods of excess stress or anxiety. It has been asserted 
that this may help affected individuals identify, on an individual level, strategies that 
may be particularly effective in facilitating better protection and management of their 
own mental health (Austin and Honer 2005, Inglis et al. 2014). This may also 
provide a useful opportunity for counselling regarding emotional implications of 
these specific events which may in turn alleviate guilt, shame, blame and stigma 
(Austin and Honer 2005. see previous section). 
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Figures 15a and 15b:  Pictorial aids representing mental illness 
pathogenesis/recovery 
(Figures from Morris et al. 2015, pers comm, 13 January. Figures ©J. Austin 2015). 
Visual aids can help explain i) how putative environmental factors (orange triangles) can be 
avoided and so blocked from the jar, to reduce risk of illness (e.g. avoiding drugs) and ii) 
how putative protective factors (blue rings) can protect against risk by making it harder for 
the jar to fill and the threshold for onset of symptoms to be met (e.g. therapy, medication 
adherence, exercise). This may also help reduce feelings of genetic fatalism.  
Fig. 15a 
Fig. 15b 
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Furthermore, studies have proposed that the information provided through PGC 
may have a psychological impact on management of mental illness (Papdimitriou 
and Dikeos 2003, Austin 2005, Austin and Honer 2007, Meiser et al. 2007, Peay et 
al. 2009, Hippman et al. 2013).  In support of this, it is well established from health 
psychology that aetiological understanding can influence health-related behaviours 
(Taylor 1983, Williams and Healy 2001, Brown et al. 2001, Walter et al. 2004, 
Husson et al. 2011, Oflaz et al. 2015); for example discussions about aetiology and 
the relative contributions of both genetic and behavioural risk emphasise that 
behaviour changes can reduce overall risk and may therefore increase perceptions 
of value and/or cost of certain health-related behaviours, and thus likelihood of their 
uptake or avoidance (Zubin et al. 1983, Austin 2005, Austin and Honer 2007, Sivell 
et al. 2008, see figures 15a and 15b). This may influence decisions regarding 
health-related behaviours, risk avoidance, and accessing medical services, to 
facilitate better self-management (Sivell et al. 2008, Austin and Honer 2007). 
Similarly, research has shown increased aetiological understanding can also 
empower an affected individuals’ sense of management of their illness by increasing 
their perceived personal control (Thompson et al. 1993, Davey et al. 2005) which 
may help further promote help-enhancing behaviours in mental illness (Zubin 1983, 
Landsverk and Kane 1998, Merinder 2000, Gamm et al. 2004, Austin and Honer 
2007, Meiser et al. 2007, Hippman et al. 2013). Increasing sense of empowerment 
is recognised as particularly important for complex diseases, such as mental illness, 
as genetic attributions to disease may result in fatalistic attitudes and feelings of 
hopelessness regarding the illness (Nuffield Council on Bioethics 2002, Alper and 
Beckwith 1993, Rose 1995, Chakravarti and Little 2003, see figure 15b) which may 
deter from uptake of health-related behaviours (Nuffield Council on Bioethics 2002, 
Chakravarti and Little 2003, Walter et al. 2004). As fatalistic viewpoints have been 
reported amongst members of families affected by psychiatric illness (Biesecker and 
Peay 2003, Peay et al. 2009), it has been discussed that PGC may be especially 
helpful in this regard (Austin and Honer 2005, Finn and Smoller 2006, Austin and 
Honer 2007, Peay et al. 2008), through helping affected individuals accept that 
“genes are not necessarily destiny,” (Papdimitriou and Dikeos 2003 p. 240) and that 
environmental factors can have a substantive protective effect. 
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That PGC may be helpful in facilitating better management and protection of mental 
health is now supported by some outcomes data. In a pilot study, parents of 
affected individuals reported that PGC gave them hope, including in regards to their 
child’s recovery and managing their mental illness (Austin and Honer 2008). 
Additionally, a study evaluating impact of PGC found significant increases in 
Empowerment, as measured by the GCOS scale, and also Self-Efficacy as 
measured by the Illness Management Self-Efficacy Scale, which measures an 
individuals’ confidence to self-manage the illness (Inglis et al. 2014). There is, 
however, no currently available outcomes data in regards to the impact of PGC on 
health-related behaviours specifically, although this is currently being explored by 
groups (Austin and Inglis 2015, pers comms, 12th February). 
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 Goals of PGC: increasing understanding of familial recurrence risk 
 
Providing information about familial recurrence risks has been identified as another 
important goal of PGC (Tsuang et al. 1994, Hodgkinson et al. 2001, Austin and 
Honer 2005, DeLisi and Bertisch 2005, Austin and Peay 2006, Austin et al. 2006, 
Finn and Smoller 2006, Hill and Sahaar 2006, Austin and Honer 2007, Austin et al. 
2008, Austin and Honer 2008, Peay et al. 2009, Hunter et al. 2010, Costain and 
Bassett 2012, Gershon and Alliey-Rodriguez 2013, Costain et al. 2014a, Costain et 
al. 2014b). 
Using family history, genetic counsellors provide a tailored risk estimate for 
psychiatric illness (Tsuang 1994, Hogkinson et al. 2001, Papdimitriou and Dikeos 
2003, Austin and Peay 2006, Austin et al. 2008). Given the lack of clinically 
available genetic testing, this remains the most accurate method of assessing risk 
for psychiatric illness (Merikangas and Risch 2003, Finn and Smoller 2006, Hunter 
et al. 2010, Meiser et al. 2013). 
Theoretically, obtaining a more accurate perception of risk can be helpful for a 
number of reasons. Firstly, risk assessments may assist in decision-making around 
family-planning (Finn and Smoller 2006, Austin et al. 2008, Hunter et al. 2010, 
Costain and Bassett 2012), as well as decisions around other important lifestyle 
choices and behaviours which may in turn reduce risk for illness development, 
facilitate better management of the condition, and promote mental well-being 
amongst both affected and unaffected individuals (Austin and Honer 2005, Austin et 
al. 2008, Meiser et al. 2013). 
Additionally, it has been proposed that more accurate perception of familial risk may 
be useful in further enhancing perceived personal control of risk and thus enhancing 
empowerment (Austin et al. 2008, Peay et al. 2009), as well as also helping to 
further reduce feelings of guilt, shame and blame within families e.g. through 
providing reassurance that parenting or personal life choices did not play a major 
role in causing the illness (Costain and Bassett 2012). 
Studies that have explored perceptions of risk amongst affected individuals and 
their relatives have generally reported that there are misconceptions about genetic 
risk, although there has been some inconsistencies in findings. Some, earlier, study 
groups reported that affected individuals with SZ or BPD underestimated risk for 
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family recurrence (Targum et al. 1981, Schulz et al. 1982); conversely, other groups 
have reported that affected individuals overestimate risk (Trippitelli et al. 1998, 
Quaid et al. 2001, Costain et al. 2014a); and that overestimation of genetic risk may 
be associated with reproductive decisions favouring fewer or no children (Austin et 
al. 2006, Meiser et al. 2007, Wilde et al. 2010, Meiser et al. 2013). Relatives of 
affected individuals have been reported to overestimate risk (Targum et al. 1981, 
Schulz et al. 1982, Austin et al. 2006, Costain et al. 2014b). 
Additionally in a study amongst parents of affected individuals, Austin and Honer 
(2008) reported familial risk was a source of anxiety and worry for respondents, with 
84% of participants (n=11) identifying that they were concerned about other 
relatives becoming ill. However there is, to best knowledge, no other evidence that 
has researched implications (i.e. rather than risk perceptions) of familial risk 
amongst affected individuals and their relatives. 
Thus, the findings from studies indicate that misconceptions about familial risk exist 
amongst affected individuals and their families, and that it may be a source of 
concern for individuals affected with psychiatric conditions and their relatives. It has 
therefore been hypothesised that PGC may be helpful in addressing this, as well as 
having other important outcomes (Austin 2005, Austin et al. 2006) 
This supposition is now supported by some data from outcomes studies, 
demonstrating that PGC facilitates more accurate perception of risk amongst 
affected individuals and their relatives (Costain et al. 2014a, Costain et al. 2014b); 
and that it reduces concern about other relatives becoming ill, most likely due to 
increased understanding of risk (Austin and Honer 2008). There is a need for further 
research in this regard.  
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Goals of PGC: Providing information, support, and facilitating decision-
making around genetic testing. 
It has been explored that PGC may also be useful in providing information, support, 
and decision-making around genetic testing. 
PGC provides a clinical framework for patients to discuss the potential impact of 
genetic information prior to testing, and for support in interpreting results. Which 
may help patients make informed decisions regarding testing, facilitate 
comprehension of results, and provide supportive counselling around the new 
information, and uncertainty that may stem from the test results (Austin et al. 2006, 
Wray and Visscher 2010, Ram et al. 2012). PGC may also ease increased 
demands on practitioners, who may not have the time, experience and/or 
knowledge to interpret test results (Wilde et al. 2010, Salmm et al. 2014). 
Although clinical testing is not currently available, some groups have proposed it 
may become a possibility for future genetic risk prediction (Hodgkinson et al. 2001, 
Wray and Visscher 2010).Specifically, there is a particular research focus on copy 
number variants, which have a higher penetrance than common variants (Collier, St 
Clair, Vassos, Kirov, Gershon and Alliey-Rodriguez 2013), although the clinical 
efficacy remains to be determined (Collins 2010 Wray and Vischer 2010) 
 Indeed, there has been concern raised about the potentially harmful effects of 
genetic testing including living with uncertainty if genetic testing could only indicate 
probability and not certainty of developing illness, which may raise levels of anxiety 
(Meiser et al. 2005, Hippman et al. 2013), trigger negative behavioural changes by 
family members towards affected individuals, and especially children,  who may be 
labelled ‘at-risk’ (Meiser et al. 2005, Finn and Smoller 2006), and potentially 
influence important life decisions including marriage and reproductive choices 
(Meiser et al. 2005). 
Testing in relation to psychiatric diagnoses opens many ethical concerns, but the 
question of whether or not testing will, and should, become clinically routine is 
somewhat overshadowed by the rise of direct-to-consumer testing (Collins 2010, 
Wray and Vischer 2010). Given that  high hypothetical demand for genetic testing 
for psychiatric  conditions has been reported (Smith et al. 1996, Jones et al. 2002, 
Meiser et al. 2005), it has been proposed that this puts an emphasised need to 
provide GC for this population (Austin et al. 2006, Austin and Honer 2007, Wilde et 
al. 2010).  
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Goals of PGC: Addressing stigma 
 
Studies have proposed that PGC may also be helpful in addressing mental illness-
related stigma. 
 It is well established that uncertainty and myths regarding the origin of mental 
illness can contribute to stigma (Austin and Honer 2005, Meiser et al. 2013 Costain 
et al. 2014b). On this basis it has therefore been proposed that improving 
understanding about what is understood about the causes of mental illness may 
therefore help dispel misconceptions and reduce uncertainty and fear, to alleviate 
stigmatising attitudes, and therefore that GC may be helpful in this regard 
(Papdimitriou and Dikeos 2003, Austin and Honer 2005, Hill and Sahaar 2005, 
Austin and Honer 2007, Lyus 2007, Peay et al. 2008, Meiser et al. 2013, Costain et 
al. 2014b). 
For example, attributing mental illness to sources such as stress or life experiences 
may help ‘de-mistify’ the illness which may result in less social avoidance and 
discrimination (Mechanic et al. 1994, Martin and Pescosolido 2000, Corrigan et al. 
2003).  
Genetic attributions to mental illness may also reduce stigma (Meiser et al. 2005, 
Austin and Honer 2005, Hill and Sahaar 2006, Austin and Honer 2007, Costain and 
Bassett 2012, Gershon and Alliey-Rodriguez 2013), as it may move ‘the locus of 
control and responsibility away from the individual towards the role of hereditary’ 
(Meiser et al. 2005). 
Furthermore it has been explored by some groups that, on a population-level, PGC 
may help address possible negative relationships between neurobiological 
explanations for mental illness by providing public education which may enhance 
understanding and dispel misconceptions (Costain et al. 2014b). In this sense, 
groups have proposed that GC may empower affected individuals and families to 
share knowledge with relatives, friends and peers, which may reduce both 
perceived and experienced stigma (Austin and Honer 2005, Austin and Honer 2007, 
Austin and Honer 2008). 
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Consistent with hypotheses, there is now some available outcomes data linking 
PGC with decreases in stigma for affected individuals (Costain et al. 2014a) and 
family members of adults with SCZ (Costain et al. 2014b). Additionally, reported 
increases in self-efficacy and empowerment following PGC (Austin and Honer 2007, 
Inglis et al. 2014), which are frequently thought of as being the opposite of 
internalised stigma, have also been reported, this, it has been proposed, providing 
further support that GC may reduce stigma (Inglis et al. 2014).  
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1.5.2 The PGC session 
 
Although a nascent discipline, a relatively clear picture regarding the basic concepts 
of PGC has been established with groups showing overall agreement in their 
approach (see for example: Tsuang et al. 1994, Papadimitriou and Dikeos 2003, 
Austin and Honer 2005, Austin and Honer 2008). 
Numerous studies have surmised that GC for psychiatric conditions is very similar to 
that for other complex disorders (Biesecker and Peay 2003, Austin and Honer 2008) 
in that it is a dynamic process that involves both information gathering and 
provision, and provision of support and counselling (Austin and Honer 2007, Austin 
and Honer 2008). As in GC for physical disorders, typical stages of the process 
involve: information gathering, information provision and support, supportive 
decision-making. 
However it has also been acknowledged that PGC sits within a more challenging 
context: aetiological understanding is limited, recurrence risk provision is difficult, 
and there are considerable psychosocial implications of mental illness for relatives 
and families (Austin and Honer 2005, Finn and Smoller 2006, Austin and Honer 
2007). 
It has been thus postulated that resultantly clinicians may feel uncomfortable and/or 
inexperienced to discuss psychiatric illness with patients, which may be, partially, 
why GC for psychiatric conditions is not practised (Peay et al. 2008). Out of 
awareness of this there is an albeit small but growing number of online resources 
now available to guide clinicians not necessarily trained in psychiatry in regards to 
the provision of PGC (for example: Genetic Alliance 2008, NSGC 2015 ; NCHPEG 
2015). Additionally Peay et al. (2008) have proposed a guiding framework for GC 
and clinicians (see table 4), partially out of growing recognition that they may feel 
uncomfortable or inexperienced to engage in such discussions. 
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Table 4: Suggested framework for guiding discussions regarding patient’s psychiatry 
history in a clinical setting 
(From Peay et al. 2008, p.11) 
 
 
 
 
Information Gathering 
 
The information gathering process of PGC typically involves identifying the patient’s 
needs and concerns and obtaining family history and individual’s psychiatric history 
(Tsuang et al. 1994, Hodgkinson et al. 2001, Papadimitriou and Dikeos 2003, Austin 
and Honer 2007).  
During the information gathering process it is important to establish the patient’s 
reasons for receiving the genetic information, both in terms of the information they 
wish to obtain and reasons behind it (Tusang et al. 1994, Papadimitriou and Dikeos 
2003, Austin and Honer 2007), to identify needs and expectations (Hodgkinson et 
al. 2001, Finn and Smoller 2006). Groups have also discussed the importance of 
identifying the patient’s existing disease construct and potential misconceptions and 
uncertainty around this (Hodgkinson et al. 2001, Papdimitriou and Dikeos 2003, 
Austin and Honer 2005, Austin and Honer 2007). 
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Family history for psychiatric illness should be taken along with other important 
health information (e.g. substance abuse, age of onset of symptoms, history of 
psychiatric hospitalisations) (Hodgkinson et al. 2001, Finn and Smoller 2006). 
Family history for other physical conditions should also be taken which may identify 
presence of another underlying genetic condition causing psychiatric symptoms, 
such as 22q syndrome, which will influence recurrence risk (Finn and Smoller 2006, 
Austin and Honer 2007). 
Assessment of the patient’s emotional, psychological and intellectual capacity is 
important to ensure the patient is able and well enough to receive the information 
(Tsuang 1994, Papadimitriou and Dikeos 2003, Austin and Honer 2007). 
 
 
Information provision and support 
 
Information about aetiology should include discussions about both genetic and 
environmental factors in psychiatric pathogenesis (Papdimitriou and Dikeos 2003, 
Austin and Honer 2007). 
Throughout this process it has been highlighted that it is important to address 
misconceptions expressed regarding aetiology (Papdimitriou and Dikeos 2003, 
Austin and Honer 2007). Emotional aspects of both misattributions and of newly 
learned genetic information, e.g. fatalistic attides/genetic determinism, should also 
be discussed and explored (Papdimitriou and Dikeos 2003), as should concepts of 
uncertainty stemming from the limitations of current aetiological understanding 
which can have emotional implications for patients (e.g. anxiey, feelings of 
disempowerment) (Austin and Honer 2007, Peay et al. 2008).  
It has been discussed in the literature that provision of recurrence risks is 
recognised a particularly challenging element of PGC (Hodgkinson et al. 2001, Finn 
and Smoller 2006, Austin and Peay 2006, Austin and Honer 2007). Firstly, concepts 
relating to familial risks are often a source of considerable anxiety and stress for 
many patients (Hodgkinson et al. 2001, Austin and Honer 2005, Finn and Smoller 
2006) and it is thus important to clarify what the patient wishes to know (Austin and 
Honer 2007).  
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Additionally perception of risk is a complex and subjective process and so risk 
information should be conveyed in several formats (Hodgkinson et al. 2001, Hill and 
Sahaar 2006, Austin and Honer 2007, see table 5), as for other genetic counselling 
settings, and the genetic counsellor should also be unbiased in their delivery of risk 
information to prevent influencing the patient’s perceptions (Hodgkinson et al. 2001, 
Hill and Sahaar 2006). 
 It is also paramount that the limitations of risk assessment for psychiatric illnesses 
based on empirical data are discussed, and resultant emotions explored and 
counselled around (Papdimitriou and Dikeos 2003, Hill and Sahaar 2006, Austin 
and Honer 2007, Austin et al. 2008).  
 
Table 5: Suggested formats for presenting risk information in PGC 
(From Austin et al. 2008, p.20) 
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Support and decision-making 
 
Relevant decisions patients may have to make may include treatment or medication 
options during pregnancy (Austin and Honer 2005), family planning (Hodgkinson et 
al. 2001, Papdimitriou and Dikeos 2003), or whether to undergo genetic testing 
(Hodgkinson et al. 2012). 
It is important than the genetic counsellor helps affected individuals make informed 
decisions that are in line with their cultural, ethnic and religious backgrounds, and 
their individual or family goals (Tsuang 1994, Papdimitriou and Dikeos 2003, Austin 
and Honer 2005); and provides support and helps the patient adjust to their decision 
(Hodgkinson et al. 2001, Austin and Honer 2005, Austin and Honer 2007). 
It is fundamental that the genetic counsellor is non-directive and promotes the 
autonomy of the patient in regards to facilitating decision-making (Tsuang 1994, 
Hodgkinson et al. 2001, Papdimitriou and Dikeos 2003, Austin and Honer 2005, 
Finn and Smoller 2006, Austin and Honer 2007). It has been asserted that this may 
be especially important in regards to providing GC for psychiatric conditions, to 
prevent potentially advocating (even unintentionally) stigma and discrimination 
against individuals with a mental illness (Austin and Honer 2007). 
 
Follow-up 
 
Follow-up typically involves sending a summarising document of the session to the 
patient. It is an important component of all genetic counselling interventions, 
including PGC (Tsuang et al.  1994, Hodgkinson et al. 2001, Finn and Smoller 
2006). It provides the opportunity to reinforce the information covered (Tsuang et al.  
1994, Hodgkinson et al. 2001, Hill and Sahaar 2006), facilitates sharing of 
information with the patient’s family and/or clinician, and encourages the patient to 
contact the genetic counsellor if any new questions or new diagnostic information 
arises, which may require revision of recurrence risks (Tsuang et al. 1994, 
Hodgkinson et al. 2001). 
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1.5.3 PGC – Indications of a need for its implementation 
 
Available evidence indicates that currently many healthcare practitioners do not feel 
prepared to deliver psychiatric genetic information. 
For example, surveys of psychiatrists have reported limitations in knowledge 
regarding both medical and psychiatric genetics (Finn et al. 2005, Hoop et al. 2008, 
Klitzmann et al. 2014), and also uncertainty regarding testing options and 
interpretation (Klitzmann et al. 2014). Despite this, affected individuals with 
psychiatric illness are rarely referred to specialist genetics services such as GC 
(Hodgkinson et al. 2001, Austin and Honer 2007, Hunter et al. 2009, Costain et al. 
2014a, Austin 2014, pers. comm., 14 November). 
Additionally, a recent study also reported that the majority of neurologists and 
psychiatrists that ordered genetic tests did not have access to a genetic counselling 
service (Salmm et al. 2014). 
Furthermore, studies amongst genetic counsellors have found that they would not 
feel prepared (Peay and McInnerney 2002) or comfortable (Feret et al. 2011, Martin 
et al. 2012) to provide GC for psychiatric disorders, largely due to a lack of 
familiarity with the illnesses (Peay and McInnerney 2002) and stigma related to 
psychiatric illness (Feret et al. 2011, Martin et al. 2012). 
On the basis of such evidence it has been proposed that a gap seemingly exists in 
the provision of genetic and aetiological information to affected individuals and their 
families, and some research groups have asserted that this may mean that, 
currently, medical informational needs of patient may not be being met (Finn and 
Smoller 2006, Meiser et al. 2013). 
Further research into concepts relating to i) informational needs of prospective 
patients and ii) knowledge and perceptions of healthcare providers may thus be 
helpful in aiding further exploration. 
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1.5.4 Demand for PGC 
 
Interest and uptake. 
Evidence exploring interest in receiving genetic counselling for psychiatric 
conditions amongst the American and Canadian populations have generally 
demonstrated that PGC is favourably viewed by potential future service-users. 
These studies have typically explored interest by presenting respondents with the 
hypothetical situation of receiving PGC, and the majority of respondents (~62-75%) 
consequently indicating that they would wish to receive the service if it were 
available and/or that they believed it would be helpful (Schulz 1982, Quaid et al.  
2001, DeLisi and Bertisch 2006, Lyus 2007). 
Furthermore, some studies have demonstrated relatively high uptake of the service 
when offered, providing further evidence that PGC is positively regarded (Austin and 
Honer 2008, Costain et al. 2014a, Costain et al. 2014b). 
There is no published data regarding interest amongst the UK population 
specifically in regards to PGC and so no indications of a demand for, nor even 
interest in receiving, the service. Such data is important because evidencing 
demand is particularly important in justifying new healthcare interventions, 
especially in the age of austerity in which mental health services are facing such 
spending cuts (Costain et al. 2014a, Costain et al. 2014b). 
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Awareness and perceptions of GC and PGC 
 
Other concepts relating to interest in PGC are awareness of the service and 
perceptions of its purpose. 
There are speculations and some available evidence that awareness is low and that 
there are misconceptions about GC and especially its role within psychiatry, 
amongst both prospective service-users and clinicians (Lyus 2007, Hunter et al. 
2010). Further, this has recently been proposed as a fundamental reason for low 
rate of referrals to a British Columbia Provincial Medical Genetics Program 
(BCPMG), which provides the world’s first specialised PGC clinic (Hunter et al. 
2010). 
In support of this, a study conducted in 2007 that explored perceptions of PGC 
amongst the American population, reported low awareness of the service, with only 
28% (n=19) of affected individuals with SCZ and 48% (n=71) of relatives having 
previously come across GC (Lyus 2007). Additionally, the study found that 
misconceptions amongst respondents regarding GC and PGC, were common, 
including false beliefs that a GC could provide genetic testing for SCZ, and a 
number of respondents reporting they did not believe a GC would provide emotional 
support.  
More widely, that there is low awareness and misconceptions regarding GC has 
been reported by other study groups assessing perceptions in other fields of GC. 
For example, retrospective studies that have surveyed affected individuals who 
have received GC have found that they attended the session typically unaware of 
the content and structure (Hallowell et al. 1997, Bernhardt et al. 2000, Metcalfe et 
al. 2007) and specifically that the counselling aspect of the session came as a 
pleasant surprise (Bernhardt et al. 2000).  
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Additionally, a study prospectively studying awareness and perceptions of GC 
amongst the Canadian general population found that 69% of affected individuals 
had not heard of GC, and that a substantial proportion had misconceptions about its 
purpose, particularly relating to perceptions that GC involves prevention of 
inheritable diseases, helping couples to have desirable characteristics, and advising 
couples whether to have children, indicating perceptions that GC is based on 
Eugenic-type values (Maio et al. 2013).  
Concepts regarding awareness and perceptions of genetic counselling are 
important because research has demonstrated they can impact engagement and 
also patient outcomes (Brown et al. 1999, Pieterse et al. 2005, Joseph et al. 2010, 
Albada et al. 2012a, Albada et al. 2012b, Maio et al. 2013). 
For example, GC can result in better outcomes when clients have a better 
understanding of what to expect (Brown et al. 1999, Pieterse et al. 2005, Joseph et 
al. 2010, Albada et al. 2012a, Albada et al. 2012b, Maio et al. 2013). This may 
reduce anxiety (Austoker and Ong 1994. Hallowell et al. 1997, Davey et al. 2005, 
Metcalfe et al. 2007) which may enable the client to be a more active participant in 
the session; build rapport with the genetic counsellor; have a more active role in 
decision-making (Metcalfe et al. 2007); and enable the genetic counsellor to ensure 
the client’s needs are met (Pieterse et al. 2005, Babul-Hirji et al. 2010, Albada et al. 
2012b, Maio et al. 2013), leading to overall better outcomes and adaptation to the 
illness (Hack et al. 2005, Metcalfe et al. 2007). Better awareness of the GC process 
may also help affected individuals better prepare in advance, for example 
formulating questions individual to their own circumstances (Hallowell et al. 1997, 
Brown et al. 1999, Metcalfe et al. 2007), enabling them to use the session more 
effectively. 
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1.5.5 PGC: Criticisms and controversies 
Opposition to biogenetic models in psychiatry – stigma, and eugenics 
 
In the modern day, the majority of academics and clinicians within the mental health 
field embrace a holistic approach which acknowledges both genetic and 
environmental models of illness and treatment, and the previous dichotomy of the 
‘nature or nurture’ conflict in psychiatry (for example, see Kessler 1980, Chakravarti 
and Little 2003) is, generally, regarded accepted as over-simplistic (Rutter 2006, 
Jaffee and Price 2007, Peay et al. 2008). Considering both genetic and non-genetic 
contributions in the underpinnings of human behaviour is widely accepted as the 
most accurate and clinically helpful explanation for mental illness (Phelan 2002, 
Phelan 2005, Austin 2015 pers comm.,13th April , Mayers 2015 pers comm., 14th 
April) and, for GC, the best approach to take to ensure best outcomes for patients 
(Austin and Honer 2007, Meiser et al. 2007, Peay et al. 2008, Mesier et al. 2013).  
However, some research groups have expressed strong concern, or outright 
objections, over adoption of genetic and/or medical approaches to mental illness 
(Conrad 1992, Beresford and Wilson 2002, Membis 2009, Beresford 2015 pers 
comm., 24th April). These objections stem predominantly from concern that such 
approaches may exacerbate stigma, prejudice and discrimination (Haslam 2000, 
Beresford and Wilson 2002, Membis 2009, Howell et al. 2011), and may induce 
adoption of divisive mentalities (Bennett et al. 2008), i.e. an ‘us and them’ way of 
thinking. Furthermore, there have been concerns raised that such approaches could 
form a fundamental basis for discrimination and even re-emergence of eugenics-
based policies against individuals with mental illness (Nuffield Council on Bioethics 
2002). 
Indeed, there is a deep and ugly historical link between psychiatry and the eugenics 
movement of the early 20th Century (Nuffield Council on Bioethics 2002). Influenced 
by the breeding programs of domesticated plants and animals, in which humans 
altered characteristics of species by replacing natural reproduction with artificial 
selection so they adapted specific characteristics in order to subsequently meet 
human needs (Brüne 2007), some researchers, clinicians and politicians came to 
believe that ‘self-domestication’ of humans could be achieved (Brüne 2007, p.1), 
whereby the qualities of the human race could be improved by selective breeding 
(Nuffield council on bioethics 2002). Resultantly, in the false belief that they might 
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therefore be able to reduce the presence of ‘bad genes’ within the human 
population and prevent so-called degeneration of ‘erbgut,’ or genetic material 
(Brüne 2007, p.1), they came to not only toy with the idea, but actually conduct 
genetic experimentations and approaches in humans. The results had profound and 
devastating consequences. 
The eugenics movement became more wide-spread across the US, Europe and 
elsewhere, with eugenic explanations being used to justify discriminatory doctrines, 
policies and practices against those deemed as having undesirable characteristics, 
including mental illness , as well as the poor and the physically disabled (Kevles 
1985, Dikköter 1998, Phelan 2002). Through marriage restrictions, involuntary 
sterilisation, segregation and institutionalisation, the reproductive rights of tens of 
thousands of people of societies’ most stigmatised individuals were not only 
controlled but sometimes completely diminished, purely on the basis that they were 
judged to be genetically inferior (Dikköter 1998, Phelan 2002, Nuffield Council on 
Bioethics 2002). 
 
Ultimately, the idea of improving the qualities of the human race by selective 
breeding was used in partial justification of the genocide of individuals –including 
thousands the mentally ill - under the Nazi regime (Nuffield Council on bioethics 
2002). Thus, even though carried out by politicians, the fundamental basis for these 
policies was provided by scientists (Harper 2010), explaining the entrenchment 
between science, and especially genetics, and eugenics (Nuffield Council on 
Bioethics 2002). 
 
Indeed many early clinicians, especially geneticists, openly supported eugenics 
(Harper 2010), and five of the six first presidents of the American Society of Human 
Genetics served on the board of the American Eugenics Societies during their 
presidencies (Paul cited Resta 1997). Although they were typically critical of the 
method of eugenics programs, there was widespread consensus that eugenic goals 
of ‘improving’ the human race could be achieved via genetic approaches (Resta 
1997, see figure 16 Nuffield Council on Bioethics 2002).  
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Figure 16: Extract from ‘Man and His Future,’ 1963. 
(Nuffield Council on Bioethics 2002, p.15, cited ‘Man and His Future, 1963.)  
In 1962 an international meeting of scientists was held to discuss anthropological and 
evolutionary concepts relating to the future of mankind. Eugenics were a major focus of 
discussions, as demonstrated by the above extract. 
 
This association between genetics and eugenic-type values extended down to 
practice of GC. With typical outcomes involving reducing the occurrence of what 
were considered ‘undesirable’ characteristics by influencing high-risk families not to 
have children; and ensuring the upholding of societal racial boundaries through 
maintaining racial homogeneity within families (Stern 2012), its early, public health-
centered practice, was sometimes hard to disentangle between eugenics (Resta 
1997, Resta 2006, see figures 17 and 18).   
 
(Fig. 16) 
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Figure 17:  Extract regarding GC by Robert F. Murray Jr, a paediatric geneticist at 
Howard University, 1968.  
(Cited Resta 2006, p.271) 
 
 
 
Figure 18: Extract regarding genetic counselling by Nash Herndon, an early president 
of the American Society of Human Genetics, 1955. 
(Cited Resta 2006, p.270) 
 
 
 
 
“These data are evidence that genetic counseling tends to have the 
desired effect; that is, to influence high risk families not to have 
further children… It is probably a long way off, but… the day may 
come when the effect of genetic counseling may well be felt in a 
significant way in the general population.” 
Murray 1968 
 “The counselor must not only be concerned with the specific 
problem in inheritance raised by a given family but must also 
attempt to make some assay of the total genetic endowment of the 
persons in question… most people would agree that it would be 
advantageous for reproduction to cease in a family producing 
successive crops of idiots and imbeciles… Generally,… advice 
concerning hereditary that is sound and advantageous for the 
individual family will also be found to be safe and advantageous 
for society as a whole.” 
Nash 1955  
(Fig. 17) 
(Fig. 18) 
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Psychiatrists, too, played a prominent role in the eugenics theorems and practices 
of this era. They were particularly interested in the theory of eugenics because it 
provided an explanation for what was then considered a degeneration of the human 
race - the seemingly increasing presence of psychiatric illness within the population 
(Brüne 2007), which did not seem fitting with evolutionary theory. The eugenic 
movement thus became closely linked to the study of hereditary in mental illness 
(Schulze et al. 2009), as psychiatric genetic research aimed to find a Mendelian 
form of inheritance to justify, some have argued, policies and practices that 
restricted their reproductive rights (Kösters et al. 2015). 
Further associations between psychiatric genetics and eugenics were also formed 
by fact that leading profiles in the field of psychiatric genetics, such as Ernst Rüdin, 
Carl Schneider and Alfred Ploetz, became key protagonists of the movement and 
policies of eugenics and racial hygiene within Germany after the Nazi takeover 
(Ritter and Roelcke 2005, Roelcke 2007). These figures served as the ‘Expert 
Committee on Questions of Population and Racial Policy’ under Reich Interior 
Minister Wilhelm Frick. The Committee’s policies for so-called ‘racial hygieneity’ 
towards the development of any Aryan race involved mass sterilisation and 
extermination of men, women and children with physical disabilities, learning 
disabilities, and serious psychiatric illness, and especially SCZ (Ritter and Roelcke 
2005, Roelcke 2007). Indeed, Rudin had a particular interest in SCZ, which he 
believed to be caused by a Mendelian-recessive gene, and his theories of 
inheritance subsequently inspired many researchers, clinicians and politicians that 
were involved in the development of mass sterilisation and extermination policies of 
individuals with SCZ (Fuller Torrey and Yulken 2010). It is estimated that between 
220, 000 and 270,000 individuals with SCZ were sterilized or killed, respresenting 
between 73% and 100% of all individuals with SCZ living in Germany between 1939 
and 1945 (Fuller Torrey and Yulken 2010). 
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Whilst behavioural genetics formed a fundamental basis of eugenic policies, it has 
been asserted that this does not imply that contemporary approaches to behavioural 
genetics is in any driven by eugenic theories nor associated with eugenic values, 
and indeed genetics research today is heavily regulated by ethical research bodies 
(Nuffield Council in Bioethics 2002). However, there still remains views amongst 
some, especially in regards to hereditary of intelligence, that such research remains 
fundamentally eugenic, and concerns that it could lead to the re-establishment of 
eugenic policies (see figure 19). 
 
 
Figure 19: Nuffield Council on Bioethics’ statement regarding link between eugenics 
and behavioural genetics research in context of contemporary practice. 
(Nuffield council on Bioethics 2002, p.22) 
 
 
 
 
 
 
 
 
 
 
 
“It is possible that contemporary understanding of the heritability 
of IQ and other behavioural characteristics, and increasing 
knowledge of the process of inheritance of other traits, could 
provide a scientific foundation for a programme of positive or 
negative eugenics were there to be the political will or power to 
construct and implement such a policy.” 
Nuffield Council on Bioethics 2002 
(Fig. 19) 
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The utility of PGC 
 
The limitations of current aetiological understanding of psychiatric disorders, due to 
the complex archaeology, has also been explored as a potential barrier to the 
provision of PGC (Austin 2005, DeLisi and Bertisch 2006, Hippman et al. 2013), as 
it has led to some questioning  of the clinical utility of the service. 
For example, common variants explain a limited proportion of risk, their functional 
consequences are not yet understood, none are causative of illness, and there is 
overlap between diagnostic boundaries (Hippman et al. 2013). Additionally 
understanding of gene-environment interactions is in its infancy (Cornelis et al. 
2010, van Os et al. 2010). These caveats limit the specificity of aetiological 
information that can be delivered to patients and also means comprehensive 
understanding and identification of protective factors in mental health – an important 
component of information provision during the PGC session - is somewhat limited 
(Papdimitriou and Dikeos 2003, Austin 2005).  
Moreover, genetic testing does not meaningfully aid with risk estimation which 
reduces accuracy of risk information, figures for which are instead derived from 
empirical data and family history (Hippmann et al. 2013). 
However, in turn, this process of estimation is clinically challenging due diagnostic 
uncertainty in regards to psychiatric diagnoses; incomplete psychiatric family 
histories: and genetic phenomena including reduced penetrance, variable 
expressivity and genetic heterogeneity (Hodgkinson et al. 2001, Costain and 
Bassett 2012, Costain et al. 2014b). Additionally, the presence of multiple distinctive 
psychiatric diagnoses within a family, and the presence of affected individuals on 
both sides of the family - not an uncommon phenomena - can make recurrence risk 
estimates challenging as in these cases, there is little empirical data to guide the 
clinician (Austin and Peay 2006). 
 In practice this means categorical answers are not available for many questions 
pertaining to aetiology, familial risk and risk-reduction strategies that patients and 
their families may have (DeLisi and Bertisch 2006) and therefore there is the 
possibility that the information provided during PGC may not only be unhelpful, but 
may even be confusing (Hippman et al. 2013), and may also induce anxiety due to 
lack of certainty (Peay et al. 2008). 
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Indeed a survey of genetic counsellors (Monaco et al. 2010) reported these 
concerns existed amongst clinicians in regards to the hypothetical provision of GC 
for psychiatric conditions, with some perceiving that the aetiology of psychiatric 
disorders as confusing for patients, and that incomplete explanations regarding 
causation would be frustrating for them.  
However, in contrast, outcomes studies have indicated that patients accept the 
incomplete nature of aetiological understanding, and that PGC is still perceived to 
be useful in spite of the uncertainty (Austin and Honer 2008, Hippman et al. 2013). 
This has led to some promoting that these issues may be a projection of clinicians’ 
concerns rather than reflecting patients’ true perspectives (Hippman et al. 2013). 
Furthermore, more widely in other aspects of medical genetics information on 
genetic risk and information very rarely provides categorical, ‘yes’ or ‘no’ answers 
(Smith et al. 2000, Harper 2010, Aasen and Skolbekken 2014), and indeed, GC is 
routinely available for other complex disorders for which clinical testing is not 
available and/or categorical answers cannot be provided (e.g. for patients carrying a 
variant of unknown significance), yet positive patient outcomes are still achieved, 
including for heart disease (Cirino et al. 2013) and breast cancer (Petrucelli et al. 
2002, Culver et al. 2013). This has prompted, for some researchers and clinicians, 
the question as to why the absence of genetic testing, or indeed the inability to 
provide answers of greater certainty, should be a barrier for provision of GC for 
psychiatric illnesses when it is not for other physical illnesses (Hippman et al. 2013, 
Costain et al. 2014b). 
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1.6 Research Question: Exploring the application of PGC within 
the UK population 
 
HYPOTHESES 
 
Following the results of the literature search, the following hypotheses were 
deducted: 
Amongst affected individuals and relatives within the UK… 
1. There will be uncertainty regarding aetiology of mental illness  
 
Consistent with previous studies reporting that comprehensive 
understanding of pathophysiology is lacking and uncertainty exists 
amongst the American and Canadian populations (Hodgkinson et al. 
2001, Holzinger et al. 2003, Austin and Honer 2005, Costain and Bassett 
2012, Costain et al. 2014a) 
 
 
2. There will be uncertainties and negative implications of familial risk, 
including that: 
i). Genetic risk will be quantitatively overestimated 
Consistent with findings of previous studies exploring perceptions of 
familial risk that have reported a tendency to overestimate risk to 
relatives (Targum et al. 1981, Schulz et al. 1982, Trippitelli et al. 1998, 
Quaid et al. 2001, Austin et al. 2006, Meiser et al. 2007, Wilde et al. 
2010, Costain et al. 2014a) 
 
ii). There will be high degrees of concern regarding risk of recurrence to 
relatives 
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Consistent with the study reporting high degree of concern amongst the 
siblings of affected individuals in the Canadian population (Austin and 
Honer 2008) 
 
iii). There will be negative implications on family-planning decisions due to the 
mental illness 
Consistent with findings that presence of mental illness is associated 
with reproductive decisions favouring fewer or no children (Austin et al. 
2006, Meiser et al. 2007, Wilde et al. 2010, Meiser et al. 2013).  
 
3. Awareness of GC will be low and there will be misconceptions about 
its process and purpose, including its role specifically within 
psychiatry 
 
Consistent with findings of previous studies exploring awareness and 
perceptions of both traditional genetic counselling (Maio et al. 2013) and 
specifically PGC (Lyus 2007) amongst the American and Canadian 
populations respectively, which have found that typically less than half of 
respondents have previously heard of GC and that there are 
misconceptions about the service. 
Also consistent with GC literature involving retrospective studies which 
have found that patients reported lacking comprehension of the content 
and structure of the session prior to attending the appointment (Hallowell 
et al. 1997, Bernhardt et al. 2000, Metcalfe et al. 2007 
 
4. There will be hypothetical interest in receiving PGC. 
 
Consistent with previous studies have indicated high interest rates, typically 
presenting respondents with the hypothetical situation of receiving GC 
following being provided information about the service (Schulz et al. 1982, 
Quaid et al. 2001, DeLisi and Bertisch 2006, Lyus 2007); and additionally 
studies reporting high rates of uptake of GC when offered (Austin and Honer 
2008, Costain et al. 2014a, Costain et al. 2014b). 
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OBJECTIVES  
 
In order to test the hypothesis, the following research objectives were 
consequently formulated: 
i) To ascertain participants’ attributions of the mental illness to i) genetic 
factors and ii) non-genetic factors, and measure respondents’ confidence in 
their attributional explanations, to thus measure certainty 
ii) To obtain respondents’ perceived risk to first-degree relatives quantitatively, 
to determine accuracy of estimations of risk 
iii) To explore implications of familial risk specifically in relation to respondents’ 
concern for other relatives becoming ill, and reported impact on family-
planning decisions. 
iv) To explore participants’ awareness of GC and beliefs about its purpose, 
including specifically within psychiatry 
v) To determine if there is hypothetical interest in receiving PGC, by querying 
whether respondents would wish to receive PGC and whether they believed 
it would be useful to them 
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2. Materials and Method 
 
Materials 
Participant information sheet and participant consent forms were constructed in line 
with Bournemouth University’s Research Ethics Code of Practice. An information 
document (‘Cover letter’) was also produced which briefly explained the rationale 
behind the study (See Appendices). 
An online ‘landing page’ for the research project was developed containing a short 
video presented by the researcher explaining the study rationale, and a link that 
directed participants to the survey. It also featured downloadable PDF versions of 
the Participant Information Sheet, Consent Form, and Cover Letter. These are 
contained in the appendices. 
 
 
Figure 20: Screenshot of Online landing page developed for survey 
(Source: Spencer-Tansley and McGhee 2015) 
 
 
(Fig. 20) 
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An additional video was produced for the survey. The script was devised and 
presented by Dr. Jehannine Austin PhD, MSc (Genetic Counselling), CCGC/CGC 
and explained the purpose and typical process of a PGC session. 
The script is in included in the appendices (Appendix G). The video may also be 
viewed at: https://www.youtube.com/watch?v=PqnxqMnPk_g 
The video was produced at Bournemouth University by Dr. Julio Montenagro. 
 
 
 
 
 
Method 
 
Ethics 
 
In line with Bournemouth University (BU) Research Ethics Code of Practice (RECP), 
the research protocol was submitted to Bournemouth University Research Ethics 
Committee on 28th January 2015. A favourable opinion was reached on 11/03/2015. 
The research did not require external review through the NHS National Research 
Ethics Service (NRES). 
As the study did not involve the collection of personally identifiable data the study 
did not fall under the auspices of the Mental Capacity Act. 
 
The panel was in agreement that given that participants had a copy of the 
participant information sheet and signed the participant agreement form (formerly 
consent form), then due consideration of ethical issues was offered and consent 
obtained, thus demonstrating informed consent. 
 
This was clarified with the ethics panel, retrospective of the study, on 25/02/2016. 
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Participants 
 
Participants were identified as any individual who has been diagnosed with a mental 
illness; or any relative of an individual who has been diagnosed with a mental 
illness.  
Inclusion criterion regarding psychiatric diagnosis were: psychosis (SCZ, BPD with 
psychosis), mood disorder (BPD, MDD) anxiety disorders (OCD, depression with 
anxiety), eating disorders (anorexia, bulimia). 
Whilst the majority of PGC literature has focussed on providing GC for psychotic 
disorders, there is growing consensus that it has wider applications and indeed is 
now being provided for other, common mental disorders including OCD and 
depression. The decision to thus include respondents with anxiety disorders and 
eating disorders in this research study was made, following discussions with Dr J. 
Austin, PhD, CCGC, Associate Professor, UBC Department of Psychiatry and 
Medical Genetics; E. Morris, CCGC, MSc, Clinical Instructor, University of British 
Columbia, Departments of Psychiatry and medical genetics; and H. Andrighetti, 
CCGC, CCGC, MSc, Clinical Instructor, University of British Columbia, Departments 
of Psychiatry and Medicial Genetics, University of British Columbia (UBC), Canada. 
 
Neurodevelopmental disorders, classed as ‘disabilities in the functioning of the brain 
that affect a child’s behaviour, memory or ability to learn’ which includes mental 
retardation, dyslexia, attention deficit hyperactivity disorder (ADHD), learning deficits 
and autism’ (WHO 2010) were not included in the inclusion criterion as it was felt 
GC for these disorders may have very different constructs and also patients may 
have different needs and perspectives in comparison to those with ‘mental 
disorders.’. Thus, research regarding provision of PGC for these disorders, whilst 
important, should be conducted separately. 
 
Illnesses defined as ‘mental disorders’ were based on the ICD-10 classification 
system (WHO 2010). 
 
All participants were also required to be over the age of 18. 
All research participants were required to be from the UK or Ireland. 
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Literature search 
PubMed database was searched to enable simultaneous searching of PubMed, 
PubMed Central, and MEDLINE. PubMed was used as it comprises more than 25 
million citations for biomedical literature from MEDLINE, life science journals, and 
online books, and so it was believed that relevant journal articles would be 
identified. 
Google scholar was also used as a search database to detect any publications that 
may have been missed by PubMed. 
 
Search terms used across both databases were: 
PSYCHIATRIC GENETIC COUNSELLING 
GENETIC COUNSELLING and MENTAL ILLNESS 
GENETIC COUNSELLING and PSYCHOSIS 
PERCEPTIONS OF GENETIC COUNSELLING 
RISK PERCEPTIONS GENETIC COUNSELLING 
 
Certain inclusion criterion for the searches was applied. This included that only 
articles written in English were selected, and that, of the journal articles, only those 
that were peer-reviewed were considered. No limitations were applied in terms of 
publication date due to the limited papers regarding PGC. Furthermore it was felt 
that it would be interesting and important to consider beliefs, attitudes and findings 
about PGC over time, as there may be changes. 
The literature search was conducted between October 2014 – October 2015 and so 
publications after this date could not have been included. 
Publications were screened to assess relevance; those that were deemed to be 
irrelevant to the search were excluded. 
Full texts of relevant articles were subsequently obtained and stored to a reference 
and citations manager (Mendeley desktop). The reference lists of these studies 
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were screened to identify any relevant publications that may have been missed from 
the database search process, or that were relevant to the findings of the search. 
Relevant publications and articles were also suggested to the researcher from 
clinicians and researchers working within the relevant fields, including Dr K 
McGhee, PhD, Bournemouth University; Dr. J. Austin,  PhD, CCGC, UBC; Dr. F 
Dagenhardt, M.D, University of Bonn,; Dr M. Nothen,.PhD, University of Bonn. 
These articles underwent the same screening process as those retrieved via 
database search. 
Clinical tools used in PGC sessions by Dr J. Austin’s research team were also sent 
to the researcher (see appendix H). 
The remaining publications were used to conduct a literature review of the findings. 
The method undertaken for the literature review is depicted in figure 21. 
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Figure 21: Diagram depicting method conducted for literature search 
 
 
 
 
 
 
(Fig. 21) 
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Choice of methodology 
 
It was decided a mixed-methods approach would be the most effective in 
addressing the research aims and objectives.  
There are several benefits to using mixed methods approach in research. Mixed 
methods enable breadth and depth of understanding and corroboration (Johnson et 
al 2007). Often one type of approach will not tell the whole story, whereas a mixed 
methods approach enables exploration of the same research problem from different 
perspectives, therefore enabling a more accurate and satisfactory answer to the 
research question, ultimately allowing for greater scope in understanding of the 
research area being investigated (Creswell and Clark 2011). 
 Indeed, sometimes the results from one method may even be contradictory to 
those obtained using the other method, which would have otherwise not been 
detected had only one method been used (Cresswell and Clark 2011), thus 
providing a more accurate and deeper exploration of the research question. 
Furthermore, the limitations of one approach can be offset by the strength of the 
other (as discussed below). 
Additionally, mixed-methods approaches can also be particularly useful in 
investigating under-researched areas (Creswell and Clark 2011), and are thus fitting 
for the study given that PGC is a nascent discipline with limited supporting literature.  
 
Quantitative research aims to verify phenomena by collecting and analysing 
numerical data (Aliaga and Gunderson 2000). It involves observations and 
measurements that can be made objectively made and repeated by subsequent 
research groups (Hancock 1998). Quantitative research enables detection of 
relationships between variables, and can also be useful in gauging opinions, 
allowing for measurement of the extent to which particular attributes or views are 
held (Costain et al. 2014b). 
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A particular strength of quantitative research is that it is not affected by bias of the 
researcher (Cresswell and Clark 2011). However, although quantitative data 
provides a more general understanding of the research question, views of individual 
participants can be lost (Cresswell and Clark 2011). 
 
Specifically, quantitative methods were used to measure attribution of illness to 
genetic and environmental factors, degree of certainty regarding the causes of 
mental illness; accuracy of estimation of risk in mental illness; awareness of GC; 
perceptions about PGC, and perceived usefulness and interest in receiving PGC. 
  
Qualitative data, in contrast, is exploratory and descriptive in its nature (Hesse-Biber 
and Leavy 2010, Hippman et al. 2013) and useful for describing and attempting to 
understand and explain phenomena (Guest et al. 2012). It is insightful for studying, 
measuring and understanding human behaviour, opinion, emotions and responses, 
and gaining insight into the underlying processes influencing these factors (Creswell 
and Clark 2011). Such elements are often personal, subjective, complex (i.e. 
influenced by a variety of factors), and not easily captured by quantitative methods 
(Guest et al. 2012). Qualitative research honours individual participants’ views, 
which may be lost in quantitative analysis. Additionally, qualitative data can be 
helpful in explaining quantitative results and identifying processes underlying them 
when using a mixed-methods approach (Cresswell and Clark 2011), thus allowing 
for greater comprehension. 
 
Specifically, qualitative data was used to explore perceptions of GC and perceived 
value of PGC. This insight can be helpful in facilitating better understanding and 
prediction of future behavioural responses to the offer of PGC as well as deeper 
insight into other concepts relating to PGC that may not be detected by quantitative 
analysis. 
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Survey development 
 
The survey questions were developed following an in-depth analysis of relevant 
literature (‘literature search,’ as described above and shown in fig.21). 
The survey questions were informed by findings of previous studies, or gaps in 
knowledge that were identified as missing in the available literature. 
Specific surveys listed in previous studies that were relevant to survey development 
are listed in table 6. 
Throughout the process of survey development the researcher had ongoing 
discussions with the research supervisor. 
Dr. J. Austin, E. Morris, H. Andrighettti (University of British Columbia) and a trainee 
genetic counsellor enrolled on the Genetic Counseling Course at UBC were also 
involved in the survey development process. 
The researcher held a supervision session in January 2015 at UBC, Canada, in 
which the research project was discussed and the original questions explored, 
developed and additional lines of enquiry were proposed. The research team 
suggested alternative methods of analyses for some questions, including, 
specifically, exploring perceptions of GC using qualitative analysis, and using Likert-
scale items to explore respondents’ attributional explanations, especially as it would 
make responses more amenable to quantitative analysis (Austin 2014, pers comms, 
26 November). 
 The research team are conducting a study also exploring perceptions of PGC in 
2016, which will incorporate several of the questions in this study. This will also 
allow for comparison between the UK and Canadian populations. 
Dr Austin and H. Andrighetti proof-read the survey before it was launched. 
A board-certified genetic counsellor (Dr. M. Bradford, PhD, MSc Genetic 
Counselling, based at Plymouth University), working within the NHS, England, also 
proof read the survey and offered suggestions (e.g. alterations in terminology) to 
make the questionnaires more user-friendly. 
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The online survey was developed using the survey software solution ‘qualtrics.’ This 
allows researchers to develop, distribute surveys and collect, download and analyse 
the relevant data. 
After a trial run of the survey was completed by both the researcher and supervisor, 
the online survey was made live and collection of respondents’ responses 
commenced. 
 
Diagrams depicting the process of survey development are provided (Figs. 22 and 
23). 
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Table 6: Key PGC/GC surveys from previous studies relevant to research 
questions and survey development 
Research question and relevant studies 
Aetiological 
attributions 
Perceptions of 
risk 
Perceptions of 
GC 
(prospective) 
Perceptions of GC 
(retrospective) Interest in PGC 
Gamm et al. 
2004 
Targum et al. 
1981 Lyus et al. 2007 Hallowell et al. 1997 
Schulz et al. 
1982 
Meiser et al. 
2005 
 Schulz et al. 
1982 Maio et al. 2013 Brown et al. 1999 
Quaid et al. 
2001 
Meiser et al. 
2007 
Trippitelli et al. 
1998 
 
Bernhardt et al. 
2000,  
De Lisi and 
Bertisch 2006 
Costain et al. 
2014a Quaid et al. 2001, 
 
Pieterse et al. 2005 Lyus et al. 2007 
Costain et al. 
2014b Austin et al. 2006 
 
Metcalfe et al. 2007 
Austin and 
Honer 2008 
 
Meiser et al. 2007 
 
Joseph et al. 2010,  
Costain et al. 
2014a 
 
Wilde et al. 2010 
  
Costain et al. 
2014b 
 
Costain et al. 
2014a 
  
 
 
Meiser et al. 2013 
  
 
 
Costain et al. 
2014b    
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Figure 22: Diagram depicting method undertaken for survey development (1) 
 
 
 
 
(Fig. 22) 
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Figure 23: Diagram depicting method undertaken for survey development (2) 
 
 
(Fig. 23) 
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Rationale for using Likert-type items to categorise responses 
This study used Likert-type items to measure psychological and behavioural 
properties of respondents (specifically, illness attributions, certainty, concern, 
interest in PGC, perceived usefulness of PGC). 
Measuring psychological and behavioural properties such as attitudes, awareness, 
character and personality traits is challenging, because there are issues as to how 
one may transform these qualities into a quantitative measure in order to conduct 
data analysis (Thambirajah 2005). Likert scales have become one of the most 
popular tools to objectively measure such psychological properties (Clason and 
Dormody 1994, Hartley 2013, Maeda 2015). 
A traditional Likert scale consists of multiple Likert ‘items,’ each of which contains a 
stem, e.g. a statement or question, and a scale consisting of fixed choice response 
alternatives (e.g. strongly disagree, disagree, agree, strongly agree) that are 
numerically ordered. Analysis is performed by analysing (e.g. summing or 
averaging) the numerical values of each response item, to develop a summated 
Likert-scale (Clason and Dormody 1994, Maeda 2015). Combined, these items 
provide a quantitative measure of opinion, attitude, or personality trait (Boone 2012). 
Although the disagree-agree format (as described above) is the most common form 
of Likert scale, other types of response options (e.g. ‘below average, slightly below 
average, average, slightly above average, above average’) are also widely used in 
research. 
Additionally, individual Likert-scale items may also be analysed. In this approach, 
the researcher does not attempt to combine the responses from the items to 
produce a summated (‘Likert’) scale. Thus, this type of approach uses Likert-type 
items, rather than Likert scales (Clason and Dormody 1994). Although Likert (1932), 
never originally considered analysis of individual items scales (Clason and Dormody 
1994) Likert-type items have become increasingly popular tools of analysis in 
clinical and health psychology research (Hartley 2013), and were used in this study 
specifically. 
There are several advantages to using Likert-scale and Likert-type items. Firstly, as 
they are so widely used they are easily understood (Neuman 2000).  They are also 
simple and easy to design, administer and analyse (Neuman 2000). Additionally the 
responses are easily quantifiable and so easily amenable to statistical analysis 
(Likert 1932, Hersen and Bellack 2013, Austin 2014, pers comms, November 26). 
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They allow for a range of responses and not concrete answers from respondents, 
and also allow for neutral answers, which may be more accurate in terms of 
reflecting respondents’ true answers, and may also be preferable to the respondent 
(Maeda 2015). 
In this study, Likert-type items were used to measure i) attributions of the mental 
illness to genetic factors ii) attribution of the mental illness to non-genetic factors iii) 
certainty regarding attributions, using a tool that had been previously developed by 
J. Austin’s research group (see Appendix H), and is currently used within their 
clinics. This allows for comparison between American and UK populations in future 
research. 
Meiser et al. (2007) similarly explored illness attributions to different factors using a 
5-point Likert-type scale, using responses from 1 (not at all important) to 5 
(extremely important). 
Likert-type items were also used to measure iv) degree of concern for other 
relatives becoming ill vi) interest in receiving PGC after receiving information about 
the service and vii) perceived usefulness of PGC amongst respondents. 
This enabled statistical analysis between variables obtained from each item, using 
non-parametric tests (as described later in ‘analysis’) to enable identification of 
relationships between variables and also compare responses from different groups 
of respondents. 
Each item consisted of a 7-point scale, to offer respondents’ more flexibility in their 
answers (Nunnally and Bernstein 1978) and also the option of a neutral response. 
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Recruitment 
 
-Gatekeepers 
Gatekeepers (i.e. individuals that control and/or facilitate research access) (Jupp 
2006) at local and national mental health charities and organisations; carers 
charities; and local mental health support groups were approached by the 
researcher via email or telephone and requested to invite their members to 
participate in the research project. 
Gatekeepers were sent the information document and the link to the Research 
Landing Page which contained the Participant Information Sheet and Consent 
Form. A reminder email or phone call was sent to organisations and gatekeepers 
that did not reply. 
Methods used to promote the research project by gatekeepers included: passing on 
information to members, advertising the study online website and promoting it via 
social media, dependent upon what method was perceived most suitable for the 
organisation’s members and framework. The researcher also attended support 
group meetings to provide a briefing of the research to members and invite them to 
participate. 
 
-Online-presence and Social Media 
Social media sites (Twitter and Facebook, see figs. 24-27) were used to promote 
the study. Tweets were regularly sent out during the data collection period inviting 
public participation in the study, and hashtags including ‘Mental Health’;‘Genetics’; 
and ‘Mental Health Matters’ were used to make the tweet viewable to twitter users 
with an interest in these trends. In addition, data collection occurred during both 
Mental Health Awareness Week and Carers Week and 
‘MentalHealthAwarenessWeek’ and ‘CarersWeek’ were used as hashtags in 
invitational tweets to make the tweet viewable to twitter users with an interest in 
these events.  
Other twitter users, including mental health charities, research organisations, and 
leading mental health advocates retweeted these invitatory tweets out of their own 
initiative or after being approached by the researcher. 
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Figure 24: Screenshot of researcher's twitter page 
(Source: Spencer-Tansley 2015) 
Twitter was used to promote the study by tweeting invitational links. Mental health charities 
and organisations also promoted the study via their own twitter accounts. 
 
 
 
Figure 25: Screenshot showing Facebook Account (‘Pysch Genetics BU)’ used to 
promote study 
(Source: Psych Genetics BU 2015). 
(Fig. 24) 
(Fig. 25) 
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Figure 26: Screenshot - Example of charity (Carers Trust) promoting study via twitter 
(Source: Carers Trust East Midlands 2015) 
 
 
 
Figure 27: Screenshot - Example of charity (WWAMH) promoting study online 
(Source: West Wales Action for Mental Health 2015). 
Bournemouth university website and Research page also featured articles around 
the study containing links directing to the study page (see figure 28). 
 
 
(Fig. 26) 
(Fig. 27) 
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Figure 28: Screenshot of research article on Bournemouth University website 
regarding research group's work, and promoting study. 
(Source: Bournemouth University 2015). 
 
 
 
-Additional recruitment approaches  
 
Participants were directly approached at various mental health awareness events 
across the south of the country and invited to participate in the study. The 
researcher also delivered presentations about the study to relevant audiences 
across the university including Adult Nursing students and Faculty staff members. 
Additionally the researcher and supervisor also spoke on a radio programme, 
‘Mental Health Matters,’ to discuss and promote participation (see fig. 29) 
(Fig. 28) 
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Figure 29: Screenshot showing webpage for ‘Mental Health Matters’ podcast link, 
featuring PGR and PGR supervisor discussing study 
(Source: Phoenix FM 2015). 
 
 
 
 
 
 
Participation 
Data was collected via two online surveys – one for affected individuals with mental 
illness and one for relatives of affected individuals - between 25 March 2015 to 21st 
July 2015. 
Once directed to the online Survey page, which contained the participant 
information sheet and consent form, informed consent was obtained. Participants 
were then able to commence with completion of the questionnaire. Upon completion 
participants were able to again download the participant information sheet and 
consent form. 
 
(Fig. 29) 
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Analysis 
Data from all partially completed surveys were used if applicable questions required 
for an analysis were answered. Respondents that indicated they were not UK/ 
Ireland residents were excluded from analysis. 
 
-Qualitative data 
 
All qualitative responses were coded by the researcher using thematic analysis. 
Thematic analysis is useful for identifying, analysing, and reporting patterns 
(themes) within data (Braun and Clarke 2006). Thematic analysis is a widely-used 
analytical method that can offer a rich, thematic description of the entire dataset 
(Braun and Clarke 2006). A particular benefit of this analytical approach is its 
accessibility, meaning it is amenable to researchers whom are not overly familiar 
with qualitative analysis (Braun and Clarke 2007). Additionally thematic analysis 
may also capture elements that that are important in relation to the overall research 
question buy may not be quantifiable (Braun and Clarke 2006), as it offers flexibility 
in terms of how themes are determined – the significance of a theme is not 
necessarily measured by its frequency, as it may be using alternative methods of 
analysis (Horning-Priest 2005). 
For this study, a read, re-read and code approach was undertaken to identify codes 
and subthemes to comprehensively categorise all the data. This started by the 
researcher familiarising themselves with the data set. Codes were then generated, 
organising the data into various groups. Throughout this process the researcher 
remained open-minded, generating as many codes as possible. An inductive, 
bottom-up approach was employed for the coding process in which analysis was not 
directed towards theory development (Braun and Clarke 2006).  Highlighters were 
originally used to code all the data and identify potential patterns within it. Extracts 
of the data from individual responses were then copied to enable collation of each 
code in separate computer files. The coding was checked with an academic 
(research supervisor) for consistency; discrepancies were discussed and consensus 
reached. 
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From this, potential themes were identified by analysing codes and subsequently 
combining or modifying codes, with some codes becoming redundant. Major 
themes, and sub-themes within the major themes, were subsequently deduced. All 
the relevant coded data extracts within the identified themes were then collated. 
Themes and sub-themes were then reviewed and refined to ensure a coherent 
pattern between all of the collated extracts within a theme. Again, developed 
themes were discussed and checked with an academic (research supervisor) for 
consistency; discrepancies were discussed and consensus reached. 
How widespread each view appeared to be in the sample was recorded so that it 
could be reported qualitatively in the text.  
 
 
Quantitative data 
Quantitative data was analysed using Microsoft Excel and the statistical package 
SPSS. 
For ordinal data, the non-parametric Mann-Whitney U-Test was used to compare 
differences between two independent groups or samples. Mann-Whitney U-Test 
tests the null hypothesis that two samples come from a population with the same 
distribution, and therefore the distributions of both groups are identical (Butler 
1985). If the p-value is small (p<.05), the null hypothesis that the difference is due to 
random sampling can be rejected and it can be instead concluded that the 
populations are distinct (Field 2009). In this study Mann-Whitney U-Test was used 
to test whether there was a significant overall difference in the magnitude of the 
variable of interest between affected individuals and relatives; and males and 
females. 
Spearman’s rank-order correlation coefficient is a non-parametric measure of 
statistical dependence between two variables (Field 20009). It is used to measure 
the degree (strength) and direction (positive or negative) of association between two 
variables. When the correlation coefficient, rs, is close to 0 this means that there is 
little relationship between the variables; whilst the further away from 0 r is, in either 
the positive or negative direction, the greater the relationship between the two 
variables. A spearman correlation of +1 or -1 occurs when each of the variables is a 
perfect monotone function of the other (Brase 2012). In this study Spearman’s rank-
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order correlation coefficient was used to test for associations between testable 
variables. 
Pearson's Chi-square test (Crosstab) was used to test the independence between 
two categorical variables (Field 2009). It enables evaluation of the likelihood of any 
observed difference between the sets of variables arose by chance; if the Pearson 
chi-square is significant (p<.05) the two variables show a relationship that is larger 
than what would be expected under chance alone and therefore there must be a 
relationship between the two variables. 
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3. Results 
A total of 60 affected individuals with mental illness and 29 relatives responded to 
the survey; 3 affected individuals not from the UK or Ireland were excluded from 
analysis. 
3.1 Demographic and diagnostic data 
Table 7: Demographic data for respondents 
Variable Affected 
individuals 
Relatives Total sample 
Gender 
Male 
Female 
 
24 
32 
 
5 
24 
 
29 
56 
Age 
18-24 
25-30 
31-35 
36-40 
41-45 
46-50 
51-55 
56-60 
61-65 
66+ 
 
6 
7 
8 
6 
5 
10 
5 
6 
1 
3 
 
6 
2 
3 
1 
2 
1 
3 
5 
6 
0 
 
12 
9 
11 
7 
7 
11 
8 
11 
7 
3 
Highest level of education 
No post-school qualifications 
Post-school qualifications 
 
10 
47 
 
5 
23 
 
15 
70 
Employment status 
In employment 
Self-employed 
Not currently working 
In full time education 
Retired 
Unable to work 
 
27 
5 
10 
2 
4 
7 
 
18 
1 
3 
6 
1 
0 
 
45 
6 
13 
8 
5 
7 
Nationality 
English 
Welsh 
Scottish 
Northern Irish 
British 
Other 
 
32 
2 
1 
2 
14 
6 
 
17 
1 
1 
8 
2 
 
49 
3 
2 
10 
16 
6 
Ethnicity 
White British 
White ‘other’ 
Asian British 
Caribbean 
Mixed – white and Asian 
Other ethnicity 
 
50 
2 
0 
0 
1 
4 
 
25 
2 
1 
1 
0 
0 
 
75 
4 
1 
1 
1 
4 
Note: for some questions, not all respondents provided reportable answers. 
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Table 8: Diagnostic data for affected individuals 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable Affected 
individuals – 
Count 
Psychiatric diagnosis 
Psychosis 
Mood disorder 
(Bipolar disorder) 
(Recurrent depression 
Anxiety disorder 
Generalised anxiety 
Anxiety with depression 
OCD 
PTSD 
Other 
Anorexia 
Borderline personality disorder 
 
 
 
 
5 
44 
(38) 
(6) 
6 
(1) 
(1) 
(2) 
(2) 
2 
(1) 
(1) 
Years since diagnosed 
0-5 
6-10 
11-20 
21-30 
31+ 
 
21 
12 
16 
5 
3 
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Table 9: Diagnostic data for relatives 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable Relatives – count 
Relationship to affected individual(s) 
Son or daughter 
Sibling 
Parent 
Partner 
Cousin 
Niece/nephew 
Aunt/uncle 
Cousin 
Grandchild 
 
5 
10 
14 
4 
1 
1 
0 
1 
0 
Relative’s psychiatric diagnosis 
Psychosis 
Mood disorder 
(Bipolar disorder) 
(Recurrent depression 
Anxiety disorder 
Anxiety with depression 
OCD 
PTSD 
Other 
Anorexia and bulimia 
 
 
 
 
8 
11 
(10) 
(1) 
8 
(3) 
(3) 
(2) 
1 
(1) 
Years since relative diagnosed 
0-5 
6-10 
11-20 
21-30 
31+ 
 
7 
4 
4 
2 
0 
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3.2  Perceptions of aetiology 
This section quantitatively explored respondents’ attributions of the mental illness to 
genetic and non-genetic factors. Respondents’ confidence in their provided answers 
was also queried, to measure certainty regarding their attributional explanations. 
In total it contained four structured questions using seven-point Likert-type response 
items.  
 
Aetiological attributions 
Respondent’s attribution of their/their relative’s mental illness to i) genetic factors 
and ii) environmental factors (“life experiences”) was queried using two 7-point 
Likert-type response items (1= “did not contribute at all”; 4 = “contributed 
somewhat”; 7= “entirely/causal role”, see figures 30a-d.).  
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Fig. 30a) Likert-type response item to assess affected individuals’ attribution to genetic 
factors in mental illness pathogenesis 
 
 
 
Fig. 30b) Likert-type response item to assess affected individuals’ attribution to 
environmental factors in mental illness pathogenesis 
 
 
 
Fig. 30c) Likert-type response item to assess relatives’ attribution to genetic factors in 
mental illness pathogenesis 
 
 
 
Fig. 30d) Likert-type response item to asses relative’s attribution to environmental 
factors in mental illness pathogenesis 
 
 
 
 
 
 
 
Figures 30a-d: Likert-type response items to assess respondents’ illness attributions 
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Aetiological attributions - results 
The majority of affected individuals (61%, n=35) and relatives (62%, n=18) indicated 
they believed genetics played somewhat to a causal role in their or their relative’s 
mental illness. A minority of affected individuals (7%, n=4) and relatives (7%,n=2) 
believed genetic factors played no role in their/their relative’s mental illness.  
Most affected individuals (86%, n=49) and relatives (72%, n=21) reported that they 
believed environmental factors played a somewhat to causal role in their/their 
relative’s mental illness; and only 1 individual (2%) and 1 relative (3%) indicated 
they believed environmental factors played no role. 
All data are shown in tables 10-11 and figs. 31-34.  
 
 
Table 10: Frequency table for attribution variables (GA, EA) for affected individuals. 
Attribution 
Variable 
Attribution TOTAL 
1  2 3 4  5 6 7  
GA 4 8 10 18 13 3 1 57 
EA 1 3 4 7 20 15 7 57 
Note: GA = attribution of mental illness  to genetic factors; EA = attribution of mental illness 
to environmental factors. 1= “Not at all”, 4 = “Somewhat”, 7= ‘Entirely.” 
 
Table 11: Frequency table showing attribution variables (GA, EA) for relatives 
 
 
Note: GA = attribution of mental illness to genetic factors;, EA = attribution of mental illness 
to environmental factors. 1= “Not at all”, 4 = “Somewhat”, 7=’Entirely.’ 
Attribution 
Variable 
Attribution TOTAL 
1 2 3 4 5 6 7  
GA 2 5 4 8 5 4 1 29 
EA 1 3 4 4 12 5 0 29 
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Figure 31: Frequency diagram showing affected individual's attribution of the 
mental illness to genetic factors 
 
Figure 32: Frequency diagram showing affected individual's attribution of the 
mental illness to environmental factors 
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Figure 33: Frequency diagram showing relative’s attribution of the mental 
illness to genetic factors 
 
Figure 34: Frequency diagram showing relative’s attribution of the mental 
illness to environmental factors 
 
128 
 
Certainty regarding aetiological attributions 
To explore certainty regarding aetiological attributions, respondents were asked to 
indicate how confident they were in the answer they provided regarding their 
attribution of the mental illness to iii) genetics iv) environmental factors (“life 
experiences”).  
Respondents’ certainty was assessed using two 7-point Likert-type response items 
(1= I am not sure at all; 7=I am absolutely certain, see fig. 35). 
 
 
 
Certainty regarding aetiological attributions – results 
 Overall the majority of respondents indicated relatively high levels of certainty 
regarding their answers provided for aetiological attribution of the mental illness. 
The majority of affected individuals (77%, n=44) indicated they were relatively to 
extremely certain regarding their attribution of the mental illness to genetic factors 
(GAC); only 5% (n=3) indicated they were not at all certain. 
For relatives, similarly, the majority 76% (n=22) indicated they were relatively to 
extremely certain about their attribution of the mental illness to genetic factors, 
although a proportion (17%, n=5) indicated complete uncertainty about their 
answers regarding the role of genetics. 
For all respondents, certainty was greater regarding the role of environmental 
factors (EAC) with 89% (n=51) of affected individuals and (86%, n=25)  indicating 
they were relatively to extremely certain about their attribution of the mental illness 
to environmental factors and only 1 individual (2%) and no relatives indicating 
complete uncertainty.  All data are given in tables 12-13 and figs. 36-39. 
Figure 35: Likert-type response to assess respondent’s certainty regarding their 
attribution of the mental illness to i) genetic factors ii) environmental factors. 
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Table 12: Frequency table for attribution certainty variables for affected 
individuals 
 
Note: GAC = Certainty regarding attribution of mental illness to genetic factors, EAC = 
Certainty regarding attribution of mental illness to environmental factors. 1= “Not at all”, 7= 
‘Absolutely certain’ 
 
Table 13: Frequency table for attribution certainty variables for relatives 
 
Certainty 
Variable 
Certainty  
1 2 3 4 5 6 7 TOTAL 
GAC 5 0 2 5 5 7 5 29 
EAC 0 0 4 1 10 9 5 29 
Note: GAC = Certainty regarding attribution of mental illness to genetic factors, EAC = 
Certainty regarding attribution of mental illness to environmental factors. 1= “Not at all”, 7= 
‘Absolutely certain’ 
 
 
 
 
 
 
Certainty 
Variable 
Certainty TOTAL 
1  2 3 4  5 6 7  
GAC 3 6 3 9 8 13 14 57 
EAC 1 2 3 7 10 17 17 57 
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Figure 36: Frequency diagram showing affected individuals’ certainty regarding 
attribution of the mental illness to genetic factors (GAC) 
 
Figure 37: Frequency diagram showing affected individual's certainty regarding 
attribution of the mental illness to environmental factors (EAC) 
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Figure 38: Frequency diagram showing relatives’ certainty regarding 
attribution of the mental illness to genetic factors (GAC) 
 
Figure 39: Frequency diagram showing relatives’ certainty regarding 
attribution of the mental illness to environmental factors (EAC) 
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Perceptions of aetiology – statistical analyses 
 
Spearman’ rank correlation coefficient 
Spearman’s rank correlation was used to test for associations between illness 
attribution variables (GA; EA) and illness attribution certainty variables (GAC; EAC).  
Correlations are shown in tables 14 and 15. 
The correlation between certainty regarding attribution of the mental illness to 
genetic factors (GAC) and certainty regarding attribution of the mental illness to 
environmental factors (EAC) was significant and positive for both affected 
individuals (rs=.389
, p=0.003) and relatives (rs=.797
** , p<0.001). Thus, greater 
certainty regarding attribution of the mental illness to genetic factors was associated 
with greater certainty regarding attribution to environmental factors. 
 
For affected individuals, the correlation between attribution of the mental illness to 
environmental factors (EA) and certainty regarding attribution of the mental illness to 
environmental factors (EAC) significantly and positive (rs=.475
**, p<.001). Thus, 
greater attribution of the mental illness to environmental factors was associated with 
greater certainty regarding attribution of the mental illness to environmental factors. 
 
No other significant associations were detected. 
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Table 14: Spearman’s rank correlations showing associations between illness 
attribution variables (GA, EA) and illness attribution certainty variables (GAC, EAC) 
for affected individuals 
 GA GAC EA EAC 
GA 1.000 .075 -.200 -.015 
GAC .075 1.000 .103 .389** 
EA -.200 .103 1.000 .475** 
EAC -.015 .389** .475** 1.000 
Note: GA = attribution of mental illness to genetic factors, GC = Certainty regarding 
attribution of mental illness to genetic factors, EA = attribution of mental illness to 
environmental factors, EC = Certainty regarding attribution of mental illness to environmental 
factors. *p <.05, **p <.01 
 
Table 15: Spearman’s rank correlations showing associations between illness 
attribution variables (GA, EA) and illness attribution certainty variables (GAC, EAC) 
for relatives 
 GA GAC EA EAC 
GA 1.000 .210 -.276 .043 
GAC .210 1.000 .155 .797** 
EA -.276 .155 1.000 .277 
EAC .043 .797** .277 1.000 
Note: GA = attribution of mental illness to genetic factors, GC = Certainty regarding 
attribution of mental illness to genetic factors, EA = attribution of mental illness to 
environmental factors, EC = Certainty regarding attribution of mental illness to environmental 
factors. *p <.05, **p <.01 
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Mann-Whitney U-Test 
 
To test for differences between illness attribution variables (GA; EA) and illness 
attribution certainty variables (GAC; EAC) between groups of respondents (i.e. 
affected individuals compared to relatives; males compared to females), Mann-
Whitney U-Test was applied.  
 
Comparing relatives and affected individuals, attribution to environmental factors 
(EA) was significantly greater for affected individuals (mean = 5.018, mean rank = 
47.64, median = 5.00 ) than for relatives (mean = 4.310, mean rank = 35.36, median 
= 5, U=590.500 ,Z= -2.233, p= 0.026, r = -.241). This result was therefore significant 
but the difference between the groups was relatively small, indicating the result is 
relatively non-substantive. 
 
Comparing genders, there were no significant differences between illness attribution 
variables or illness attribution certainty variables between males and females. 
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Summary of findings 
The majority of respondents attributed mental illness to both genetic and non-
genetic factors. Very few respondents indicated they believed genetics had no role 
to play whatsoever, and only two respondents believed genetics had contributed 
entirely to the mental illness (i.e. played a causal role). 
Attribution to environmental factors was significantly greater amongst affected 
individuals than relatives, but there were no other significant differences between 
affected individuals and relatives, nor between males and females. 
Degree of certainty regarding respondents' attribution to both genetic and 
environmental factors was relatively high, with over 65% of respondents indicating 
they were somewhat to extremely confident in the answers they provided regarding 
their attribution of the mental illness to both genetic factors and environmental 
factors. A proportion of relatives (17%) indicated complete uncertainty about the role 
of genetic factors in pathogenesis, however. 
For all respondents greater certainty regarding attribution to genetic factors was 
significantly associated with greater certainty regarding attribution to environmental 
factors. 
For affected individuals, greater attribution to environmental factors was significantly 
associated with greater certainty regarding attribution to environmental factors. 
No other significant associations were detected. 
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3.3 Familial risk - perceptions and implications 
The section of this study explored perceptions and implications of familial risk 
amongst respondents by enquiring respondents’: 
i. Degree of concern for other relatives becoming ill, queried using a 7-point 
Likert-type response item. 
ii. Perceptions of quantitive risk to first degree relatives, assessed by obtaining 
respondents’ estimates of risk to offspring and sibling, 
iii. Impact of mental illness on family-planning 
 
 
i. Concern for other relatives developing mental illness 
Respondent’s concern for other relatives developing mental illness was queried 
using a 7-point Likert-type response item (1= not at all concerned; 4= somewhat 
concerned; 7= very concerned; see figure 40. 
 
 
 
 
 
 
 
 
 
Figure 40: Likert-type response item to assess respondent’s concern for other relatives 
developing mental illness. 
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Concern for other relatives developing mental illness – results 
Of the 86 respondents that answered this question, 84% (n=48) of affected 
individuals and 55% (n=16) of relatives reported they were somewhat to extremely 
concerned about other relatives also developing mental illness. Almost quarter of 
affected individuals (n=13, 23%) reported being ‘very concerned’ about the risk to 
other relatives. 
Conversely, 7% of affected individuals (n=4) and 14% of relatives (n=4) reported not 
being at all concerned about other relatives becoming affected. 
All frequencies are shown in table 16 and figs. 41-42. 
 
Table 16: Frequency table showing respondents’ concern for other relatives 
developing mental illness 
 
Group Concern TOTAL 
1 2 3 4 5 6 7 
Affected 
individuals 
4 2 3 9 18 8 13 57 
Relatives 4 4 5 4 6 5 1 29 
Note: 1 = ‘Not at all concerned’; 4 =’Somewhat concerned’; 7 =’ Very concerned.’ 
Responses interpreted as indicating being ‘somewhat’ concerned or more are highlighted in 
yellow. 
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Figure 41: Frequency diagrams showing affected individuals’ concern 
for other relatives developing mental illness. 
 
Figure 42: Frequency diagram showing relatives' concern for other 
relatives developing mental illness. 
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Concern: statistical analyses 
Mann Whitney U-Test 
Mann-Whitney U Test was applied to test for differences in concern between groups 
of respondents (i.e. affected individuals compared to relatives; males compared to 
females). 
 
Comparing affected individuals and relatives, concern was significantly greater 
amongst affected individuals (mean rank = 48.67, median =5.00) than relatives 
(MDN= = 4.00, U= 532.000; Z= -2.738, p=0.006). Effect size value size ( r = -0.295) 
suggest this approached moderate practical significance. 
 
Gender had no significant effect on concern when analysing all respondents 
together (U= 752.500, Z = -.701, p>0.05). However, analysing relatives and affected 
individuals separately revealed that concern was significantly greater amongst 
female affected individuals (mean rank = 32.11 , median = 5.00, mean =5.219)  than 
male affected individuals (median = 5.00, mean rank = 23.69, mean =  4.500, U = 
268.500, Z = -1.962, p = .05). Effect size value (r = -.262) suggests a small to 
moderate practical significance. 
 
Spearman’s rank correlation 
 
In order to identify potential variables influencing concern spearman’s rank 
correlation was used to test for associations between concern and i) illness 
attribution variables (GA; EA) and ii) illness attribution certainty variables (GAC; 
EAC). 
All correlations are shown in table 17. 
 The only testable variable significantly associated with concern was attribution of 
mental illness to genetic factors (GA). This correlation was significant and positive, 
for both affected individuals (rs=.324, p=0.014) and relatives (rs =.558, p=0.002).  
Thus, for all respondents, greater concern for relatives becoming ill was associated 
with greater attribution of the mental illness to genetic factors (GA).  
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Table 17: Spearman’s rank correlations between concern and attribution and 
attribution certainty variables for affected individuals and relatives 
Concern 
(group) 
Testable variable 
GA GAC EA EAC 
Concern 
(Affected 
individuals) 
.324** .187 .005 .009 
Concern 
(Relatives) 
.558** -.063 -.308 -
.158 
 
Note: GA = attribution of mental illness to genetic factors, GC = Certainty regarding 
attribution of mental illness to genetic factors, EA = attribution of mental illness to 
environmental factors, EC = Certainty regarding attribution of mental illness to environmental 
attribution. *p <.05, **p <.01 
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ii. Perceptions of familial risk (Risk estimation) 
To explore accuracy of perceptions of quantitative risk amongst respondents, 
respondents were asked to estimate the chances of i) the offspring and ii) the sibling 
of an individual with their or their relative’s mental illness also developing mental 
illness. 
Anchored options provided were: 1% (representing an approximation of population base rate) 
10% (representing an approximation of actual first-degree relative risk), 25%, 50%, 100%. (three 
higher than actual risks*) “Don’t know” and “Other” were two alternative options 
provided. 
*For depression, estimations of 50% or 100% were considered ‘higher than actual’ risks, as age-
adjusted risk to first-degree relatives is 5-30%. 
 
 
Perceptions of familial risk (Risk estimation) - Results 
 
Risk to offspring 
For all diagnoses, 16% of affected individuals (n=9) and 19% of relatives (n=5) 
reported that they did not know the risk of recurrence to offspring. 
Of the 70 respondents that provided actual estimates to offspring, 63% of affected 
individuals (n=30) and 82% of relatives (n=18) overestimated risk. 30% of 
respondents (n=21) correctly estimated risk to offspring. Only one respondent, a 
relative, underestimated risk to offspring.  
All data are shown in tables 18-19 (following page) 
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Table 18: Frequency table showing affected individuals’ estimation of risk to 
offspring. 
Note: BPD = Bipolar disorder 1, Bipolar disorder 2, rapid cycling. ‘Psychosis’ = 
schizophrenia, schizoaffective disorder, psychotic depression. Depression = recurrent 
depression, clinical depression. Anxiety disorders = anxiety, anxiety with depression, OCD, 
PTSD including with depression and/or anxiety. Diagnoses grouped according to ICD-10 
classification. ‘Other’ = anorexia. Overestimations are highlighted in yellow; responses 
reporting uncertainty of risk are highlighted in turquoise. a = 15% estimate included, b= 75% 
estimate included. n=57. 
Table 19: Frequency table showing relatives’ risk estimation to offspring.  
Note: BPD = Bipolar disorder 1, Bipolar disorder 2, rapid cycling. ‘Psychosis’ = 
schizophrenia, schizoaffective disorder, psychotic depression. Depression = recurrent 
depression, clinical depression. Anxiety disorders = anxiety, anxiety with depression, OCD, 
PTSD including with depression and/or anxiety. Diagnoses grouped according to ICD-10 
classification. ‘Other’ = anorexia. Overestimations are highlighted in yellow; responses 
reporting uncertainty of risk are highlighted in turquoise. n=27. 
Psychiatric 
Diagnosis 
Risk estimation to offspring – affected individuals  
1% 10% 25% 50% 100% I don’t 
know 
TOTAL 
BPD 0 11a 8 14 1 4 38 
Psychosis 0 1 0 0 1 3 5 
Depression 0  2 2 0 2 6 
Anxiety 
disorders 
0 3 1 2b 0 0 6 
Other 0 1 0 1 0 0 2 
Psychiatric 
Diagnosis 
Risk estimation to offspring – relatives  
1% 10% 25% 50% 100% I don’t 
know 
TOTAL 
BPD 0 1 2 4 1 2 10 
Psychosis 1 1 1 4 0 1 8 
Depression 0 0 0 1 0 0 1 
Anxiety 
disorders 
0 1 1 4 0 1 7 
Other 0 0 0 0 0 1 1 
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Figure 43: Bar chart showing accuracy (%) of respondents’ risk estimation to 
offspring 
  
Note: Represents respondents providing an estimate of risk; respondents that indicated they 
did not know risk were excluded. For all diagnoses. n=70. 
 
 
Risk to sibling 
 
Of all respondents that answered this question (n=82), across all diagnoses, 11% of 
affected individuals (n=6) and 19% relatives (n=5) reported that they did not know 
the risk to sibling. 
Of the respondents that provided an estimate of risk (n=71), 28% of affected 
individuals (n=14) and 29% of relatives (n=6) correctly estimated risk. Conversely, 
60% affected individuals (n=30) and 48% of relatives (n=10) overestimated risk. 
28% (n=14) of affected individuals and 28% (n=6) relatives correctly estimated risk. 
12% affected individuals (n=6) and 24% relatives (n=5) underestimated risk.  
28% of affected individuals (n=14) and 29% of relatives (n=6) correctly estimated 
risk. 12% of affected individuals and 24% relatives underestimated risk. 
All data are shown in tables 20-21 and fig. 44. 
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Table 20: Frequency table showing affected individuals’ risk estimation to sibling.  
Psychiatric 
Diagnosis 
Risk estimation to siblings – affected individuals  
1% 10% 25% 50% 100% I don’t 
know 
TOTAL 
BPD 4 10 14 4 1 4 37 
Psychosis 0 1 1 2 0 1 5 
Depression 0 1 0 4 0 1 6 
Anxiety 
disorders 
2 1 1 2c 0 0 6 
Other 0 1 0 1 0 0 2 
Note: BPD = Bipolar disorder 1, Bipolar disorder 2, rapid cycling. ‘Psychosis’ = 
schizophrenia, schizoaffective disorder, psychotic depression. Depression = recurrent 
depression, clinical depression. Anxiety disorders = anxiety, anxiety with depression, OCD, 
PTSD including with depression and/or anxiety. Diagnoses grouped according to ICD-10 
classification. Overestimations are highlighted in yellow; responses reporting uncertainty of 
risk are highlighted in turquoise. C = 75% risk estimate included. n=56. 
Table 21: Frequency table showing relatives’ risk estimation to sibling.  
Note: BPD = Bipolar disorder 1, Bipolar disorder 2, rapid cycling. ‘Psychosis’ = 
schizophrenia, schizoaffective disorder, psychotic depression. Depression = recurrent 
depression, clinical depression. Anxiety disorders = anxiety, anxiety with depression, OCD, 
PTSD including with depression and/or anxiety. Diagnoses grouped according to ICD-10 
classification.. Overestimations are highlighted in yellow; responses reporting uncertainty of 
risk are highlighted in turquoise. C = 75% risk estimate included. n=26. 
 
Psychiatric 
diagnosis 
Risk estimation to sibling – relatives   
1% 10% 25% 50% 100% I don’t 
know 
TOTAL 
BPD 1 3 2 2 0 2 10 
Psychosis 3 1 2 0 0 1 7 
Depression 0 0 0 1 0 0 1 
Anxiety 
disorders 
1 2 2 1 0 1 7 
Other 0 0 0 0 0 1 1 
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Figure 44: Bar chart showing accuracy of respondents’ risk estimations to sibling 
 
Note: Represents respondents providing an estimate of risk; respondents that indicated they 
did not know risk were excluded. For all diagnoses. n=71 
 
Perceptions of familial risk (Risk estimation) - Statistical analyses 
Mann Whitney U-Test 
To attempt to identify factors influencing accuracy of risk estimation, Mann-Whitney 
U-Test was used to enable comparison between respondents who overestimated 
risk to offspring and those who did not overestimate risk to offspring in regards to i) 
illness attribution variables (GA; EA) ii) illness attribution certainty variables (GAC; 
EAC) and ii) concern for other relatives becoming ill (C).  
Concern for relatives becoming ill was significantly greater amongst respondents 
that overestimated risk (MDN = 5, mean rank = 38.86) than those who did not 
overestimate risk (MDN = 4, mean rank = 28.16, U = 366.500, Z = -2.094, p = 
0.036). 
Analysing affected individuals and relatives separately, concern for relatives 
becoming ill was significantly greater amongst affected individuals that 
overestimated risk (MDN = 5.5, mean rank =28.05 ) than those that did not 
overestimate risk (MDN = 4.5, mean rank = 12.39,U = 163.500, Z = -2.355, p = 
.019). 
No other significant differences were found. 
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iii. Effect of mental illness on family planning decisions 
To assess impact on family-planning, respondents were presented with the 
following question: 
‘Has your diagnosis of mental illness affected your decision-making regarding family 
planning, or do you think it may in the future? 
Anchored responses provided were ‘Yes,’ ‘No’  or ‘other’ in which respondents were 
provided with a free-form response to write their own answer. 
Respondents that selected ‘Yes’ were also asked to describe how the mental illness 
had impacted their family-planning decisions. 
Anchored responses provided with ‘A decision to have more children,’ ‘A decision to 
have less children,’ ‘A decision to have no children,’ or ‘Other’ in which respondents 
were provided with a free-form response to write their own answer. 
 
Effect on family-planning decisions - Results 
Of the 55 affected individuals that provided answers for this question, almost half 
(n=27, 49%) reported that their mental illness had influenced their family-planning 
decisions. Of these respondents, 68% (n=19) reported it had favoured a decision to 
have fewer or no children. 
 
Fewer relatives (14%, n=4) indicated that their family history of mental illness had 
influenced their family-planning decisions, and only 2 relatives (7%) reported it had 
resulted in a decision to have fewer or no children. 
 
All frequencies are shown in tables 22-23 and fig. 45. 
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Table 22: Frequency table showing impact of mental illness on family-planning 
decisions for affected individuals and relatives. 
 
Group Affected family-planning? TOTAL 
Yes No Other 
Affected 
individuals 
27 23 5 55 
Relatives 4 21 3 28 
 
 
Table 23: Frequency table describing effect of mental illness on family-planning 
decisions 
Group Effect on family-planning  TOTAL 
More children Less children No children Other 
Affected 
individuals 
0 4 15 8 27 
Relatives 0 0 2 2 4 
Figure 45: Frequency diagram showing impact of mental illness on family-
planning decisions for respondents. 
 
Significantly more affected individuals (red bars) reported effects on family-planning than 
relatives (blue bars)  
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Effect on family planning – statistical analyses 
 
Chi-square test 
 
Chi-square test revealed a significant difference on impact on family planning 
between affected individuals and relatives (χ 2 (1, n=75) = 9.925, p= 0.002). Odds 
ratio = 6.163. 
 
Using the equation 
  
Whereby RR = risk ratio; OR = odds ratio  
Pref = Prevalence of the outcome in the reference group 
 
Gives RR as 3.375 
 
This seems to represent that the chances of affected individuals reporting effect on 
family planning is 3.375 times higher than relatives. 
 
Comparing genders, there was no significant difference between males and females 
when all respondents were analysed together (χ²  (1, n=74) = .323, p>.05).  
 
However, analysing affected individuals and relatives separately, there was a 
significant difference between female affected individuals and male affected 
individuals in regards to family-planning (χ² (1, n=49) = 4.426, p =.046).  Odds ratio 
= 3.529. 
Using the equation 
  
Whereby RR = risk ratio; OR = odds ratio  
Pref = Prevalence of the outcome in the reference group 
Gives RR as 2.156 
 
This seems to represent that, based on the odds ratio, the chances of female 
affected individuals reporting effects on family planning is 2.156 times higher than 
male affected individuals. 
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Mann-Whitney U-test 
To attempt to identify factors influencing family-planning decisions, Mann-Whitney 
U-Test was applied to compare differences between respondents who reported 
effects on family-planning, and those who reported no effect on family-planning, in 
regards to i) illness attribution variables (GA; EA) ii) illness attribution certainty 
variables (GAC; EAC) and ii) concern for other relatives becoming ill (C).  
 
Analysing all respondents together, attribution of mental illness to genetic factors 
(GA) was significantly greater amongst respondents whom reported effects on 
family planning (median=4.00) than those who did not (median = 3.50, U = 437.500, 
Z = -2.692, p = 0.007). Effect size value (r=-.311) suggests moderate practical 
significance, indicating this difference is both significant and substantive. 
 
Additionally, concern for other relatives becoming ill (C) was significantly greater 
amongst respondents whom reported effects on family planning (median = 5.00) 
than those who did not (MDN =4.500, U = 431.500, Z = -2.746, p = 0.006, Effect 
size value (r=-.317) suggests moderate practical significance, indicating this 
difference is both significant and substantive. 
 
Analysing only affected individuals, attribution of mental illness to genetic factors 
(GA) was significantly greater amongst affected individuals whom reported effects 
on family planning (median = 4.00) than those who did not (median = 3.00, U = 
164.500, Z = -2.921, p = 0.003, r=-.413); the medium effect size indicates this 
difference is both significant and substantive. 
 
Additionally, certainty regarding the attribution of illness to genetic factors (GAC) 
was significantly greater amongst affected individuals whom reported effects on 
family planning (median= 6.00) than those who did not (median = 5.00, U =202.500, 
Z= -1.970, p= 0.049, r=-.281).   
 
No other significant differences were found between respondents. 
 
 
 
 
 
150 
 
Summary of findings 
Across all diagnostic categories, the majority of respondents quantitatively 
overestimated risk to both sibling and offspring of somebody with their or their 
relatives’ mental illness. Of all respondents providing estimates, almost half believed 
the risk to offspring to be 50% or higher. Overall, there was greater accuracy in 
regards to risk estimation to sibling in comparison to risk estimation to offspring. 
A notable proportion of respondents also indicated complete uncertainty regarding 
risk to first-degree relatives, with almost 20% (n=14) respondents reporting that they 
did not know the risk to offspring and almost 15% (n=11) that they did not know the 
risk to sibling. 
Concern about familial risk was high amongst respondents, with almost three 
quarters of respondents (n=64) reporting being concerned about familial risk, and 
almost a third (n=27) indicating very high degrees of concern. Concern was 
significantly greater amongst affected individuals in comparison to relatives, and 
affected individuals that were female in comparison to affected individuals that were 
male, indicating both being female and having a mental illness is associated with 
greater concern over familial risk. 
Additionally, for all respondents, concern was significantly and positively associated 
with attribution of mental illness to genetic factors, indicating greater endorsement of 
a genetic explanation of illness is associated with greater concern over familial risk. 
In regards to family-planning, almost half of affected individuals (n=27) reported that 
their mental illness had affected their family planning decisions, and of these 
respondents the majority (n=19) stated this resulted in decisions favouring having 
fewer or no children. Conversely, only 4 relatives reported that their relatives' mental 
illness had influenced their family-planning decisions. 
For all respondents, attribution to genetic factors was significantly greater amongst 
respondents that reported effects on family-planning than those that did not.  
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3.4 Awareness and perceptions of GC and PGC 
This section examined respondents’ awareness of genetic counselling prior to 
taking part in the study, and qualitatively assessed respondents’ perceptions of GC 
and quantitatively assessed perceptions of PGC, prior to respondents receiving 
information about genetic counselling. 
 
i. Awareness of GC 
To assess prior awareness of GC, respondents were presented with the question: 
“Had you heard of the term "genetic counselling" before participating in this study? 
You do not have to know what it is.” Anchored responses provided were ‘yes’ or 
‘no.’ 
Respondents who identified they had previously heard of GC were then asked to 
identify how they had previously come across the service. 
Respondents were presented with anchored responses, listed in table 24, and 
asked to select the most relevant answer. Respondents were also provided with the 
alternative option ‘other,’ which provided a drop-down free-entry box in which they 
could write their own answer. 
 
Awareness of GC - Results 
Of the 84 respondents that answered this question, the majority of affected 
individuals reported no prior awareness of GC, with (62%, n=34) having not heard 
of GC prior to participating in this study. Conversely the majority of relatives (66%, 
n= 19) reported they had heard of GC prior to participation.  
All data are given in table 24. 
 
Table 24: Frequency table showing awareness of GC prior to partaking in study 
Group Prior awareness of GC? TOTAL 
Yes No 
Affected individuals 21 34 55 
Relatives 19 10 29 
4 
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Chi-square test showed significantly greater awareness amongst relatives than 
affected individuals (χ² (1, n=84) = 5.688,p= 0.022). Odds ratio = 3.076. 
 
Using the equation: 
RR= (Probability exposed)/(probability non-exposed) 
Gives the equation:  
Whereby RR = risk ratio; OR = odds ratio  
Pref = Prevalence of the outcome in the reference group 
 This seems to represent that relatives were 1.716 times more likely to have heard 
of GC as affected individuals. 
There was no significant difference in awareness between males and females (χ² 
(1, n=83) =.829 , p>.05).  
 
 
ii. Sources of exposure to GC 
Respondents whom stated they had heard of GC prior to taking part in the study 
(n=40) were asked to indicate how they had come across GC and were provided 
with anchored responses: 1)Have received PGC 2) Have received GC for another health 
condition 3) Relative/friend has received GC 4) News 5) Internet 6) TV/Film 7) 
School/college/university 8) Am/ am training to become a GC 9) Through my job 10) Other 
(see table 25 and figure 27b), as well as the option to write their own alternative 
response. 
Results are given on the following pages 
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Sources of exposure to GC - Results 
Over half of respondents (58%, n=23) that reported awareness of GC reported 
exposure via media/communication sources (i.e. internet, TV and newspapers, see 
figure 27b). 10% respondents (n=4) had come across GC through their education 
(e.g. school/college/university), whilst only 8% respondents (n=3) were qualified or 
training to become genetic counsellors.  Only 5% of respondents (n=2, both 
relatives) had actually received GC for another health condition, whilst only one 
respondent (~3%) reported that a friend or relative had received GC. 
‘Other’ responses that were listed by relatives included having a relative that was 
interested in GC (n=1) and through NHS-related courses (n=1). Full data are shown 
in table 25 and figures 46-48. 
 
Table 25: Frequency table showing sources of exposure to GC for respondents that 
reported prior awareness 
Group Source of exposure TOTAL 
1 2 3 4 5 6 7 8 9 10 
Affected 
individuals 
0 0 1 5 7 3 2 1 2 0 21 
Relatives 0 2 0 4 2 2 2 2 1 4 19 
Note: 1)Have received PGC 2) Have received GC for another health condition 3) 
Relative/friend has received GC 4) News 5) Internet 6) TV/Film 7) School/college/university 
8) Am/ am training to become a GC 9) Through my job 10) Other 
 
154 
 
Figure 46: Pie chart showing sources of exposure to GC reported by 
respondents 
 
The majority of respondents (58%, n=23) had come across GC through 
media and communication mediums such as news, TV, internet and films, 
represented collectively by the green segment of the pie chart. 
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Figure 47: Frequency diagram showing sources of exposure to GC for 
affected individuals  
 
Figure 48: Frequency diagram showing sources of exposure to GC for relatives 
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iii. Perceptions of genetic counselling (qualitative analysis) 
To explore perceptions of genetic counselling prior to receiving any information 
about the service, all respondents were presented with the open-ended question:  
‘What is the first thing that comes to mind when you hear the term ‘genetic 
counselling’?’  
and were invited to write their own response. 
Results are presented below. 
 
Perceptions of genetic counselling (qualitative analysis) – Results  
 
Because of the differential awareness of GC between affected individuals and 
relatives, responses were analysed separately; however, the same major themes 
were identified between the two groups and so were pooled for means of reporting. 
Table 26 (on next page) shows views expressed according to group along with 
frequencies of each theme, to enable comparisons
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 Table 26: Themes, subthemes and examples for perceptions of GC 
 
TOTAL 
Response
s 
(n=80;100
%) 
AFFECTED 
INDIVIDUAL
S 
Responses 
(n=53;100%) 
RELATIVES 
Responses 
(n=27;100%) 
Uncertainty about purpose – What is genetic counselling? 
“What is it?”; “Can’t see the connection between genetics and counselling.” 
8 (10%) 7 (13%) 1 (4%) 
Statements conceptualising GC as “just therapy” 
i) Psychotherapeutic counselling ii) Family therapy iii) Therapy for relatives of ill affected individuals 
“Prevents distress”; “Just counselling.”; “Therapy for related affected individuals.”; “Therapy for family members of the sick 
person.” 
9 (11%) 7 (13%) 2 (7%) 
Statements associating GC with disease – Genetic counselling and disease 
i)Genetic conditions ii)  iv) Non-genetic contributions to disease iii) Family history of mental illness  
‘Family history of illness’; ‘Inherited problems’; ‘Nature and nurture.’ 
46 (58%) 28 (53%) 18 (67%) 
Statements associating GC with concepts of familial risk – “Genetic counselling is about genetic risk” 
i) To offspring ii) To self and relatives iii) Genomic technologies for risk assessment (i.e. genetic testing) 
“Risk of children developing the disorder”; “Chances of (children) inheriting the disorder”; “Isolating the risk gene and discussing 
chances of it being passed on.” 
18 (23%) 9 (17%) 9 (33%) 
Statements conceptualising GC as a medically therapeutic/supportive intervention” 
i) Coping/therapy/support in regards to having/at risk of having an illness ii) Facilitates psychological adjustment to the illness iii) 
Reduces self-blame 
“Therapeutic counselling for people affected by genetic conditions.” ;”Coming to terms with illness/risk .””Reinforce the belief that 
it’s not the individual’s fault they developed this illness.” 
11 (14%) 6 (11%) 5 (19%) 
Statements associating GC with decision-making in regards to having/being at risk of having illness 
i) Advice to base decisions on ii) Understanding treatment options iii) Risk-reduction strategies iv) Reproductive decision-making 
“Advice regarding choices”:“Taking action before illness manifests”; “Information about genetic conditions when deciding to start 
a family.” 
7 (9%) 4 (8%) 3 (11%) 
Statements associating GC with ethical/moral issues 
i) Eugenic-type values/directive counselling  
“Being told not to have children so you don’t pass on your defective genes.”;“To remove abnormality from the gene 
pool.” 
ii) May cause psychological distress 
 “Gives people options but also dilemmas.” “Might cause worry/anxiety.” 
9 (11%) 
3 (4%) 
6 (8%) 
8 (15%) 
3 (6%) 
5 (9%) 
1 (4%) 
0 
1 (4%) 
Table 26: Themes, subthemes and examples for perceptions of GC 
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“What is genetic counselling?” 
One relative and several affected individuals stated that they had not heard of 
genetic counselling before taking parting in the study and were uncertain about what 
it meant, or what it would involve and/or what its purpose may be.  
 
“What is it?” (Relative); 
 
 “Can’t see the link between genetics+ counselling.” (Affected individual) 
 
 
GC is “just therapy” 
A number of affected individuals and two relatives conceptualised GC as a 
therapeutic intervention but not specifically in relation to having or being at risk of 
having genetic conditions: 
 
“Preventing distress”; (Affected individual) 
 
 “Just counselling, nothing too specialised.” (Relative) 
 
A few affected individuals specifically indicated they believed GC may be a form of 
therapy for related affected individuals:  
 
“councelling(sic) around people genetically related.” 
 
“Bringing the whole family together to talk about any mental ill health…” 
 
Additionally, a small proportion of respondents conceptualised GC as counselling 
specifically for relatives of affected individuals affected by medical conditions: 
 
 “Talking with and supporting the relatives of the person with the illness.” 
(Affected individual) 
 
“Counselling provided for family of a mentally ill person, to try and prevent 
them also suffering the same condition.” (Relative)  
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Genetic counselling and disease” 
The majority of respondents correctly conceptualised GC as a medical intervention 
regarding disease; and most affected individuals and relatives associated GC with 
genetic conditions and/or family history of a medical disorder. 
 
“…. I’d guess it’s about inherited problems” (Affected individual) 
 
 “Someone seeking genetic counselling may be concerned about hereditary 
illness in their family.” (Relative) 
 
Several respondents named specific genetic conditions including Huntingdon’s, 
muscular dystrophy, cystic fibrosis, and cancer: 
 
“Someone seeking genetic counselling may be concerned about hereditary 
illness in their family e.g. heart conditions, cancer etc.” (Relative) 
 
“That it is to do with passing on faulty genes, for example Tay Sach’s 
disease.” (Individual) 
 
Only one respondent indicated that GC may also involve discussions non-genetic 
contributions to disease: 
 
“Counselling about Nature N(sic) Nurture” (affected individual). 
 
A proportion of respondents discussed GC in relation to genetic contributions 
mental illness specifically:  
 
“The professionals would look at the biological workings of the family as a 
whole to identify any trends or similarities which may lead to a conclusion that 
mental health issues are possibly hereditary…” (Relative) 
 
“Counselling about the genetic factors affecting mental illness…” (Individual) 
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 “GC involves information about familial risk” 
A proportion of respondents associated GC with concepts regarding familial risk of 
genetic disease. Respondents typically discussed how GC might involve information 
or advice regarding risk to offspring or future descendants, as well as to themselves 
and other family members: 
 
“Talking through how mental illness may affect children by passing on the 
illness through the blood line.” (Relative) 
 
“An examination regarding the breakdown of inherited genetic traits (with 
regards to mental health or otherwise) and potential risk factors for 
subsequent descendants.” (Affected individual) 
 
 “Advice given in regard to a parent to be or a family on the likelihood of 
genetics effecting their offspring, or indeed current family members in the 
future.” (Relative) 
 
“…discussing the likelihood of that gene affecting future or existing members 
of the family.” (Individual) 
 
In addition a small number of respondents specifically alluded to concepts related to 
genomic technologies (e.g. testing) for medical conditions, in order to obtain risk 
assessments: 
 
“The analysis of ones genes to determine those which carry the propensity for 
certain conditions.” (Relative) 
 
 “Isolating the gene which causes the illness and discussing the likelihood of 
that gene affecting future or existing members of the family.” (affected 
individual) 
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“GC may be supportive/therapeutic for those with a medical condition” 
 
Several respondents conceptualised GC as helpful, supportive, and facilitating 
coping for those with/at risk of a genetic/medical condition, including alluding that it 
may facilitate psychological acceptance to illness or risk: 
 
“Therapy for people’s who’s(sic) genes show potential to have an illness.” 
(Relative) 
 
“Counselling for coping with a congenital(sic) illness” (affected Individual) 
 
 “Counselling regarding the genetic history of a disorder and how to come to 
terms with it.”(affected individual) 
 
 “…If hereditary, the counselling aspect would be to help those come to terms 
with the possibility that they may ‘inherit’ a relative’s mental health condition or 
one similar.” (Relative) 
 
Additionally one affected individual indicated that GC may reduce feelings of self-
blame around illness causation by alleviating feelings of self-blame regarding the 
illness: 
 
“It makes me think that a sufferer of a particular mental illness could be 
counselled about the likelihood that their disability has been passed onto them 
and therefore hopefully re-inforce the belief that it is not their own fault that 
they have developed such a disability.” 
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 “GC may help with decision-making” 
A few respondents conceptualised GC as an information-provision service that may 
provide advice that may facilitate decision-making relation to having an illness or 
being at risk of having an illness, that may reduce risk of illness or facilitate better 
management, including better understanding available treatment options and risk 
reduction strategies: and some reflected on their own experiences of GC:  
 
“Have had genetic counselling in the past as have a family history of muscular 
dystrophy. Was visited by a specialist health visitor and advised regarding 
choices.” (Relative) 
 
 “Finding the suitable genetic precipitant for a particular health issue and how 
to digest information with regards to future decisions/treatments.” (affected 
individual) 
 
 “…Being given advice that it may be in my interests to take action before a 
disease/illness manifests, e.g. pre-emptive surgery to prevent cancer.” 
(affected individual)  
 
A small proportion of respondents associated GC with reproductive settings and/or 
reproductive decision-making: 
 
“I think it means being advised about genetic disorders when deciding to have 
a family…” (affected individual).  
 
“It makes me think of a couple hoping to start a family but are concerned 
about the risk factor of having a child who may develop a mental illness…” 
(Relative) 
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Ethical/moral issues 
Several respondents raised ethical and moral issues that may be associated with 
providing GC. 
 
A few affected individuals associated GC with eugenic-type values, with some 
conceptualising it as a directive approach that may be used to influence individual’s 
reproductive decisions, to reduce the presence of certain genes/characteristics 
within the population: 
 
“There is the fear that it has the potential to slip into eugenic thinking.” 
(affected individual) 
 
 “The idea that certain characteristics have been deemed as undesirable by 
others and people are given counselling to irradiate(sic) the abnormality from 
the gene pool. It feels cold, unfeeling, unhelpful, disrespectful… and is 
extremely worrying.” (Individual) 
 
 “Being told not to have a kid because U(sic) may pass on your defective 
genes.” (Individual) 
 
 
Additionally, a small number of affected individuals and one relative made 
statements associating GC with psychological distress. A proportion (n=2) proposed 
that the information received may increase anxiety and induce worry and/or fear in 
affected individuals, including themselves personally, particularly in relation to 
concern regarding familial risk, alluding to concepts of genetic determinism: 
 
“Trying to put a mentally ill person into a position where they are worrying 
about their children being ill like themselves…” (Individual) 
 
“It would be horrible for me to find out I have given this illness to my children. 
And they might give it to my grandchildren.” (Individual) 
 
Whilst another individual simply stated: 
“Being given bad news.” 
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A few other respondents alluded that the information gained may present cognitive 
burden by inducing decision-making uncertainty or presenting new psychological 
and/or ethical considerations for people, and some specifically due to the uncertain 
nature of genetic information: 
 
“Would give people options but also dilemmas…” (Relative) 
 
“…I wonder if the suggestion of counselling for a problem that might or might 
not occur could cause more anguish and problems than it might alleviate.” 
(Individual) 
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iv. Perceptions of Psychiatric genetic counselling (quantitative 
analysis) 
 
To explore baseline beliefs and perceptions regarding the process and purpose of 
GC specifically for psychiatric conditions, respondents were presented with 
statements about PGC (listed in figs 49-52), prior to watching the informational 
video, and asked to indicate whether they believed them to be true or false. 
 
Perceptions of Psychiatric Genetic Counselling (quantitative analysis) – 
Results 
Of the 82 respondents that answered this question, over 96% of affected individuals 
(n=53) and 100% (n=55) of relatives believed that a GC would provide information 
about the genetic contributions to mental illness. 89% respondents (n=73) correctly 
believed that a genetic counsellor would provide information about the chances of 
other children becoming ill. 
 
However fewer affected individuals (71%, n=39) and relatives (74%, n=20) believed 
that GC could provide information about non-genetic factors involved in mental 
illness pathogenesis. Comparatively fewer respondents (74%, n=61) also believed a 
GC would provide information about protecting mental health. Additionally, only 55% 
of affected individuals (n=30) and 70% of relatives (n=19) believed a GC would 
provide emotional support. 
 
Almost half of affected individuals (n = 24) and 52% of relatives  incorrectly believed 
that a genetic counsellor could arrange genetic tests to diagnose mental illness in 
themselves or their relatives, and 35% of affected individuals (n=19) and 30% of 
relatives (n=8) incorrectly believed pre-natal testing for mental illness could be 
arranged through a genetic counsellor. Almost 20% of affected individuals (n=9) 
believed a genetic counsellor would advise them whether or not to have children, 
and 15% of relatives (n=4) reported that they believed genetic counsellor would 
advise their affected relative whether or not have children. 
Full data are given in figs. 49-52. 
 
 
 
166 
 
Figure 49: Perceptions of PGC - Affected individuals: Agreement with correct 
statements 
 
 
 
 
 
 
Figure 50: Perceptions of PGC - Affected individuals: Agreement with incorrect 
statements 
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(n = 55) 
Key: 1)Gather information about my family's medical history 2)Gather information about my family's 
history of mental illness 3)Provide information about the chances of my children (including form future 
pregnancies) also becoming ill 4)Provide information about the chances of other relatives also becoming ill 
5)Provide information about the genetic contributions in mental illness 6)Provide information about the 
non-genetic factors in mental illness 7)Discuss ways I can protect my mental health 8)Discuss ways my 
relatives can protect their mental health 9)Provide referrals and information to other services that may be 
relevant to me 10)Provide emotional support 
Key: 1) Advise me whether or not to have children 2) Arrange genetic tests to diagnose mental illness 
in myself or my relatives 3)Arrange genetic tests to test for mental illness in future pregnancies 
4)Prevent future children from having mental illness 5)Arrange gene therapy to cure mental illness 
6)Decide what medications I should take for my mental illness 
(n = 55) 
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Figure 51: Perceptions of PGC – Relatives: Agreement with correct statements 
 
 KEY: 1)Gather information about my family's medical history 2)Gather information about my family's history of mental 
illness 3)Provide information about the chances of my children (including form future pregnancies) also becoming ill 
4)Provide information about the chances of other relatives also becoming ill 5)Provide information about the genetic 
contributions in mental illness 6)Provide information about the non-genetic factors in mental illness 7)Discuss ways I can 
protect my mental health 8)Discuss ways my relative with a mental illness can protect their mental health 9)Provide 
referrals and information to other services that may be relevant to my relative with a mental illness 10)Provide referrals 
and information to other services that may be relevant to me 11)Provide emotional support 
 
Figure 52: Perceptions of PGC – Relatives: Agreement with incorrect statements 
 
KEY: 1) Advise me whether or not to have children 2) Advise my relative with a mental illness whether or not to have 
children 3) Arrange genetic tests to diagnose mental illness in myself or my relatives 4) Arrange genetic tests to test for 
mental illness in future pregnancies 5)Prevent future children from having mental illness 6)Arrange gene therapy to cure 
mental illness 7)Decide what medications my relative should take for their mental illness 8)Tell me what medications I can 
take to prevent myself from developing mental illness 
 
(n = 27) 
(n =27) 
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Summary of findings 
 
Collectively less than half of respondents reported having heard of GC prior to 
participation, and awareness was significantly lower amongst affected individuals in 
comparison to relatives. Of the respondents that had heard of GC almost 60% 
stated awareness was via media and communication sources such as the 
television, films and internet. A small proportion reported being GC’s themselves. 
To a degree respondents indicated an understanding of the process and goals of 
both traditional GC (assessed qualitatively) and GC specifically within psychiatry 
(assessed quantitatively). 
For example, the majority of respondents conceptualised GC, qualitatively, as a 
medical intervention for affected individuals with or at risk of having a genetic 
condition; that it often involves learning about genetic risk to family members, and 
some identified that it may help with decision-making, typically in regards to 
reducing genetic risk. A number of respondents also discussed how GC may have 
therapeutic values, predominantly conceptualised as enabling psychological or 
emotional acceptance of the condition or risk (e.g. “coming to terms with the 
condition.”). 
In regards to perceptions of GC specifically for psychiatric conditions, almost all 
respondents correctly identified that a GC would gather family history of mental 
illness, discuss information about the genetic contributions to mental illness, and 
provide estimates for the risk of a child developing mental illness, for example. 
However respondents also demonstrated some limited comprehension and 
misconceptions regarding the practice and purpose of both GC and PGC. 
For example, in regards to perceptions of GC, respondents often conceptualised the 
patient’s role as passive, e.g. the patient was given information, or being told what 
action to take, in contrast to GC being a two-way, dynamic exchange between 
patient and counsellor. Additionally, other psychotherapeutic outcomes of GC, such 
as reducing guilt and self-blame, alleviating anxiety, and addressing shame and 
stigma were not discussed by the majority of respondents, with only one proposing 
that GC may reduce ‘self-blame.’ Furthermore, whilst the majority of respondents 
discussed concepts relating to risk communication and genetics, only one 
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respondent indicated that information about aetiology may incorporate information 
about non-genetic factors (i.e. “nature v. nurture”). 
Notably, a few affected individuals also associated GC with eugenic-type values, 
conceptualising the role of the GC as directive, with the GC influencing the patient’s 
decision-making in regards to family-planning – as one respondent put it: 
“counselling to irradiate (sic) abnormalities from the gene pool.”  
In regards to GC specifically for psychiatric conditions, comparatively fewer 
respondents correctly identified a GC would provide emotional support, discuss the 
contribution of genetic factors in mental illness pathogenesis, and provide 
information about protecting mental health, which are in practice integral to PGC 
interventions. Additionally, almost half of respondents incorrectly believed that a GC 
would provide diagnostic testing and prenatal testing, which is not currently clinically 
available for psychiatric conditions, and almost 20% believed a GC would influence 
reproductive decision-making and advise an affected individual whether or not to 
have children, rather than promoting autonomous decision-making. 
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3.5 Interest in receiving PGC 
 
Interest in receiving PGC was initially assessed before respondents had received 
information about GC and PGC.  
Respondents that indicated they would not like to have PGC, or were unsure about 
whether they would like to have PGC, were invited to indicate why they might not 
wish to receive PGC, and provided with anchored responses, listed in figures 27a 
and 27b. 
 Respondents then watched the informational video which provided information 
about PGC and clarified some common misconceptions about the service. 
Following the informational video, respondents’ interest in receiving PGC was then 
assessed again, using a Likert-type response item. 
Respondents’ perceived usefulness of the service, also using a Likert-type response 
item, was also assessed following the informational video. 
 
 
Results are given in the following pages 
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i. Interest in PGC prior to watching informational video 
 
Prior to watching the informational video, respondents were asked ‘Would you like 
to have genetic counselling regarding your mental illness (for affected 
individuals)/the mental illness in your family (for relatives)’. 
Anchored responses were ‘Yes,’ ‘No,’ or ‘Not sure.’ 
 
Interest in PGC prior to watching informational video - results 
 
Of the 83 respondents that answered this question, 45% affected individuals (n=25) 
and 46% of relatives (n=13) indicated they would like to receive PGC. 24% (n=13) 
of affected individuals and 29% (n=8) of relatives indicated they would not like to 
receive PGC. 31% (n=17) affected individuals and 25%  (n=7) relatives indicated 
they were uncertain about whether they would like to receive PGC. 
Chi square analysis on interest in receiving PGC did not differ significantly between 
affected individuals and relatives (χ² (1, N=59) = .089, p>.05), or between males 
and females χ² (1, N=58) = 4.230, p=.075). 
Frequencies are shown in table 27. 
 
Table 27: Frequency table showing demand for PGC prior to watching informational 
video 
 
 
 
Group Like to receive PGC? TOTAL 
Yes No Not sure 
Affected 
individuals 
25 13 17 55 
Relatives 13 8 7 28 
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ii. Reasons for not wanting PGC prior to watching informational video 
 
Respondents that selected ‘No’ or ‘Not sure’ in response to the question ‘would you 
like to have PGC’ were invited to explain why they may not wish to receive the 
service. 
Respondents were provided with a list of statements (see figures 53-54) and asked 
to select any answers any which applied to them. 
 
Reasons for not wanting PGC prior to watching informational video - results 
 
Of the 43 respondents that answered this question, half of affected individuals 
(n=14) and 47% of relatives (n=7) identified that they would not wish to receive PGC 
because they did not know enough about the service. Almost a third of affected 
individuals (n=9) reported being worried that they would find out things they wish 
they hadn’t; 20% of relatives (n=3) reported this a possible deterrant.  A proportion 
of respondents (21%, n=9) believed they would not be able to afford an appointment 
with a GC. 
Several affected individuals (21%, n=6) reported that they would not wish to receive 
PGC because they did not have or did not want to have children, however no 
relatives reported this as a potential reason. Conversely, a number of relatives 
(n=4,26%) but only one affected individual reported not knowing their family history 
of mental illness as a potential barrier. 
Full data for all items are shown in figures 53-54 (following page). 
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Statement 
% Individuals
(n=28)
Key: 1) I do not know enough about psychiatric genetic counselling 2) There is no role/only a 
small role for genetics in mental illness 3) MY mental illness is not genetic - no other affected 
individuals in my family have this mental illness 4) Scientists still don't know what gene(s) 
cause mental illness  5) I don't know my family history of mental illness 6) I don't want to 
have genetic testing  7) I do not have children or do not want to have children  8) I am 
worried the genetic counsellor might tell me not to have children 9) I don't want to know the 
chances of me or my relatives developing mental illness 10) The people I care most about 
are past the age at which they'd develop mental illness 11) I am worried I will find out things 
I wish I hadn't 12) I am worried the genetic counsellor will tell me my mental illness is my 
fault 13) I am worried the genetic counsellor might tell me there is nothing I can do about 
my mental illness 14) I am not currently unwell 15)There is not a lot that can be done to 
prevent mental illness 16) I do not have the time 17) I do not think I can afford an 
appointment with a genetic counsellor 18) I am worried it will affect my insurance or privacy  
Figure 53:  Reasons for not wanting PGC prior to watching informational video (Affected individuals) 
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Statement 
% Respondents
(n=15)
Key: 1) I do not know enough about psychiatric genetic counselling 2) There is no role/only a small 
role for genetics in mental illness 3) MY RELATIVE'S mental illness is not genetic - no other affected 
individuals in my family have this mental illness 4) Scientists still don't know what gene(s) cause 
mental illness  5) I don't know my family history of mental illness 6) I don't want to have genetic 
testing  7) I do not have children or do not want to have children  8) I am worried the genetic 
counsellor might tell me not to have children 9) I don't want to know the chances of me or my 
relatives developing mental illness 10) I am too old to develop mental illness 11) The people I care 
most about are past the age at which they'd develop mental illness 12) I am worried I will find out 
things I wish I hadn't 13) I am worried the genetic counsellor will tell me my relative's mental illness is 
my fault 14) I am worried the genetic counsellor might tell me there is nothing I can do about my 
relative's mental illness 15) My relative is not currently unwell 16 )There is not a lot that can be done 
to prevent mental illness 17) I do not have the time 18) I do not think I can afford an appointment 
with a genetic counsellor 19) I am worried it will affect my insurance or privacy  
Figure 54: Reasons for not wanting PGC prior to watching informational video (Relatives) 
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iii. Interest in receiving PGC following informational video 
 
After watching the informational video, respondents’ interest in receiving PGC was 
queried using a 7-point Likert-type response item (1= I definitely would not like to 
have PGC; 4 = I might like to have PGC, 7=I definitely would like to have PGC; see 
figure 55). 
 
 
 
 
Interest in receiving PGC following informational video – results 
 
Of the 50 affected individuals and 24 relatives that answered this question, 78% of 
affected individuals (n=39) and 79% of relatives (n=19) indicated they might or 
would definitely like to receive GC if it were available. 52% of affected individuals 
(n=26) and 46% of relatives (n=11) indicated high levels of interest in receiving 
PGC. 
Conversely, 18% of affected individuals (n=9), and only 1 relative (4%) indicated 
that they definitely would not want to receive PGC. 
All data items are shown in table 28.  
 
 
 
 
 
 
Figure 55: Likert-type response to assess interest in PGC following informational 
video 
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Table 28: Frequency table showing respondents’ interest in receiving PGC following 
informational video 
Group Like to receive PGC? TOTAL 
1 2 3 4 5 6 7 
Affected 
individuals 
9 2 0 7 6 6 20 50 
Relatives 1 2 2 3 5 6 5 24 
Note: 1 = I definitely would NOT want to have PGC, 4 = I might like to have PGC 7= I 
definitely WOULD want to have PGC.  
Responses interpreted as indicating somewhat to definite interest in receiving PGC 
are highlighted in yellow. 
 
 
Interest in receiving PGC following informational video: statistical analysis 
 
Mann-Whitney U-Test 
To test for differences in interest in receiving PGC between groups of respondents 
(affected individuals compared to relatives, and males compared to females) Mann 
Whitney-U Test was applied. 
There was no significant difference in interest between affected individuals (MDN 
=6.00) and relatives (MDN =5.00), U=557,000 Z = -.510, p>.05; or between males 
(MDN = 5.00) and females (MDN = 6.00, U – 527.000, Z = -.872, p >.05). 
Analysing affected individuals separately, there was no significant difference in 
interest in PGC between males (MDN = 5.00) and females (MDN = 6.5), U = 
260.00, Z = =.716, p >.05); or between male relatives (MDN = 4) and female 
relatives (MDN = 5.5), U = 27.00, Z = -1.025, p >.05). 
Thus, it appears that neither gender nor having a mental illness significantly 
influenced interest in receiving PGC. 
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Spearman’s rank correlation 
 
To attempt to identify variables influencing interest Spearman’s rank correlation was 
used to test for association between interest in receiving PGC and i) illness 
attribution variables (GA, EA); ii) illness attribution certainty variables (GAC, EAC); 
and iii)concern for other relatives becoming ill (C). 
All correlations are shown in table 29. 
Table 29: Spearman’s rank correlations showing association between respondents’ 
interest in receiving PGC; illness attribution variables; illness attribution certainty 
variables; and concern for other relatives becoming ill. 
Group Testable variable 
GA GAC EA EAC C 
Affected 
individuals 
.382** -290* -135 -115 .411** 
Relatives -.195 .074 .156 .025 .174 
Note: GA = attribution of mental illness to genetic factors, GC = Certainty regarding 
attribution of mental illness to genetic factors, EA = attribution of mental illness to 
environmental factors, EC = Certainty regarding attribution of mental illness to environmental 
factors. *p <.05, **p <.01 
 
Amongst affected individuals, there was a significant and positive association 
between interest in receiving PGC and attribution of the mental illness to genetic 
factors (GA) (rs = .382, p=0.006). 
There was also significant and positive association between interest in receiving 
PGC and concern for other relatives also becoming ill (C) (rs = .411, p=0.003). 
Additionally, there was a significant and negative association between interest in 
receiving PGC and certainty regarding attribution of mental illness to genetic factors  
(GAC) (rs=-.290, p = .043). 
Thus, for affected individuals, greater interest in was associated with greater 
attribution to genetics in mental illness causation; greater concern for other relatives 
becoming il; and greater uncertainty regarding role of genetics in pathogenesis. 
No significant associations were found for relatives. 
178 
 
iv. Perceived usefulness of PGC following informational video – 
Quantitative analysis 
 
After watching the informational video respondents’ perceived usefulness of PGC 
was queried using two 7-point Likert-type response items (1= not at all useful; 4 = 
somewhat useful, 7=extremely useful; see figures 56a-d). 
Affected individuals were invited to report their perceived usefulness of PGC to both 
themselves and their family members. 
Relatives were invited to report their perceived usefulness of PGC to both 
themselves and their affected relative. 
All data are given in tables 30-31 and figs. 57-60 
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Fig. 56a) Likert-type response item to assess affected individuals’ perceived 
usefulness of PGC to self 
 
 
 
 
 
Fig. 56b) Likert-type response item to assess affected individuals’ perceived 
usefulness of PGC to family members 
 
 
 
Fig. 56c) Likert-type response item to assess relatives’ perceived usefulness 
of PGC to self 
 
 
 
 
 
 
Fig. 56d) Likert-type response item to assess relatives’ perceived usefulness 
of PGC to their affected relative 
 
 
Figures 56 a-d:Likert-type response items to assess perceived 
usefulness of PGC 
180 
 
Perceived usefulness of PGC following informational video - Results 
 
Perceived usefulness to self 
Of the 51 affected individuals and 24 relatives that answered this question, 75% of 
affected individuals (n=38) and 79% of relatives (n=19) perceived PGC as 
somewhat to extremely useful to themselves. Almost half of respondents (45%, 
n=34) selected ‘6’ or ‘7’ on the Likert-scale, indicating that they believed PGC would 
be highly useful to themselves. 
Conversely, 12% of affected individuals (n=6) and 13% of relatives (n=3) indicated 
they did not believe PGC would be at all useful for themselves. 
 
Perceived usefulness to others 
Affected individuals: 
66% of affected individuals (n=33) perceived PGC as potentially somewhat to 
extremely useful to their family members. 
However, 22% (n=11) of affected individuals believed PGC would be not at all 
useful to their family members. 
Relatives: 
92% of relatives (n=22) perceived PGC as somewhat to extremely useful to their 
affected relative. No relatives perceived PGC to be not at all useful to their affected 
relative. 
 
All data are given in tables 30-31 
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Table 30: Frequency table showing affected individuals’ perceived usefulness of PGC 
Perceived 
usefulness 
Perceived usefulness TOTAL 
1 2 3 4 5 6 7 
For self 6 2 5 9 6 7 16 51 
For family 
members 
11 5 1 9 8 7 9 50 
Note: 1 = “Not at all”, 4 = ‘Somewhat”, 7 = “Extremely”. Responses interpreted as PGC 
considered as somewhat to very useful are highlighted in yellow. 
 
 
 
Table 31: Frequency table showing relatives’ perceived usefulness of PGC  
Perceived 
usefulness 
Perceived usefulness  TOTAL 
1 2 3 4 5 6 7 
For self 3 1 1 5 3 4 7 24 
For 
affected 
relative 
0 1 1 2 4 6 10 24 
 Note: 1 = “Not at all” Somewhat”,, 7 = “Extremely”. Responses interpreted as PGC 
considered as somewhat to very useful are highlighted in yellow. 
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Figure 57: Frequency diagrams showing affected individuals’ perceived usefulness of 
PGC to self 
 
 
 
Figure 58:  Frequency diagram showing affected individuals’ perceived usefulness of 
PGC to family 
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Figure 59: Frequency diagram showing relatives’ perceived usefulness of PGC to 
self 
 
Figure 60: Frequency diagram showing relatives’ perceived usefulness of PGC to 
their affected relative 
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Perceived usefulness of PGC following informational video: Statistical 
analyses 
 
Mann Whitney U-Test 
Mann Whitney U-Test showed no significant difference in perceived usefulness for 
self between affected individuals (MDN = 5.000) and relatives (MDN = 5.000, 
U=608 Z=-.046, p >.05 ); or between males and females (MDN = 5.000, U = 
552.500, Z = -.701, p >.05).  
Thus neither gender nor having a mental illness influenced perceived usefulness of 
PGC. 
 
Spearman’s rank correlation coefficient 
 
In order to identify potential variables influencing respondents’ perceived usefulness 
of PGC, Spearman’s rank correlation was used to test for associations between 
perceived usefulness of PGC and i) illnes attribution variables (GA, EA) ii) illness 
attribution certainty variables (GAC, EAC) and iiI) concern for other relatives 
becoming ill (C) 
All correlations are shown in tables 32 and 33. 
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Table 32: Spearman’s rank correlations between affected individual’s perceived 
usefulness of PGC and illness attribution variables (GA, EA); illness attribution 
certainty variables (GAC, EAC); and concern 
 
 
Note: GA = attribution of mental illness to genetic factors, GC = Certainty regarding 
attribution of mental illness to genetic factors, EA = attribution of mental illness to 
environmental factors, EC = Certainty regarding attribution of mental illness to environmental 
factors. *p <.05, **p <.01 
 
 
 
Table 33: Spearman’s rank correlations between relatives’ perceived usefulness of 
PGC and attribution variables; attribution certainty variables; and concern. 
 
Note: GA = attribution of mental illness to genetic factors, GC = Certainty regarding 
attribution of mental illness to genetic factors, EA = attribution of mental illness to 
environmental factors, EC = Certainty regarding attribution of mental illness to environmental 
factors. *p <.05, **p <.01 
 
Affected individuals’  
perceived usefulness of 
PGC 
Testable Variable 
GA GAC EA EAC C 
For self .291* -.244 -.090 -.087 .405** 
For relatives .309* -.120 -.045 -.034 .454** 
Relatives’ perceived 
usefulness of PGC 
Testable Variable 
GA GAC EA EAC C 
For self -.194 -.005 .169 .019 .249 
For affected relative -.059 .386 -.218 .435* .271 
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Amongst affected individuals, there was a significant and positive association 
between perceived usefulness of PGC for self and attribution of the mental illness to 
genetic factors (GA) (rs= .291, p=0.038). 
Additionally, there was a significant and positive association between perceived 
usefulness of PGC for family members and attribution of the mental illness to 
genetic factors (GA) (rs= .309, p= 0.029). 
There was also a significant and positive association between perceived usefulness 
of PGC for self and concern for other relatives becoming ill (rs= .405, p=0.003). 
Additionally, there was a significant and positive association between perceived 
usefulness of PGC for family members and concern for other relatives becoming ill 
(rs= .454, p=0.001). 
 
Thus, perceived usefulness of PGC to both self and to family members was 
associated with greater attribution of the mental illness to genetics factors, and 
greater concern for relatives becoming ill.  
 
 
Amongst relatives, none of the tested variables reached or approached significant 
significance in association with perceived usefulness to self. 
Perceived usefulness of PGC for their affected relatives was significantly associated 
with certainty regarding attribution to genetic factors (GAC)(rs=.435, p=0.034). 
No other significant correlations were found. 
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Summary of findings 
 
Prior to watching the informational video interest in PGC was relatively low amongst 
both affected individuals and their relatives, with less than half of all respondents 
reporting that they would wish to receive PGC. Additionally, there was high degrees 
of uncertainty regarding the service, with almost a third of respondents (29%, n= 24) 
reported they did not know whether they would like to have PGC. 
The major reasons for not wishing to receive PGC reported by respondents was not 
knowing enough about the service, reported by almost half of respondents, and 
concern that they may find out information they wish they hadn’t, reported by almost 
a third of respondents. Over a fifth of respondents also believed that they would not 
be able to afford an appointment, when PGC would, in fact, be free of charge if 
provided on the NHS. For affected individuals, not having or not wanting children, 
and scientists not knowing which genes cause mental illness, were other frequent 
reasons given for hypothetical decline. Conversely, for relatives, not knowing their 
family history of mental illness was cited as a reason by a number of respondents. 
After watching the informational video, interest is PGC was much higher, with 78% 
of respondents (n=58) reported they might or would like to receive PGC. 
Additionally, 76% of respondents (n=57) believed PGC would be useful to 
themselves; 92% (n=22) of relatives believed PGC would be useful to their affected 
relation; and 66% (n=33) of affected individuals believed PGC would be useful to 
their family members, providing further indications that PGC was favourably viewed. 
For affected individuals, greater interest in PGC was significantly associated with 
greater attribution to genetics in mental illness causation; greater uncertainty 
regarding the role of genetics in illness causation; and greater concern for other 
relatives becoming ill. 
Similarly, for affected individuals, greater perceived usefulness of PGC following the 
informational video was significantly associated with greater attribution of the mental 
illness to genetic factors and greater concern for other relatives becoming ill. 
No significant associations between interest in, nor perceived usefulness of, PGC 
amongst relatives were detected. 
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3.6 PGC – Perceptions of value (qualitative analysis) 
 
To explore perceptions regarding the value of PGC, respondents’ were invited to 
write what aspects of PGC they considered useful to themselves, their family 
members (for affected individuals), and their affected relative (for relatives), after 
watching the informational video. 
PGC – Perceptions of value (qualitative analysis) – Results 
 
The same major themes were identified between affected individuals’ and relatives’ 
responses: increasing understanding about mental illness, increasing understanding 
about familial risk, management (protective/coping strategies), and 
psychotherapeutic values. Therefore respondents’ answers are pooled for means of 
reporting, however contextual differences between groups of respondents are 
highlighted in the text. 
Tables 34-37 reports theme and sub-themes identified, and separately reports i) 
affected individuals responses and ii) relatives’ responses 
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Better understanding mental illness 
 
Almost all respondents reported that increased understanding of the mental illness 
would be a useful aspect of PGC. 
The majority of respondents identified specifically that understanding of causal 
factors in mental illness pathogenesis, and especially gaining better understanding 
of interaction between genetic and environmental factors, would be valuable: 
 
“I think being able to understand mental illness better whilst looking at what 
may contribute to mental illness…” (relative) 
 
“Understanding the illness: especially relationship between environment and 
genes.” (affected individual) 
 
“Gain more understanding of genetic research and links between genetics and 
mental health conditions.” (affected individual) 
 
Several respondents discussed how they would particularly value this information in 
the context of the individual, e.g. discussing their/their relatives own life experiences 
and their personal family history of mental illness, and how this may have 
contributed to illness onset or risk of illness: 
 
 “To have some kind of more definite answer as to how much my 
experiences(sic) have been a physiological problem.” (affected individual) 
 
“Understanding more specifically about why the mental illness has affected my 
brother.” (relative) 
 
“The chance to talk through your own individual circumstances.” (relative) 
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A few affected individuals also discussed how, through gaining increased insight 
into the mental illness, they believed PGC may help their relatives to better 
understand their symptoms and/or their behaviour: 
 
 “Understanding the complex nature of mood swings and how I cannot always 
recognise the state I am in until after the event which leaves my family 
completely at a loss as to how to deal with me.” (affected individual) 
 
 “…It might also help them to understand why I’m such a giant pain in the arse 
at times.”  (affected individual) 
 
 
Managing mental illness 
 
The majority of respondents discussed that a valuable aspect of PGC may be 
facilitating better management of mental health. 
 
Respondents identified that discussion of and identification of strategies that both 
promote mental well-being in both themselves and their other family members, and 
coping strategies for affected individuals with regards to managing their symptoms, 
would be helpful: 
 
“…It would also be useful to learn ways of improving and maintaining good 
mental health and wellbeing.” (relative) 
 
 “Ways to protect mine and my relative’s mental health.” (affected individual) 
 “Helping my son to understand more about his illness and how to manage 
it…” (relative) 
 
“…the use of different strategies to manage my mood swings.” (affected 
individual) 
 
Specifically, a number of respondents specifically identified that the opportunity for 
discussions on an individual basis would be especially valuable: 
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“Treating people as affected individuals so as to work out what will be suitable 
for them as regards managing their mental health.” (relative) 
 
 “helping him (affected family member) cope with his mental illness better… 
talking about what does and doesn’t work for him.” (relative) 
 
“…advice that is personal to us(family)…” (relative) 
 
Additionally, a few affected individuals discussed how PGC may facilitate better 
management of mental illness on a psychological level, through empowering their 
sense of control of the condition: 
 
 “..With greater insight into our weaknesses are we able to better combat 
them, and I feel the more I know about the matter the more effective I will be 
in attaining a close-to-normal level of functionality.” (affected individual) 
 
“Understanding the cause and contributing factors. Strategies to deal and heal 
from this awareness – not to just deal with guilt/shame/powerlessness but to 
feel more ‘empowered’ and in control of my thoughts/behaviours and life going 
forward.” (affected individual) 
 
“…How to better self-manage and make decisions based on positive rational 
thoughts…” (affected individual) 
 
A small proportion of relatives expressed their hopes that, through increasing 
understanding of the biological contributions to mental illness, PGC may encourage 
treatment adherence amongst their affected family member: 
 
“…He (affected relative) might also be more open to medication if he 
understands how it might help him.” 
 
“…Helping him (affected relative) understand why medication can help 
manage his symptoms (i.e. that a genetic basis means a biological basis)” 
 
“Finding ways to explain to my brother…why it’s important for him to take his 
medication as he does not want to do this.” 
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Shame, stigma, self-blame , guilt and anxiety 
 
Many of the respondents providing answers discussed how, through increasing 
understanding of causation and addressing current beliefs and attitudes regarding 
causation, PGC may have psychotherapeutic values for both affected individuals 
and their relatives. 
 
A number of respondents identified that this increased understanding may help with 
guilt-reduction. For example, several affected individuals explored how it may 
reduce their or their parents’ sense of responsibility regarding onset of the mental 
illness: 
 
 “Unburdening the guilt that it was my fault or my parents’ guilt that it was their 
fault.” (affected individual) 
“My mother feels particularly guilty, I hate that. She is incredible and I want her 
to realise it’s not her fault.” (affected individual) 
 
“I think it would be extremely useful for my parents to know that my upbringing 
is not what brought this all on.” (affected individual) 
 
 “My mum – there’s been a lot of guilt there, that’s what’s been hardest for her 
I think. She focuses on small events that happened in life and blames 
them/her role in them. I think talking about biology/genetics part to play in it 
would really help.” (affected individual) 
 
Whilst some respondents expressed that PGC may help reduce affected individuals’ 
sense of self-blame and guilt regarding the illness, and especially how the mental 
illness had impacted the family: 
 
“Finding ways to explain to my brother why his diagnosis isn’t his fault…” 
(relative) 
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“Showing her it’s not her (affected relative’s) fault. She blames herself for her 
way of thinking” (relative) 
 
 “Having someone to work through the guilt and regret I have about things 
which I have done whilst very sick.” (affected individual) 
 
“Looking at coping with guilt surrounding the impact my illness has had on my 
family.” (affected individual) 
 
A number of relatives and one affected individual indicated that PGC may help 
alleviate affected individuals’ sense of shame regarding the mental illness – and 
therefore possibly reducing stigma - through increasing understanding of causation 
to subsequently ‘normalise’ the mental illness: 
 
“To be assured it’s a "normal disease" and nothing to be ashamed of. And 
even if there is something in my family history I couldn't have avoided it or 
changed it.” (affected individual) 
 
 “Being able to accept that he is not ‘biologically weird’ compared to his 
friends. For him the shame about the mental illness is the hardest thing and I 
think this might be really useful in changing his thoughts around this…” 
 
“Helping him to understand that his diagnosis is… not due to him being weak.” 
 
Additionally, a small number of respondents indicated belief that PGC may help 
facilitate psychological acceptance of their illness, including through appearing their 
attributional search regarding explanations for their mental illness: 
“Counselling that might answer for me ‘at last’ the reasons why I developed 
(mental illness)…” (affected individual) 
 
 “Understanding why I am why I am.” (affected individual) 
 
 “To find out why him.”(relative) 
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“Helping my son to understand more about his illness… also about the 
potential causes. Also to come to terms with his illness and to feel less 
ashamed.” (relative) 
 
One affected individual also indicated PGC it may be useful in reducing anxiety over 
genetic risk within the family through addressing fatalistic ideas about genetic 
determinism: 
 
“They (relatives) have a better understanding about the illness and what "not 
causes it. Its not the family history and doesn’t have to affect everyone now or 
in the future” 
 
 
 
Familial risk 
 
Several affected individuals and a few relatives identified that an assessment of risk 
for their children developing psychiatric conditions, including current children and 
those born in the future, would be useful to them:  
 
“A realistic assessment of the risks that my son faces (affected individual) 
 
 “Talking about the risks of my children developing mental illness, and what I 
could do as a parent to help minimise this risk.” (affected individual) 
 
“…Interested in causes and risk of passing on condition to next generation.” 
(relative) 
 
“Providing information on the likelihood of having passed on the mental 
disorder to our child.” (relative) 
 
A small number of respondents conceptualised the value as gaining a greater 
understanding of the implications of genetic contributions to mental illness rather 
than retrieving a specific risk assessment: 
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 “… Its not the family history and doesn't have to affect everyone now or in the 
future.” 
 
“Explain things to relatives about any things that happen to some people (sic) 
and not others..” 
 
Only two respondents discussed how increased understanding of familial risk may 
be useful specifically in regards to discussions about family-planning: 
 
“I think having a discussion about mental illness in my family… and my 
husband's (mental illness) would be useful although its not likely that it would 
change our decision to have children. We're in our mid thirties, so this is very 
much an issue for us.” (affected individual) 
 
 “My partner in the future - might not have experience of mental illness so 
might be a scary concept for them. I'd imagine if it came to discussions about 
starting a family etc this service would be useful to them.” (relative) 
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Summary of findings 
Both affected individuals and relatives identified valuable elements of PGC, 
and although there were contextual differences the same major themes of 
value were reported by the two groups of respondents. 
 
The majority of respondents discussed that increased understanding of 
mental illness and especially of contributing factors, ascertained through both 
the provision of aetiological information and addressing pre-existing beliefs, 
would be a valued aspect of PGC. 
 
Many respondents also reported that PGC may facilitate better management 
of mental health for both unaffected and affected individuals within the family. 
Respondents discussed how this may be obtained on both a practical-basis 
(e.g. through identifying effective strategies) and also on a psychological-basis 
(e.g. by increasing sense of control over mental well-being and subsequently 
facilitating protective behaviours and attitudes). A number of relatives also 
proposed that they believed PGC may encourage treatment adherence 
amongst their affected family-member. 
 
Several respondents specifically identified that discussions regarding both 
aetiology and management of mental health that were individualised to the 
patient (e.g. incorporating own family history, own mental health history, 
discussing effective and ineffective protective strategies) would be an 
especially valued aspect of PGC. 
 
Respondents also discussed how, largely through increasing understanding of 
aetiology and exploring and challenging currently held beliefs and attitudes 
regarding the mental illness, PGC may have psychotherapeutic values for 
both affected individuals and their relatives including reducing guilt and self-
blame, shame, and anxiety over genetic risk. 
 
Better understanding familial risk, and better understanding the implications of 
genetic contributions to mental illness, especially for children, was also 
identified as a useful aspect of PGC by a small number of respondents. Only 
two respondents conceptualised this specifically in regards to family-planning 
decision-making and discussions 
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3.8  Reasons for not wanting PGC after watching informational 
video (Qualitative analysis). 
 
Respondents that selected an answer of ‘4’ or lower in regards to whether they 
would like to have PGC were invited to list any reasons they might not wish to have 
PGC in a free-form entry response. 
 
Reasons for not wanting PGC after watching informational video 
(Qualitative analysis) – Results 
 
 Several themes were identified by respondents (see table 38). For relatives, only 
four respondents’ answered this section and so answers have been pooled to be 
reported in the text. 
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Table 34: Reasons for not wanting PGC (post-informational video) 
 
 
 
 
 
Themes and subthemes - Reasons for not wanting PGC 
 
AFFECTED 
INDIVIDUALS Responses  
(n=17;100%) 
RELATIVES 
Responses 
(n=5; 100%) 
It would not be useful to me/my family personally 
i) I am happy with my current coping strategies/am 
currently mentally stable 
ii) It would not be helpful for my recovery 
9 (53%) 
5 (29%) 
5 (29%) 
1 (20%) 
1 (20%) 
0 
PGC may cause psychological distress 
 
i) I might hear things I don’t want to hear regarding the 
risk to my children 
ii) It might affect my decision to have children 
iii) The new information might compromise my mental 
well-being 
iv) It might increase stigma by endorsing genetic 
contributions to mental illness 
6 (35%) 
2 (12%) 
0 
3 (18%) 
1 (6%) 
1 (20%) 
0 
1 (20%) 
0 
0 
I am not worried about familial risk 
 
i) I do not wish to have children 
ii) I am confident that my children have not inherited this 
illness/are well 
3 (18%) 
1 (6%) 
2 (12%) 
 
1 (20%) 
0 
1 (20%) 
I support alternative approaches in psychiatry 
i) Greater emphasis should be given to environmental 
factors in causation of mental illness 
ii) The role of genetics in causation is contestable 
3 (18%) 
2 (12%) 
2 (12%) 
0 
0 
0 
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It would not be useful to me/my family  
 
A number of respondents identified that they did not believe PGC would be helpful 
to them. A few affected individuals (n=5) and one relative reported that they would 
not wish to receive PGC as they were currently stable in terms of their mental health 
or were currently coping well in terms of management of their condition, or 
supporting their relative’s condition:: 
“I am very happy with my coping strategies and acceptance…” (Affected 
Individual) 
…had extensive therapy am stable+have been for a very long 
time+understand all I need to so the resource best used for someone 
struggling with these issues as I'm not.” ( Affected individual) 
“…suspect the opportunities for it might be difficult to provide for many people 
due to cost and I (along with my family) am at a stage in life where we have 
learned to cope with my (partners) condition…” (Relative) 
Similarly several affected individuals (n=5) reported that they believed it would be 
ineffective to them personally, including because they felt it was too late on from 
their diagnosis to be of benefit and/or it would not change the fact that they have 
mental health problems: 
 “it is irrelevant for my recovery” 
“Dubious as to how effective or useful it would be to me.” 
 “I feel it would be futile as it is too late to do much about my mental illness” 
“It's not going to make any difference to reality” 
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I am worried PGC may cause psychological distress. 
 
Several affected individuals (n=6) and one relative identified that they may not want 
to receive PGC as they were concerned they may learn new information that may 
cause them, or others, psychological distress including anxiety, stress and/or worry. 
For a number of affected individuals this concern especially centered around 
genetic risk information, and learning the potential implications for their children: 
“…It could unearth some bits or get me worrying about stuff too much when 
an important time expecting my 1st child” (affected individual) 
“It might stir things up and I might hear things I don't want to hear e.g. that my 
son might have bipolar.” (affected indidivual) 
Similarly, one relative reported that they were worried the new information may 
induce psychological distress and new dilemmas, and influence decision-making 
especially in relation to family-planning: 
“…I just don't want to know right now. I don't want it to affect my decision in 
having children, raising children, etc.” (Relative) 
Other affected individuals (n=3) identified that the PGC process, and especially new 
information learned through it, may compromise their current stability in terms of 
mental health: 
“I have always found in the past when I have been unwell or vulnerable that 
counselling might make me look inwards too much and might increase my 
depressive state.” (affected individual) 
“I don't want to open a can of worms. I am in control of my condition, my 
children are both well (ish), I fear that genetic councilling (sci)would put that at 
risk” (Individual) 
In addition, another affected individual identified that attributing psychiatric illness to 
genetics may have negative psychological impacts generally, potentially by 
increasing stigma and/or resulting in deterministic attitudes: 
“…could actively harm those with a diagnosed mental health issue just by 
reinforcing idea that genes are a key factor (just by being called 'genetic 
counselling').” (affected individual)  
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I am not worried about familial risk 
A number of affected individuals (n=3) and one relative identified that they would not 
be interested in receiving PGC because they were not concerned about risk to other 
relatives, specifically either because they did not have children, or were not worried 
that their children would develop mental health problems: 
“…I have no wish to have children.” (Individual) 
“…I am confident that my children… will not develop serious mental health 
problems.” (Individual) 
 “I am convinced my child has not inherited this mental disorder.” (relative 
 
I support alternative approaches in psychiatry 
Several affected individuals (n=3) identified that they would not like to receive PGC 
because they contested the role of genetics in causation and/or believed greater 
emphasis should be given in both research and clinical practice, of environmental 
factors in psychiatry:  
 
“I think psychiatry needs to address the imbalance of the belief of the 
environment and genetic causation of mental distress to work more on the 
environment. Knowing inequality, social issues, poverty, etc as influences, I 
want to see more emphasis on changing that.” (affected individual) 
 
“…the 'genetic' focus on this pre-supposes the role of importance genetics in 
'mental illness' which is contestable. Yes, we all have genes and there's 
bound to be a genetic influence somewhere .. but we know a lot more about 
the role of trauma and adverse life experiences in psychosis and it feels lots 
more helpful to focus on creating safer and more supportive families and 
communities than getting sucked into genes…” (affected individual) 
 
 “do not believe in the neuron/gene/DNA science-ification of consciousness, 
which is very unfortunately the scientific hegemony of this age and is giving 
birth, especially in the neuroscience community, to a form of scientific 
fundementalism… Which from 'the research', isn't conclusive.” (affected 
individual). 
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Summary of findings  
Respondents reported several reasons for which they may not want to receive PGC. 
A number of respondents discussed how GC, as a genetics-based approach, did 
not fit within their own beliefs about the disease construct, or their own personal 
philosophies in regards to approaches to psychiatry and psychiatric healthcare. 
A few respondents also reported that they did not believe PGC would be helpful to 
them, either because they were currently stable with their own coping strategies, or 
did not believe it would be helpful or meaningful for them personally. 
Some respondents also expressed concerns that PGC may induce psychological 
distress. Specifically this was in regards to the new information and the potential 
impact this could have on them, and often in regards to concerns for their children. 
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4. Evaluation of findings 
4.1 Discussion 
This study highlights some important findings relevant for consideration 
regarding the application of PGC within the UK.  
 
Perceptions of aetiology  
The majority of respondents attributed the mental illness to both genetic and 
environmental factors indicating a multifactorial explanation for mental illness 
is endorsed. This is consistent with previous studies that have explored 
aetiological perceptions amongst affected individuals and their relatives. 
(Gamm et al. 2004, Meiser et al. 2005, Meiser et al. 2007, Peay et al. 2008, 
Baines and Wittkowski 2013). The potential clinical implication of this finding is 
that it indicates lay beliefs about causation are in line with scientific 
explanations of illness and also the aetiological models that would be 
discussed in PGC, and that genetic education, such as that provided by PGC, 
would be more readily and positively received. 
 
That the majority of respondents reported relative certainty about their 
attribution of the mental illness to both genetic and environmental factors in 
psychiatric pathogenesis is surprising and in contrast to the hypothesis that 
respondents would be uncertain about aetiology, based on studies that have 
reported that there is uncertainty and that misconceptions exist amongst 
affected individuals and families regarding psychiatric aetiology (Hodgkinson 
et al. 2001, Holzinger et al. 2003, Austin and Honer 2005, Costain and 
Bassett 2012, Costain et al. 2014b).   
 
In direct contrast, however, when respondents’ perceived value of PGC was 
explored using qualitative analysis the majority reported that they would still 
value information and discussions about contributions to mental illness and 
especially the relative contributions between genetic and non-genetic factors 
in pathogenesis. Furthermore, respondents’ answers revealed – including 
amongst those who had reported high levels of certainty about their 
understanding quantitatively- that there was a tendency towards the adoption 
of oversimplified ideas about causation amongst affected individuals and their 
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family members, such as affected individuals considering the mental illness 
being due to them ‘being weak’, parents experiencing profound guilt owing to 
their feelings of responsibility for the onset of their child’s illness, and affected 
individuals feeling ashamed of the mental illness due to beliefs that the mental 
illness makes one “biologically weird” or not “normal”.  
 
To this degree, the findings highlight the strength of using mixed-methods in 
this study. Collecting both quantitative and qualitative data enabled deeper 
exploration of respondents’ perceptions of aetiology, as well as insight into the 
emotional and psychological elements associated with beliefs about origins, 
which resultantly revealed that there were uncertainties, oversimplified ideas, 
and gaps in knowledge regarding the nature and origins of the mental illness, 
consistent with study hypothesis and fitting with previous literature. 
 
The implication of these findings is that PGC - a major goal which is to 
facilitate comprehensive understanding of aetiology whilst also providing 
supportive psychotherapeutic counselling around these concepts- may thus 
be clinically valuable to the UK population. 
Given that outcomes studies of practice have produced some encouraging 
data indicating value of PGC in terms of increasing perceived aetiological 
understanding and reducing misconceptions (Austin and Honer 2008, Costain 
et al. 2014a, Costain et al. 2014b), and furthermore the additional potential 
psychosocial outcomes this increased knowledge may bring for service-users 
including reduced self-blame (Costain et al. 2014a), stigma (Costain et al. 
2014a) and increased hope and empowerment (Austin and Honer 2008, Inglis 
et al. 2014) , the findings of this study therefore justify further research 
regarding their perceptions and understanding of aetiology and pathology 
amongst the UK population, and the potential value of PGC in this regard. 
 
 
 
 
 
 
205 
 
Familial risk 
This study explored several aspects relating to familial risk amongst 
respondents. It found misconceptions about risk of familial recurrence, with a 
tendency to overestimate degree of familial risk of recurrence; high degree of 
concern over such risk; and also, for affected individuals, that family-planning 
decisions may be influenced by the presence of mental illness, with a 
tendency towards decisions favouring having fewer or no children. 
Furthermore, in regards to perceived value of PGC respondents themselves 
identified that they would value an increased comprehension of familial risk 
and also the implications of genetic contributions to mental illness. These 
findings raise the possibility that PGC, a major goal of which is to increase 
understanding of familial risk, may thus be potentially helpful for the UK 
population. 
 
In line with study hypothesis and previous studies exploring attitudes and 
beliefs about familial risk amongst affected individuals and their relatives 
(Austin and Honer 2008, Peay et al. 2008), the majority of respondents 
reported being concerned about the risk of family members developing a 
mental illness, and moreover, a large number reported very high levels of 
concern. Furthermore, statistical analysis showed concern was significantly 
and positively associated with attribution to genetic models, indicating 
endorsement of a genetic model may be associated with greater levels of 
concern over familial risk. 
 
Furthermore perceived familial recurrence risk was overestimated, and often 
dramatically, by the majority of respondents. This was both consistent with 
hypothesis and in line with the majority of studies that have previously 
explored perceptions of genetic risk for psychiatric conditions (SCZ and BPD) 
amongst non-UK populations (Targum et al. 1981, Schulz et al. 1982, 
Trippitelli et al. 1998, Quaid et al. 2001, Austin et al. 2006, Costain et al. 
2014a, Costain et al. 2014b). Notably there was a tendency to overestimate 
risk across the diagnostic boundaries, not only for diagnoses which are 
typically considered more ‘serious’ (i.e. SCZ, psychosis) or have a higher 
heritability (i.e. SCZ, BPD in comparison to anxiety-related disorders or 
depression). To best knowledge there is little available published evidence (if 
any) exploring perceptions of risk regarding anxiety disorders e.g. OCD, 
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PTSD, and limited literature for depression. This finding therefore indicates a 
need for further research into risk estimations amongst the population for 
other, more common, psychiatric diagnoses. 
 
Impact on family planning, typically favouring decisions towards having fewer 
or no children, was also reported by the majority of affected individuals, 
consistent with findings of previous studies (Austin et al. 2006, Meiser et al. 
2007), and also consistent with study hypothesis. Furthermore, there was a 
significant and positive association between attribution of the mental illness to 
genetic factors and impact on family-planning, supporting previous findings 
that a genetic model of explanation may negatively influence reproductive 
decisions (Meiser et al. 2007). 
Conversely, contrary to study hypothesis, very few relatives reported that the 
mental illness had impacted their family-planning decisions. This is interesting 
as it highlights potential differences in regards to information needs and 
concerns, and therefore practice of GC, between affected individuals and 
relatives. This is a concept that been previously discussed (Austin et al. 2006, 
Austin and Honer 2008), and will be explored later (see ‘avenues for future 
research’).  
 
Given the encouraging data reporting a reduction in concern over familial risk 
(Austin and Honer 2008), facilitation of better understanding of the true 
empiric risk estimate amongst patients following PGC (Costain et al. 2014a, 
Costain et al. 2014b), these findings thus provide tentative indications that 
PGC could be helpful to this population. Further research regarding 
perceptions and implications of risk amongst the UK population, and the 
potential value of PGC in this regard, is thus warranted. 
 
On a final note however it must also be considered that, whilst the quantitative 
findings of this study, explored above, thus provide indications that provision 
of familial risk information may be helpful to respondents, increased 
understanding of familial risk was in fact reported by only a small number of 
respondents as a valuable aspect of PGC after watching the informational 
video. Furthermore, whilst interpretation of the quantitative data provides 
some indications that facilitating decision-making with family-planning would 
be an especially helpful aspect of PGC, owing to the high reported impact on 
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family-planning decisions amongst affected individuals, as few as 2 
respondents actually discussed value of PGC specifically in regards to family-
planning decision-making. 
Conversely, other aspects of PGC such as increased aetiological 
understanding, facilitating management of mental health, and 
psychotherapeutic values of PGC, were discussed to a greater extent by 
respondents. 
These contrasts between interpretations derived from the quantitative and 
qualitative data in regards to familial risk are interesting, and further 
emphasise the value of using mixed-methods approach in the approach to this 
study. 
 
Indeed it has been previously explored, to a degree that, in the literature that 
although GC is very typically associated with risk communication, in terms of 
practice of PGC provision of a specific risk assessment may not actually be 
required by the patient, especially once aetiology has been discussed, indeed 
even if obtaining a risk assessment was the presenting reason for attending 
the session (Austin and Honer 2007, Morris 2015, pers comms, 10 January, 
Austin 2015, pers comms, 16 February). It may be that discussing aetiology 
may be perceived to have the desired outcomes for the patient, e.g. 
increasing sense of control, realising genes are not ‘destiny,’ reducing anxiety, 
shame and guilt – to the extent that the risk estimate and/or providing 
accurate genetic information thus becomes less relevant, or even irrelevant, to 
the patient – even if it was the reason for them presenting for PGC. From a 
philosophical approach, in terms of approaches to practice, this approach 
would be supported by the counselling model, i.e. that education is not an 
overall goal but rather a means to facilitating other, important goals (Resta 
2006). This may therefore partially explain the inconsistencies between 
interpretations from the quantitative and qualitative data regarding familial risk 
collected in this study. 
  
Whilst no clinical implications regarding this could be drawn from a sample of 
such small scale, it does highlight that concepts relating to patient desires and 
wishes in regards to communication about risk information, that extends 
beyond focusing on their apparent ‘needs,’ identified from exploring their 
current comprehension (or miscomprehension) of familial risk or aetiology, are 
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also helpful and important to consider in regards to considering goals of 
interventions, such as PGC. 
 
Awareness and perceptions of GC and PGC 
The findings of the study collectively indicate that, in line with hypothesis, 
awareness and comprehension of GC is relatively low amongst the UK population. 
This is consistent with evidence from other studies that have explored awareness 
and perceptions of GC amongst the public (Hallowell et al. 1997, Bernhardt et al. 
2000, Metcalfe et al. 2007, Lyus et al. 2007, Maio et al. 2013). As the majority of 
respondents were of the information-seeking population – and indeed some 
respondents were trained GC’s themselves - it is likely that awareness and 
understanding is much less for the general population. 
Although awareness was higher than has been reported by previous studies (Lyus 
2007, Maio et al. 2013), it remained that less than half of respondents had 
previously heard of GC. Furthermore that awareness was significantly lower 
amongst affected individuals in comparison to relatives, consistent with previous 
studies exploring awareness of GC amongst the population (Lyus et al. 2007) is 
interesting, and likely reflects increased exposure of relatives due to a number of 
factors, including that they are more proactive in information-seeking; have 
increased access to mediums through which they come across genetic counselling 
(e.g. work and media) which their relatives do not due to their incapitation; and/or 
are perceived to have differential information needs by healthcare practitioners 
(Lyus et al. 2007).  In regards to future implementation, this may mean it would be 
especially important to provide supporting information to affected individuals that are 
referred for PGC.  
In terms of preconceptions of GC and PGC, although to a degree respondents 
showed good comprehension of GC (assessed qualitatively) and PGC (assessed 
quantitately) there were also some limitations in their understanding and some 
profound misconceptions about the practice and purpose of GC. 
 
This included almost 50% respondents incorrectly believing PGC would involve 
diagnostic or prenatal testing, which is not currently clinically available and would 
not routinely be offered at GC. This finding is also consistent with that of a previous 
study exploring perceptions of PGC amongst the American population in which a 
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large proportion of respondents believed testing would be available for psychiatric 
conditions (Lyus 2007), and provides indications that testing may be expected at the 
point of referrals in the future.  
 
Furthermore, fewer respondents also identified that GC for psychiatric conditions 
would involve the provision of emotional support, as has been reported by other 
study groups exploring perceptions of GC for physical illnesses (Bernhardt et al. 
2000) and psychiatric illness (Lyus 2007). This is particularly interesting given that i) 
available literature regarding goals of PGC have emphasised the importance of 
psychosocial aspects of the intervention and ii) in this study, a large majority of the 
respondents identified the emotional aspects of PGC as being particularly valuable 
in regards to their perceptions of the service, following information about the 
service. 
 
 Similarly, in regards to perceptions of traditional GC, assessed qualitatively, whilst 
a small number of respondents identified that GC may have therapeutic benefits, 
this was predominantly limited to facilitating acceptance of risk, whilst alleviating 
guilt, shame, stigma, self-blame and anxiety, which are other, commonly reported 
and well-established, psychosocial outcomes of GC practice (Biesecker 2001, 
McCarthy Veach et al. 2007) were not typically discussed. Additionally, in 
respondents’ answers there was a notable emphasis on concepts relating to genetic 
risk, even in regards to decision-making aspects of GC (i.e. ‘reducing risk’) and 
psychological and emotional aspects of GC (i.e. ‘coming to terms with risk’). In 
practice, GC for multifactorial disorders has a much wider scope and purpose than 
risk communication (McAllister et al. 2011, Austin et al. 2014). 
 
Awareness and perceptions – practical implications 
Low awareness and comprehension have potentially important practical 
considerations, because a growing body of evidence this could have a major 
influence on future delivery of the service. 
For example. lack of awareness and comprehension of purpose of PGC may 
influence service uptake and engagement, because those who are not aware of the 
service will be less likely to access it (Metcalfe et al. 2007, Maio 2013), and 
additionally those who are less aware of how it may be relevant and valuable to 
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them personally will also be less likely to engage, even if they are referred (Maio et 
al. 2013). 
Secondly awareness and comprehension may influence patient outcomes, for 
example through increasing anxiety, reducing the patients’ ability to effectively 
prepare in advance for the session and therefore maximising the utility of the 
session, and potentially influencing patient’s expectations and therefore potentially 
satisfaction with the service (Bernhardt et al. 2000, Davey et al. 2001, Metcalfe et al. 
2007); as is supported by a growing body of GC process and outcomes studies for 
physical illnesses (Davey et al. 2005, Hallowell et al. 1997, Brown et al. 1999, 
Metcalfe et al. 2007, Maio et al. 2013). 
Thus, considering both the findings presented here and previously published 
literature, this highlights the need for more research pertaining awareness and 
perceptions of both GC and PGC amongst the lay public in regards to future 
application of PGC. 
Awareness and perceptions – ethical considerations 
On a further note, participants’ perceptions of GC and PGC also raise issues of an 
ethical nature, which are important for consideration. 
 
For example, respondents expressed concern that both GC and PGC may cause 
psychological distress, with this being given as a key reason given for respondents 
not wanting to have PGC. Indeed for some respondents this concern remained even 
after following information about the service, stating their concerns that the 
information may cause them worry, potentially even jeopardising their current 
mental state. 
Indeed literature regarding provision of GC more generally has also discussed the 
psychological and emotional impact of receiving genetic information regarding any 
genetic condition (Bisecker 2001, Davey et al. 2005, Resta 2006). Furthermore, that 
PGC may cause psychological distress, especially due to the uncertain nature of the 
aetiology of psychiatric conditions, has been reported and explored as a concern 
amongst genetic counsellors in regards to providing PGC (Monaco et al. 2010, 
Hippmann et al. 2013). Additionally, in regards for GC within psychiatry it has been 
asserted that the psychological state of the patient should be assessed by the 
clinician, to ensure that they are well enough to receive such information (Tsuang 
1994, Papadimitriou and Dikeos 2003, Austin and Honer 2007). 
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These negative outcomes would however be the antithesis of goals of contemporary 
practice, which aims to minimise distress, empower individuals and facilitate 
adaptation to the illness over time (Resta 2006, Resta et al. 2006, McCarthy-Veach 
et al. 2007, McAllister et al. 2011) Furthermore, available evidence that has 
assessed interventions of PGC specifically has reported that PGC  is associated 
with positive outcomes, including increased sense of empowerment (Inglis et al. 
2014), reduction of guilt, and also that the intervention did not increase 
psychological distress (Costain et al. 2014a, Costain et al. 2014b). 
 
Thus, respondents’ concerns that PGC may cause psychological distress highlight a 
need for further research pertaining this, and especially support previous assertions 
emphasising the need to further develop an evidence base for PGC. This would 
help ensure optimal practice and also address any controversies pertaining to such 
concerns and potential issues. 
 
Other ethical considerations in regards to the provision of PGC that were highlighted 
in this study was the association of both GC and PGC with eugenic-type values, 
with respondents, in qualitative analysis, conceptualising its practice as directive, 
with the genetic counsellor influencing reproductive decision-making to reduce the 
presence of certain genes within the population. 
Consistent with these beliefs, in quantitative analysis, a relatively large proportion of 
respondents believed, specifically in regards to providing GC for psychiatric 
conditions, that a genetic counsellor would advise affected individuals whether or 
not to have children, which has been previously reported by studies that have 
explored perceptions of GC amongst the general public (Maio et al. 2013). 
Additionally, that a proportion of respondents also believed a goal of PGC would be 
to ‘prevent’ mental illness in children could also be considered, arguably, to be 
associated with eugenic values (Maio et al. 2013). 
Fundamentally, these beliefs about the purpose and practice of GC is in contrast to 
the non-directive approach of modern day practice of genetic counselling, which 
strives to promote autonomous decision-making (Resta 2006) - a viewpoint which is 
considered to be the direct opposite of a eugenics-based approach (Gottesmann 
and Shields 1982, Maio et al. 2013). 
 
Psychiatric genetics has a troubled and ugly history, with deep associations with the 
eugenics movement of the early 20th Century. Through policies, the foundations of 
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which were based on flawed genetic theorums, the reproductive rights of tens of 
thousands of society’s most stigmatised individuals – including those with mental 
and learning difficulties - across America and Europe were entirely diminished. 
Consequently widespread segregation, mass involuntary sterilisation and 
institutionalisation was conducted on a huge scale (Nuffield Council on Bioethics 
2002, Brüne 2007). 
In Nazi Germany  hundreds of thousands of mentally ill individuals were murdered 
through ‘racial hygiene’ policies inspired by the works of leading figures in the field 
of psychiatric geneticists, such as Ernst Rüdin (Ritter and Roelcke 2005, Roelcke 
2007). providing further associations between genetic approaches within psychiatry 
and the eugenics movement. Indeed, even the practice of early GC itself, with its 
wider, ‘public-health’ centered approach which meant it had a directive, and in turn, 
sometimes discriminatory and prejudiced approach against those considered 
genetically inferior in society, including mentally ill individuals (Resta 2006). 
 
Although these eugenic policies no longer drive modern genetic approaches in science and 
healthcare policy (Nuffield Council on Bioethics 2002), the findings presented here 
indicate that past eugenic ideas and practices may potentially still, for some, be 
associated with contemporary genetic approaches within psychiatry, including, in 
the case of this study, in regards to the provision of GC for psychiatric conditions. 
  
Whilst the small sample size of this study limits the generalisability of this finding to 
the wider UK population, it does raise important questions for future research focus, 
as it may indicate a potential need to raise the profile of not only genetic 
counselling, but also genetic approaches within psychiatry more widely. 
 
Thus, the findings presented in this study that there are, for some potential service-
users, concerns regarding psychological distress, and that there are associations of 
its practice with eugenic-type values, further emphasises the need for more 
research into awareness and perceptions of PGC in regards to future 
implementation of PGC within the UK. 
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Interest in receiving PGC 
Prior to this study there was no published data evidencing interest or demand 
regarding PGC. Overall the findings of this study demonstrate that PGC was 
favourably viewed amongst respondents, and that there was an interest in receiving 
PGC; however that initial interest prior to receiving information about the service 
was very low. The results presented here overall provide tentative indications that, 
whilst PGC may be welcomed by service-users in the future, efforts to raise the 
profile of GC, and especially within psychiatry, may be important in future efforts to 
implement PGC within the UK. 
Initially, before receiving information about PGC, respondents’ interest in receiving 
PGC, with only 46% positively identifying that they would wish to receive PGC, was 
much lower in comparison to studies conducted amongst other populations, which 
have typically reported interest rates around 65-80% amongst respondents (Quaid 
2001,DeLisi and Bertisch 2006,  Lyus 2007). Uncertainty regarding the service was 
also high, with some ~30% respondents indicating they were unsure as to whether 
they would wish to have PGC. 
Conversely, after watching the informational video about the service, interest was 
much higher, with 75% respondents indicating they would wish to receive PGC. 
Similarly the majority of respondents believed PGC would be ‘useful,’ with 92% of 
relatives reporting they believed it would be useful to their affected relative. Whilst 
perceived usefulness is not a valid indicator of utility of a healthcare service, it could 
reasonably be interpreted as further evidence of a keeness in receiving PGC 
amongst respondents. 
The initial lack of interest in PGC is an interesting finding. A likely factor is 
respondents’ lack of awareness and comprehension of the service, and this can be 
supported by several bodies of evidence from the study. 
First and foremost, respondents in this study were deliberately provided with little 
information about GC and PGC prior to participation in order to obtain base-line 
rates of interest. In contrast, it is likely that other studies exploring interest, that 
reported higher rates of interest (Quaid 2001,DeLisi and Bertisch 2006,  Lyus 2007) 
provided respondents with more information about the service e.g. in participant 
information sheets, directly through the researcher or clinician, especially those 
studies conducted in clinical research settings, and also by presenting participants 
with a definition of the service during the study. The implication is that these 
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situations may not reflect real-life situations in which patients may be offered GC, 
e.g. if the referring clinician has limited comprehension of the service, and thus, 
without adequate information provision, the findings of this study provide indications 
that interest rates may in fact be lower. 
Furthermore, the reasons given by respondents for not initially wishing to receive 
PGC also support the assertion that low comprehension about the service may have 
influenced low interest rates. For example, not knowing enough about the service 
was the major reason given by respondents, as well as concerns that they would 
not be able to afford an appointment (when in fact it would be free on the NHS), and 
that they did not know the family history of mental illness and/or did not want to 
have children (when in fact the scope of GC goes beyond that of risk 
communication, and these would not be caveats to accessing PGC).  
Finally, that interest was much higher following the informational video provides 
further support. The video not only provided information about the service but also 
addressed key misconceptions, such as belief that the major focus of PGC is 
discussing risk to offspring, or involves genetic testing. Although due to the 
differential methods of analysis used, differences in interest prior and following the 
informational video could not be statistically tested, it was clear that interest rates 
were much higher following the video. 
Collectively, therefore, the study of these findings provides supporting evidence that 
misconceptions and lack of comprehension regarding the service may impact 
engagement and behavioural responses to being offered PGC in the future, 
consistent with available literature regarding PGC (Hunter 2010) and GC more 
generally (Maio et al. 2013). 
In regards to perceived value of PGC, respondents’ expressed beliefs that PGC 
may help with facilitating better understanding of aetiology; identification and 
comprehension of protective factors and management strategies; better 
understanding of genetic risk; increased sense of empowerment; and 
psychotherapeutic values, especially reducing guilt, shame, blame. 
Notably these are commonly reported goals and outcomes of non-psychiatric GC 
and, further, are in line with the core goals of the model of empowerment and thus 
the GCOS-24 scale (McAllister et al. 2011). These goals are also consistent with 
findings from previous groups from other countries that have both hypothesised the 
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potential value of PGC (Hodgkinson et al. 2001, Austin and Honer 2005, Hill and 
Sahaar 2006, Finn and Smoller 2006, Austin and Honer 2007, Peay et al. 2008) and 
also study groups that have provided actual outcomes data for PGC (Austin and 
Honer 2008, Costain et al. 2014a, Costain et al. 2014b, Inglis et al. 2014), indicating 
agreement between goals of approaches described by clinicians and researcher in 
previous, non-UK groups  (Tsuang 1994, Hodgkinson et al. 2001, Papadimitriou and 
Dikeos 2003, Austin and Honer 2007) and perspectives of UK respondents – 
potential future service-users - in this study. 
This thus provides further, qualitative data supporting interest and keeness, 
measured objectively, in receiving PGC amongst respondents following provision of 
information. 
Therefore the findings presented in this study collectively demonstrate that, overall, 
PGC was favourably viewed amongst members of the UK population; however they 
also indicate a potential need to increase awareness and address misconceptions 
around GC, and especially its role within psychiatry. This is worthy of future 
consideration in regards to exploring the application of PGC within the UK. 
 
 
4.2 Avenues for future research. 
This study has highlighted several areas for future investigation that will help guide 
implementation efforts within the UK and wider. Fundamentally, outcomes data, 
obtained through the provision of GC within the UK, is critically needed. This would 
provide data regarding uptake when offered, which is especially important in 
psychiatry in which engagement with medical services is traditionally low. Indeed, 
research groups that have provided PGC have demonstrated that rates of actual 
uptake has been lower than rates of interest (Austin and Honer 2008, Costain et al. 
2014a). This knowledge would thus provide greater insight into demand for PGC, 
and will also identify additional barriers to its delivery. 
In addition, outcomes data would enable assessment of PGC by exploring client 
outcomes and satisfaction with the service. This would therefore add to the 
accumulating data evidencing positive outcomes of PGC (Inglis et al. 2014), to 
justify making the service more routinely available within the UK. This is especially 
fundamental in healthcare, in which any new intervention, and expenditure of money 
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and time, must be justified by rigorous outcomes data (Costain et al. 2014b); and 
would be especially important within the UK, as the austerity forces the need for 
evidence-based practice and efficacious healthcare interventions. Such assessment 
will also be critical in guiding delivery in clinical settings within the UK to ensure 
client’s needs in relation to GC are being met. This information would also be 
particularly valuable given that client’s perceived informational needs may differ pre- 
and post-intervention; and therefore it would be optimal to guide practice based on 
data derived from actual practice rather than perceptions prior to receiving the 
service. 
Specifically, a number of relatives indicated that PGC may assist with medication 
adherence by their affected family member, largely, it seemed, due to their relative 
understanding more about the biology and thus having more biological and 
psychological faith in medications and the idea of being able to better manage their 
symptoms. Consistent with this, research from health psychology and GC has 
consistently asserted that knowledge enhancement and consequential alteration of 
the disease construct can have a psychological impact on influencing health-related 
behaviours through empowering affected individuals and increasing their perceived 
personal control, and this is supported by a body of outcomes data. This would be a 
particularly valuable area of research as, in psychiatry, engagement and compliance 
with health advice, and especially in relation to medication, is often low. 
Future studies involving larger sample sizes would also be a valuable area of 
research and would provide greater insight that may guide optimal practice in the 
UK. Specifically, this study reported findings from a broad range of relatives, and 
therefore further investigation amongst subgroups of relatives would be valuable as 
it is likely that the informational needs and perceptions of PGC differ (Austin et al. 
2006). For example, siblings of affected individuals in their childbearing ages may 
have differential information needs than parents of affected individuals (Austin and 
Honer 2008). Future studies may help identify and ultimately address the issues 
faced by, and the informational needs of, these groups. Similarly, whilst there is now 
a firm body of literature in relation to provision of GC for psychotic disorders (Austin 
et al. 2006, Lyus et al. 2007, Austin and Honer 2008, Costain et al. 2014a, Costain 
et al. 2014b), there is much less for other, more common disorders, such as OCD 
and MDD; and it is likely that affected individuals with these diagnoses may face 
different issues and have differential information needs. The accrual of larger 
sample sizes of different subgroups of service-users would enable identification of 
217 
 
similarities and differences in terms of factors influencing interest, perceived value, 
and engagement with the service. This information would help inform delivery of 
PGC more widely, to ensure the best outcomes for all patients and optimal delivery. 
There is no data available amongst psychiatric healthcare practitioners in relation to 
provision of PGC, and therefore research exploring their perceptions would be 
valuable. Fundamentally, healthcare practitioner’s perceptions of value for affected 
individuals and relatives may differ from that of patients’, and their insight and views 
may provide additional insight and help identify additional potential goals of PGC, 
especially within the UK, and may identify additional potential barriers to delivery 
efforts. In addition, research into health care practitioners knowledge of psychiatric 
genetics, and the attitudes towards the provision of psychiatric genetic information, 
may identify potential training needs of clinicians within the UK – as has been 
identified as a need by previous groups (Martin et al. 2012), and has been asserted 
as fundamental by other groups in regards to strategies to provide PGC (Costain 
and Bassett 2012, Costain et al. 2014b) 
Finally, this research focussed on perceived value of PGC. Whilst aspects that were 
considered unhelpful were not considered, as they are beyond the scope of this 
research project, such information may also be useful in helping guide optimal 
practice. In this regard, outcomes data (i.e. post-intervention) would be preferential 
as again perceptions are likely to differ pre- and post-intervention, and post-
intervention views would be most reflective of actual practice of PGC.  
 
 
4.3 Limitations 
There are some inherent limitations to the study. 
Firstly, the survey design creates some limitations. Although the mixed-methods 
approach allowed for capture of a broad range of views and beliefs; for data 
collected qualitatively, statistically valid generalisations cannot be undertaken and 
causal relationships between certain variables cannot be determined. 
In addition, the collection of attitudinal data could potentially result in inherent bias. 
First and foremost, although the surveys were completed anonymously, awareness 
of the researcher’s background may have skewed results. Specifically, out of 
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awareness of the researcher’s associations with genetic counselling and psychiatric 
genetic research, respondents may have selected against giving an obviously 
undesirable or response. This is particularly notable given the use of the 
researcher’s twitter account to publically promote the study as well as their other 
research interests. Resultantly respondent’s answers may not reflect their true 
opinions. Secondly, participants might not gave provide all the details that shaped 
their thinking at the time of answering the question, meaning their answers give a 
limited scope in regards to their true perceptions and attitudes. This is particularly 
notable as the qualitative questions featured towards the end of the questionnaire, 
where participants may have been tired. Similarly, the use of a survey provided less 
qualitative data than other qualitative approaches, such as focus groups or 
interviews, which also likely also limited the scope of answers in regards to 
reflecting participants’ full perceptions, and also made interpretation of certain 
elements or themes more challenging. 
A further limitation is the relatively small sample size of the study, which may result 
in sample bias. Despite recruitment through a diversity of sources, the views of 
those who chose to participate in the study may not be generalizable to that of the 
wider UK population. For example, those who chose to participate may be more 
proactive in their or their relative’s mental health; in their information-seeking 
activities; and/or have greater insight into their or their relative’s personal recovery. 
This is particularly relevant to consider for those participants recruited from websites 
and self-help groups. Conversely, the study did not include hospitalised patients 
who may have different insight and perceptions pertaining to the questions 
investigated. Further, the study also excluded non-English speaking participants, 
which may result in the exclusion of certain populations from this research. This is 
important as mental illness may be perceived differently amongst different cultures, 
and similarly approaches to healthcare and/or treatment may differ. 
Another important point of consideration to this degree is that respondents who 
chose to participate in the study may have a natural interest in psychiatric genetics, 
perhaps owing to a family history of mental illness for example; or conversely, they 
may be strongly opposed to genetic attributions to mental illness and wish to voice 
their rejection of healthcare services based on such models. Consequently their 
evaluations may not reflect those of the general population. This issue is of 
particular importance because participants’ pre-conceptions of chance for other 
relatives to develop mental illness, and attributional theories to mental illness, could 
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impact their perception of value of psychiatric genetic counselling, even after 
receiving an explanation of the service. 
The coding process is a further limitation of the study design as it opens the 
possibility for subjectivity by the researcher. In the coding process, there is a level of 
researcher imposition, in which the researcher is making their own decisions and 
assumptions as to what is and is not important in regards to the respondents’ 
answers. Furthermore, the researcher interprets participants’ responses, and these 
interpretations could not be verified due to anonymity of data collection. Additionally, 
the wording of some of the questions assumed a reasonable degree of education; 
some responses indicated the respondent had not fully comprehended the question 
but, again, their answer could not be verified or clarified due to anonymity of data 
collection.  
Further, the description of genetic counselling provided in the survey will also be a 
critical factor influencing participants’ responses. The video content was based on 
the definition of genetic counselling provided by the NSGC, and was formulated and 
presented by Dr. Jehannine Austin, president of the and founder of the NSGC. 
However, certain components of the video may have influenced participants’ 
responses. For example, some participants indicated suggestions of ways to 
improve their mental health as not helpful or even patronising; whilst others reported 
this would be a particularly useful part of genetic counselling. Affected individuals’ 
reactions to such information will be personal to them and dependent on their 
previous experiences; and reactions to such specific details may influence 
participant’s overall perceptions and responses to genetic counselling on the whole. 
A further technical limitation pertaining to the use of the video is that one respondent 
was unable to watch the video on their mobile device. No other respondents 
indicated they had encountered this problem but it is a possibility. Likewise, some 
respondents’ may have missed out on certain parts of the audio, which was not 
possible to investigate. This is a further factor that must be considered. 
In addition, specifically, the issue of differential and/or multiple diagnoses for 
respondents meant that it was difficult to statistically analyse familial risk data. 
Although familial risk was overestimated by the majority of respondents, this limits 
generalisability of this finding to the whole of the UK population. Future research 
methods exploring this for the UK would be needed. 
  
220 
 
5 Conclusion 
 
This study is, to best knowledge, the first of its kind to explore the application 
of PGC within the UK. 
 
It provides evidence of an interest and keenness in receiving PGC amongst 
this population. It also demonstrates that uncertainties, misconceptions and 
concerns exist amongst affected individuals and their relatives regarding 
aetiology of psychiatric conditions and concepts relating to familial risk, 
providing tentative indications that PGC may be clinically helpful to this 
population. 
 
However the findings presented here also indicate that awareness of genetic 
counselling is low amongst the UK population, especially amongst affected 
individuals. The findings also provide evidence of limited comprehension, and 
some profound misconceptions, about the purpose and process of genetic 
counselling, including its role specifically within psychiatry. This includes 
association of its practice with eugenic type values and also beliefs and 
anxieties that PGC may cause psychological distress, which collectively raises 
concerns of an ethical nature. These results highlight a potential need to raise 
the profile of genetic counselling, and especially its place within the field of 
psychiatry. 
 
With no other published data currently available regarding the application of 
PGC within the UK, further exploration of the findings presented here, in larger 
sample sizes, are thus needed to provide recommendations regarding the 
future of PGC within the UK. 
 
None the less, the results highlight some interesting and potentially important 
concepts in regards to the application of PGC that are deserved of such 
further investigation. 
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APPENDICES 
Appendix A -  Survey – Affected individuals. 
Psychiatric Genetic Counselling in the UK 
 
1. Demographic and diagnostic data 
1. What is your age? Please tick your answer. 
 18-24  
 25-30  
 31-35  
 36-40  
 41-45  
 46-50  
 51-55  
 56-60  
 61-65  
 66+  
 
2. What is your gender? Please tick your answer. 
 Male  
 Female  
 Would prefer not say  
 
3. What is the highest degree or level of schooling you have completed? Please tick 
your answer. 
 Would prefer not to say  
 No schooling completed 
 Secondary school without GCSE's/O-levels  
 GCSE's/O-levels  
 A-levels or equivalent (e.g. BTEC)  
 Bachelor's degree ( 
 Higher degree (e.g. master's degree, doctorate - please decribe in the space 
provided):  
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 4. What is your current employment status? Please tick your answer. 
 In employment (full or part-time)  
 Self-employed  
 Not currently working  
 In full time education  
 Retired  
 Unable to work  
 Would prefer not to say  
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5. What is your ethnic group? Please tick your answer. 
 White (British)  
 Irish traveller  
 Black or Black British - Caribbean  
 Black or Black British - African  
 Asian or Asian British - Indian 
 Asian or Asian British - Pakistani  
 Asian or Asian British - Bangladeshi  
 Chinese  
 Mixed - White and Black Caribbean  
 Mixed - White and Black African  
 Mixed - White and Asian  
 Other ethnic background (please describe)  
 
 Would prefer not to say  
 
6. How would you describe your nationality? Please tick your answer. 
 English  
 Welsh  
 Scottish  
 Northern Irish  
 British  
 Other (please describe below) 
 
7. Is the UK your country of permanent residence? 
 Yes  
 No (please describe below) 
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8. What is your psychiatric diagnosis? Please tick your answer 
 Bipolar disorder 1  
 Bipolar disorder 2  
 Schizophrenia  
 Schizoaffective disorder) 
 Other (please describe):  
 
 
Q9.  How many years ago were you first diagnosed? Please write your answer in 
the space provided: 
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1. Please circle a number between 1 and 7 according to how much you think your mental illness was caused by genetic 
factors. For example, circling 1 would indicate that you believe that genetic factors did not contribute at all to your 
mental illness, circling 4 would indicate that you believe that genetic factors contributed somewhat, and circling 7 
would indicate that you believe your mental illness was caused entirely by genetic factors. 
 
2. Now, please circle a number between 1 and 7 according to how confident or sure you are of the answer you 
provided above. For example, circling 1 would indicate that you are not at all sure that the answer you provided is 
correct, and circling 7 would indicate that you are absolutely certain that the answer provided above is correct. 
Section A 
 
 
 
1 2 3 4 5 6 7 
 
 
 
 
 
1 2 3 4 5 6 7 
 
 
 
 
 
 
 
 
I am not 
sure at all 
I am 
completely 
confident 
Genetics did 
not contribute 
at all 
Genetics 
alone caused 
my  mental 
illness 
Genetics 
contributed 
somewhat 
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4. Now, please circle a number between 1 and 7 according to how confident or sure you are of the answer you 
provided above. For example, circling 1 would indicate that you are not at all sure that the answer you provided is 
correct, and circling 7 would indicate that you are absolutely certain that the answer provided above is correct. 
 
3. Please circle a number between 1 and 7 according to how much you think your mental illness was caused by your 
life experiences. (You can think about this as things that have happened to you, or environmental factors, such as 
where you have lived). For example, circling 1 would indicate that you believe that your experiences did not 
contribute at all to your mental illness, circling 4 would indicate that you believe that your experiences contributed 
somewhat, and circling 7 would indicate that you believe your mental illness was caused entirely by your 
experiences. 
 
 
1 2 3 4 5 6 7 
 
 
 
 
 
 
 
1 2 3 4 5 6 7 
 
 
 
 
 
 
 
My experiences 
did not 
contribute at 
all 
My experiences 
alone caused my 
mental illness 
I am not 
sure at all 
I am 
completely 
confident 
My 
experiences 
contributed 
somewhat 
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Section B 
1.Please circle a number between 1 and 7 according to how concerned you are 
about other family members developing the same mental illness as you have. 
For example circling 1 would indicate that you are not at all concerned, circling 4 
would indicate that you are somewhat concerned, and circling 7 would indicate that 
you are extremely 
concerned.  
 
 
 
 
1 2 3 4 5 6 7 
 
2. For someone with the same mental illness as you, how likely do you think it is 
that their child, who is not currently unwell and has never been, will also develop 
the mental illness in the future? Please tick the answer that you think is the most 
accurate.  
 1%  
 10% 
 25%  
 50%  
 100%  
 Not sure  
 Other (please state in the space provided)  
 
I am not at 
all 
concerned 
I am 
extremely 
concerned 
I am 
somewhat 
concerned 
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3. For someone with the same mental illness as you, how likely do you think it is 
that their sibling (i.e. brother or sister), who is not currently unwell and has never 
been, will also develop this mental illness in the future? Please choose the answer 
that you think is the most accurate. 
 1%  
 10% 
 25%  
 50%  
 100%  
 Not sure  
 Other (please state in the space provided) 
 
 
 
4. Has your diagnosis of mental illness affected your decisions about having a 
family, or do you think it may in the future? 
 Not sure  
 No 
 Yes – please describe how: 
 A decision to have more children 
 A decision to have less children 
 A decision to have no children 
 Other (please explain below) 
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Section C 
1. What is the first thing that comes to mind when you hear the term ‘genetic 
counselling’? 
Please write your answer in the space provided below:  
 
2. Had you heard of "genetic counselling" before participating in this study? You do 
not have to know what it is. 
 Yes  
 No  
 
3. Have you received genetic counselling regarding your mental illness? 
 No  Please move onto question four (question below) 
 Yes  Please move onto SECTION D   
 
4. How did you come across genetic counselling before today? Please tick the 
answer which is most relevant to you 
 I have been referred to or have seen a genetic counsellor regarding another 
health condition  
 A relative or friend has seen a genetic counsellor  
 I have read about genetic counselling in the news  
 I have read about genetic counselling on the internet  
 I have seen a movie/ TV programme in which a genetic counselling was 
mentioned or portrayed  
 I learned about genetic counselling at school/college/university  
 I am a genetic counsellor/ I am studying to become a genetic counsellor  
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 I have contact with genetic counsellors through my job  
 Other (please give more information in the space provided below 
 
5. What do you think a genetic counsellor might do, if anything, in relation to your 
mental illness? Please indicate your answer to each statement by ticking either YES 
or NO.  
 YES  NO  
Gather information about my family's 
medical history (1) 
    
Gather information about my family's 
history of mental illness (2) 
    
Provide information about the 
chances of my children (including 
form future pregnancies) also 
becoming ill (3) 
    
Provide information about the 
chances of other relatives also 
becoming ill (4) 
    
Provide information about the genetic 
contributions in mental illness (5) 
    
Provide information about the non-
genetic factors in mental illness (6) 
    
Advise me whether or not to have 
children (7) 
    
Arrange genetic tests to diagnose 
mental illness in myself or my 
relatives (8) 
    
Arrange genetic tests to test for 
mental illness in future pregnancies 
    
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(9) 
Prevent future children from having 
mental illness (10) 
    
Arrange gene therapy to cure mental 
illness (11) 
    
Discuss ways I can protect my 
mental health (12) 
    
Discuss ways my relatives can 
protect their mental health (13) 
    
Provide referrals and information to 
other services that may be relevant to 
me (14) 
    
Provide emotional support (15)     
Decide what medications I should 
take for my mental illness (16) 
    
Other (please give more information 
in the space provided below) (17) 
    
 
 
6. Would you like to have genetic counselling regarding your mental illness? 
 Yes Please move onto question 8 
 No Please move onto question 7 (below) 
 Not sure Please move onto question 7 (below) 
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7. Why might you not want to have genetic counselling regarding your mental 
illness? Please tick any answers that apply 
 I do not know enough about psychiatric genetic counselling (1) 
 There is no role/only a small role for genetics in mental illness (2) 
 MY mental illness is not genetic - no other affected individuals in my family have 
this mental illness (3) 
 Scientists still don't know what gene(s) cause mental illness (4) 
 I don't know my family history of mental illness (5) 
 I don't want to have genetic testing (6) 
 I do not have children or do not want to have children (7) 
 I am worried the genetic counsellor might tell me not to have children (8) 
 I don't want to know the chances of me or my relatives developing mental illness 
(9) 
 The people I care most about are past the age at which they'd develop mental 
illness (10) 
 I am worried I will find out things I wish I hadn't (11) 
 I am worried the genetic counsellor will tell me my mental illness is my fault (12) 
 I am worried the genetic counsellor might tell me there is nothing I can do about 
my mental illness (13) 
 I am not currently unwell (14) 
 There is not a lot that can be done to prevent mental illness (15) 
 I do not have the time (16) 
 I do not think I can afford an appointment with a genetic counsellor (17) 
 I am worried it will affect my insurance or privacy (18) 
 Other (Please give more information in the space provided): (19) 
____________________ 
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8. The researcher will now show you a video. Please take your time to watch it, and 
then answer the questions below. 
 
- Now that you have watched a film about what psychiatric genetic counselling is, 
please circle a number showing how useful you think it would be for you.  
For example, circling 1 would indicate that you would not find it at all useful, circling 
4 would indicate that you would find it somewhat useful, and circling 7 would 
indicate that you would find it extremely useful. 
 
 
 
 
1 2 3 4 5 6 7 
 
9. Which aspects of psychiatric genetic counselling that you heard about in the film, 
if any, do you think would be particularly useful to you? Please write your answer in 
the space provided below: 
 
10. Please circle a number showing how useful you think psychiatric genetic 
counselling would be for your close relatives (for example, your parents, your 
brothers or sisters, or your children)? 
For example, circling 1 would indicate that you think they would not find it at all 
useful, circling 4 would indicate that you think they would find it somewhat useful, 
and circling 7 would indicate that you think they would find it extremely useful. 
It would 
not be at 
all useful 
It would be 
extremely 
useful 
 
278 
 
 
 
 
 
1 2 3 4 5 6 7 
 
11.  Which aspects of psychiatric genetic counselling that you heard about in the 
film, if any, do you think would be particularly useful to your close relatives? Please 
write your answer in the space provided below: 
 
12. If psychiatric genetic counselling was offered to you, would you want an 
appointment? Please circle a number between 1 and 7 to show your answer. 
For example, circling 1 would indicate that you definitely would NOT want to have 
an appointment, circling 4 would indicate that you might want to have an 
appointment, and circling 7 would indicate that you definitely WOULD want to have 
an appointment. 
 
 
 
 
1 2 3 4 5 6 7 
 
It would not be 
at all useful for 
my relatives 
It would be 
extremely useful 
for my relatives 
 
I definitely would 
NOT want an 
appointment 
I definitely 
WOULD want an 
appointment 
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13. Please explain any reasons why you might NOT want to have a psychiatric 
genetic counselling appointment in the space below: 
 
END OF SURVEY for affected individuals that had NOT received PGC. 
 
Section E 
1. Who provided you with the psychiatric genetic counselling? Please tick your 
answer. 
 A person specially qualified as a genetic counsellor  
 A psychiatrist  
 A nurse 
 My GP 
 I'm not sure 
 Other (please give more information in the space provided) 
 
2. How did you get to have the psychiatric genetic counselling session? Please tick 
your answer 
 I referred myself (self-referral)  
 A healthcare worker (e.g. doctor/nurse) referred me  
 The session was part of an appointment with a healthcare worker  
 Other (please give more information in the space provided) 
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3. Please circle a number between 1 and 7 showing how useful you found the 
psychiatric genetic counselling session. 
For example, circling 1 would indicate that you did not find it at all useful, circling 4 
would indicate that you found it somewhat useful, and circling 7 would indicate that 
you found it extremely useful. 
 
 
 
1 2 3 4 5 6 7 
 
 
 
4. What topics were covered during the psychiatric genetic counselling session? 
Please show your answer to each statement by ticking either YES or NO 
 YES  NO  
Discussed my family history of mental 
illness with me (1) 
    
Discussed information about the 
genetic contrinbutions to mental illness 
with me (2) 
    
Discussed information about the non-
genetic factors to mental illness with 
me (3) 
    
Discussed family planning decisions in 
relation to my mental illness (4) 
    
Discussed ways to protect my own     
 
Not at all 
useful 
Extremely 
useful 
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mental health (5) 
Discussed ways to protect my 
relatives' mental health (6) 
    
Discussed strategies to help me cope 
better with my mental illness (7) 
    
Discussed genetic testing regarding 
mental illness (8) 
    
Provided information about the 
chances of my relatives also 
developing mental illness (9) 
    
Provided information about the 
chances of children in my family 
(including from future pregnancies) 
also developing mental illness (10) 
    
Provided referrals and information to 
other services that may be relevant to 
me (e.g. support groups/referral to 
psychiatrist/psychotherapy) (11) 
    
Provided emotional support (12)     
Other (please give more information in 
the space provided): (13) 
    
 
5. Were there any aspects of the psychiatric genetic counselling that you found 
particularly useful or helpful? If yes, what were they? Please write your 
answer in the space provided below: 
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6. Were there any topics that you would have liked more information about, or that 
were not covered during the session that you would have liked to have been? 
Please write your answer in the space provided below: 
 
 
 
7. Were there any aspects of this service that you did not find useful or helpful, or 
felt uncomfortable talking about? Please write your answer in the space provided 
below: 
 
8. Did you share any information you from your genetic counselling session with 
your relatives or friends? If yes, what did you discuss, and with who? Please write 
you answer in the space provided below: 
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9. Are there any ways in which your psychiatric genetic counselling session could 
be improved to make it more useful or helpful to you? Please write you suggestions 
in the space provided below: 
 
 
10. Please choose a number showing to how useful you think psychiatric genetic 
counselling could be for your close relatives (for example your parents, your 
brothers or sisters, or your children).For example, circling 1 would indicate that you 
think it would not be at all useful to them; circling 4 would indicate that you think it 
would be somewhat useful to them; and circling 7 would indicate that you think it 
would be extremely useful to them. 
 
 
 
 
1 2 3 4 5 6 7 
 
 
 
11. What aspects of psychiatric genetic counselling, if any, do you think would be 
particularly helpful or useful to your close relatives? Please write your answer in the 
space provided below: 
 
Not at all 
useful 
Extremely 
useful 
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END OF SURVEY 
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Appendix B – Survey – Relatives. 
 
1. Demographic and Diagnostic data 
1. What is your age? Please tick your answer. 
 18-24  
 25-30  
 31-35  
 36-40  
 41-45  
 46-50  
 51-55  
 56-60  
 61-65  
 66+  
 
2. What is your gender? Please tick your answer. 
 Male  
 Female  
 Would prefer not say  
 
3. What is the highest degree or level of schooling you have completed? Please tick 
your answer. 
 Would prefer not to say  
 No schooling completed 
 Secondary school without GCSE's/O-levels  
 GCSE's/O-levels  
 A-levels or equivalent (e.g. BTEC)  
 Bachelor's degree ( 
 Higher degree (e.g. master's degree, doctorate - please decribe in the space 
provided):  
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 4. What is your current employment status? Please tick your answer. 
 In employment (full or part-time)  
 Self-employed  
 Not currently working  
 In full time education  
 Retired  
 Unable to work  
 Would prefer not to say  
 
5. What is your ethnic group? Please tick your answer. 
 White (British)  
 Irish traveller  
 Black or Black British - Caribbean  
 Black or Black British - African  
 Asian or Asian British - Indian 
 Asian or Asian British - Pakistani  
 Asian or Asian British - Bangladeshi  
 Chinese  
 Mixed - White and Black Caribbean  
 Mixed - White and Black African  
 Mixed - White and Asian  
 Other ethnic background (please describe)  
 
 Would prefer not to say  
 
6. How would you describe your nationality? Please tick your answer. 
 English  
 Welsh  
 Scottish  
 Northern Irish  
 British  
 Other (please describe below) 
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7. Is the UK your country of permanent residence? 
 Yes  
 No (please describe below) 
 
8. What is your relative’s psychiatric diagnosis? Please tick your answer  
 Bipolar disorder 1  
 Bipolar disorder 2  
 Schizophrenia  
 Schizoaffective disorder) 
 Other (please describe):  
 
 
Q9.  How many years ago was your relative first diagnosed? Please write your 
answer in the space provided: 
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1. Please circle a number between 1 and 7 according to how much you think your relative’s mental illness was caused 
by genetic factors. For example, circling 1 would indicate that you believe that genetic factors did not contribute at all 
to your relative’s mental illness, circling 4 would indicate that you believe that genetic factors contributed somewhat, 
and circling 7 would indicate that you believe your relative’s mental illness was caused entirely by genetic factors. 
 
2. Now, please circle a number between 1 and 7 according to how confident or sure you are of the answer you 
provided above. For example, circling 1 would indicate that you are not at all sure that the answer you provided is 
correct, and circling 7 would indicate that you are absolutely certain that the answer provided above is correct. 
Section A 
 
 
 
1 2 3 4 5 6 7 
 
 
 
1 2 3 4 5 6 7 
 
 
 
 
 
 
 
I am not 
sure at all 
I am 
completely 
confident 
Genetics did 
not contribute 
at all 
Genetics 
alone caused 
my relative’s 
mental illness 
Genetics 
contributed 
somewhat 
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4. Now, please circle a number between 1 and 7 according to how confident or sure you are of the answer you 
provided above. For example, circling 1 would indicate that you are not at all sure that the answer you provided is 
correct, and circling 7 would indicate that you are absolutely certain that the answer provided above is correct. 
 
3. Please circle a number between 1 and 7 according to how much you think your relative’s mental illness was caused 
by their life experiences. (You can think about this as things that happened to them, or environmental factors, such as 
where they have lived). For example, circling 1 would indicate that you believe that your relative’s experiences did 
not contribute at all to their mental illness, circling 4 would indicate that you believe that your relative’s experiences 
contributed somewhat, and circling 7 would indicate that you believe your relative’s mental illness was caused 
entirely by their experiences. 
 
 
 
 
 
1 2 3 4 5 6 7 
 
 
 
 
 
 
1 2 3 4 5 6 7 
 
 
 
 
 
My  relative’s 
experiences did 
not contribute 
at all 
My relative’s 
experiences alone 
caused their 
mental illness 
I am not 
sure at all 
I am 
completely 
confident 
My  relative’s 
experiences 
contributed 
somewhat 
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Section B 
1. Please circle a number between 1 and 7 according to how concerned you are 
about other family members also becoming ill with your relative's mental illness.  
For example circling 1 would indicate that you are not at all concerned, circling 4 
would indicate that you are somewhat concerned, and circling 7 would indicate that 
you are very concerned. 
 
 
 
 
1 2 3 4 5 6 7 
 
2. For someone with the same mental illness as your relative, how likely do you 
think it is that their child, who is not currently unwell and has never been, will also 
develop the mental illness in the future? Please tick the answer that you think is the 
most accurate.  
 1%  
 10% 
 25%  
 50%  
 100%  
 Not sure  
 Other (please state in the space provided)  
 
 
 
 
I am not at 
all 
concerned 
I am very 
concerned 
I am 
somewhat 
concerned 
291 
 
3. For someone with the same mental illness as your relative, how likely do you 
think it is that their sibling (i.e. brother or sister), who is not currently unwell and has 
never been, will also develop this mental illness in the future? Please tick the 
answer that you think is the most accurate. 
 1%  
 10% 
 25%  
 50%  
 100%  
 Not sure  
 Other (please state in the space provided) 
 
 
 
4. Has the mental illness in your family affected your decisions about having a 
family, or do you think it could in the future? 
 Not sure  
 No 
 Yes – please describe how: 
 A decision to have more children 
 A decision to have less children 
 A decision to have no children 
 Other (please explain below) 
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Section C 
1. What is the first thing that comes to mind when you hear the term ‘genetic 
counselling’? 
Please write your answer in the space provided below:  
 
2. Had you heard of "genetic counselling" before participating in this study? You do 
not have to know what it is. 
 Yes  
 No  
 
3. Have you received genetic counselling regarding your relative’s mental illness? 
 No  Please move onto question four of this section (below) 
 Yes  Please move onto SECTION E 
 
4. How did you come across genetic counselling before today? Please tick the 
answer which is most relevant to you 
 I have been referred to or have seen a genetic counsellor regarding another 
health condition  
 A relative or friend has seen a genetic counsellor  
 I have read about genetic counselling in the news  
 I have read about genetic counselling on the internet  
 I have seen a movie/ TV programme in which a genetic counselling was 
mentioned or portrayed  
 I learned about genetic counselling at school/college/university  
 I am a genetic counsellor/ I am studying to become a genetic counsellor  
 I have contact with genetic counsellors through my job  
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 Other (please give more information in the space provided below 
 
5. What do you think a genetic counsellor might do, if anything, in relation to the 
mental illness in your family? Please show your answer to each statement by ticking 
either YES or NO (see next page) 
 YES  NO  
Gather information about my family's 
medical history (1) 
    
Gather information about my family's 
history of mental illness (2) 
    
Provide information about the chances 
of children in my family (including from 
future pregnancies) also becoming ill 
(3) 
    
Provide information about the chances 
of other relatives also becoming ill (4) 
    
Provide information about the genetic 
contributions in mental illness (5) 
    
Provide information about the non-
genetic factors in mental illness (6) 
    
Advise me whether or not to have 
children (7) 
    
Advise my relative with a mental illness 
whether or not to have children (8) 
    
Arrange genetic tests to diagnose 
mental illness in myself or my relatives 
(9) 
    
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Arrange genetic tests to test for mental 
illness in future pregnancies (10) 
    
Prevent future children from having 
mental illness (11) 
    
Arrange gene therapy to cure mental 
illness (12) 
    
Discuss ways my relative with a mental 
illness can protect their mental health 
(14) 
    
Discuss ways I can protect my own 
mental health (13) 
    
Provide referrals and information to 
other services that may be relevant to 
my relative with a mental illness (15) 
    
Provide referrals and information to 
other services that may be relevant to 
me (16) 
    
Provide emotional support (17)     
Decide what medications my relative 
should take for their mental illness (18) 
    
Tell me what medications I can take to 
prevent myself from developing mental 
illness (19) 
    
Other (please give more information in 
the space provided on the next page) 
(20) 
    
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6. Would you like to have genetic counselling regarding the mental illness in your 
family? 
 Yes Please move onto question 8 
 No Please move onto question 7 
 Not sure Please move onto question 7 
 
7. Why might you not want to have genetic counselling regarding the mental illness 
in your family? Please tick any answers that apply 
 I do not know enough about psychiatric genetic counselling (1) 
 There is no role/only a small role for genetics in mental illness (2) 
 MY RELATIVE'S  mental illness is not genetic - no other affected individuals in 
my family have this mental illness (3) 
 Scientists still don't know what gene(s) cause mental illness (4) 
 I don't know my family history of mental illness (5) 
 I don't want to have genetic testing (6) 
 I do not have children or do not want to have children (7) 
 I am worried the genetic counsellor might tell me not to have children (8) 
 I don't want to know the chances of me or my relatives developing mental illness 
(9) 
 I am too old to develop mental illness (10) 
 The people I care most about are past the age at which they'd develop mental 
illness (11) 
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 I am worried I will find out things I wish I hadn't (12) 
 I am worried the genetic counsellor will tell me my relative's mental illness is my 
fault (13) 
 I am worried the genetic counsellor might tell me there is nothing I can do about 
my relative's mental illness (14) 
 My relative is not currently unwell (15) 
 There is not a lot that can be done to prevent mental illness (16) 
 I do not have the time (17) 
 I do not think I can afford an appointment with a genetic counsellor (18) 
 I am worried it will affect my insurance or privacy (19) 
 Other (Please give more information in the space provided): (20) 
____________________ 
 
8. The researcher will now show you a video. Please take your time to watch it, and 
then answer the questions below. 
 
- Now that you have watched a film about what psychiatric genetic counselling is, 
please circle a number showing how useful you think it would be for you.  
For example, circling 1 would indicate that you would not find it at all useful, circling 
4 would indicate that you would find it somewhat useful, and circling 7 would 
indicate that you would find it extremely useful. 
 
 
 
 
1 2 3 4 5 6 7 
 
 
 
It would 
not be at 
all useful 
It would be 
extremely 
useful 
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9. Which aspects of psychiatric genetic counselling that you heard about in the film, 
if any, do you think would be particularly useful to you? Please write your answer in 
the space provided below: 
 
 
 
10. Please circle a number showing how useful you think psychiatric genetic 
counselling would be for your relative with a mental illness? 
For example, circling 1 would indicate that you do not think it would be at all useful 
for them, circling 4 would indicate that you think they would find it somewhat useful, 
and circling 7 would indicate that you think they would find it extremely useful. 
 
 
 
 
 
 
1 2 3 4 5 6 7 
 
11.  Which aspects of psychiatric genetic counselling that you heard about in the 
film, if any, do you think would be particularly useful to your relative with a mental 
illness? Please write your answer in the space provided below: 
 
 
It would not be 
at all useful for 
my relative 
It would be 
extremely useful 
for my relative 
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12. If psychiatric genetic counselling was offered to you, would you want an 
appointment? Please circle a number between 1 and 7 to show your answer. 
 
For example, circling 1 would indicate that you definitely would NOT want to have 
an appointment, circling 4 would indicate that you might want to have an 
appointment, and circling 7 would indicate that you definitely WOULD want to have 
an appointment. 
 
 
 
 
 
1 2 3 4 5 6 7 
13. Please explain any reasons why you might NOT want to have a psychiatric 
genetic counselling appointment in the space below: 
 
END OF SURVEY for respondents that had NOT received PGC 
 
I definitely would 
NOT want an 
appointment 
I definitely 
WOULD want an 
appointment 
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Section D. 
1. Who provided you with the psychiatric genetic counselling? Please tick your 
answer. 
 A person specially qualified as a genetic counsellor  
 A psychiatrist  
 A nurse 
 My GP 
 I'm not sure 
 Other (please give more information in the space provided) 
 
 
2. How did you get to have the psychiatric genetic counselling session? Please tick 
your answer 
 I referred myself (self-referral)  
 A healthcare worker (e.g. doctor/nurse) referred me  
 The session was part of an appointment with a healthcare worker  
 Other (please give more information in the space provided) 
 
3. Please circle a number between 1 and 7 showing how useful you found the 
psychiatric genetic counselling session. 
For example, circling 1 would indicate that you did not find it at all useful, circling 4 
would indicate that you found it somewhat useful, and circling 7 would indicate that 
you found it extremely useful. 
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1 2 3 4 5 6 7 
 
 
4. What topics were covered during the psychiatric genetic counselling session? 
Please show your answer to each statement by ticking either YES or NO 
 YES (1) NO (2) 
Discussed my family history of mental 
illness with me (1) 
    
Discussed information about the genetic 
contrinbutions to mental illness with me (2) 
    
Discussed information about the non-
genetic factors to mental illness with me (3) 
    
Discussed family planning decisions in 
relation to my mental illness (4) 
    
Discussed ways my relative with a mental 
illness can protect their mental health (6) 
    
Discussed ways to protect my own mental 
health (5) 
    
Discussed genetic testing regarding mental 
illness (7) 
    
Provided information about the chances of 
my relatives also developing mental illness 
(8) 
    
Provided information about the chances of 
children in my family (including from future 
pregnancies) also developing mental illness 
(9) 
    
Provided referrals and information to other 
services that may be relevant to me or my 
    
Not at all 
useful 
Extremely 
useful 
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relative (e.g. support groups/referral to 
psychiatrist/psychotherapy) (10) 
Provided emotional support (11)     
Other (please give more information in the 
space provided below): (12) 
    
 
 
 
5. Were there any aspects of the psychiatric genetic counselling that you found 
particularly useful or helpful? If yes, what were they? Please write your answer in 
the space provided below: 
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6. Were there any topics that you would have liked more information about, or that 
were not covered during the session that you would have liked to have been? 
Please write your answer in the space provided below: 
 
 
7. Were there any aspects of this service that you did not find useful or helpful, or 
felt uncomfortable talking about? Please write your answer in the space provided 
below: 
 
 
8. Did you share any information you from your genetic counselling session with 
your relatives or friends? If yes, what did you discuss, and with who? Please write 
you answer in the space provided below: 
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9. Are there any ways in which your psychiatric genetic counselling session could 
be improved to make it more useful or helpful to you? Please write you suggestions 
in the space provided below: 
 
10. Please circle a number between 1 and 7 showing how useful you think 
psychiatric genetic counselling would be for your relative with a mental illness. 
For example, selecting 1 would indicate that you do not think it would be at all useful 
for them, selecting 4 would indicate that you think they it would be somewhat useful, 
and selecting 7 would indicate that you think it would be 
extremely useful for them. 
 
 
 
1 2 3 4 5 6 7 
11. What aspects of psychiatric genetic counselling, if any, do you think would be 
particularly helpful or useful to your relative with a mental illness? Please write your 
answer in the space provided below: 
 
END OF SURVEY  
 
 
 
Not at all 
useful 
Extremely 
useful 
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Appendix D – Cover letter 
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Appendix E – Participant information form 
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Particpant information form (ctd). 
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Particpant information form (ctd.) 
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Appendix F – Consent form 
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Appendix G – Video script 
“Psychiatric genetic counselling is something that’s often quite misunderstood I 
think. People have some misperceptions about what it might be. So specifically, 
when people hear the phrase psychiatric genetic counselling they tend to think 
about pregnancy, childbearing decisions and conversations about “What are the 
chances that my son or daughter might have a psychiatric illness?” 
 Those are absolutely things we can discuss in the context of psychiatric genetic 
counselling, but we can also do way more than that. 
For example people who have experiences themselves of psychiatric problems 
often feel really guilty or ashamed about having that illness. They will often feel that 
perhaps they have done something themselves that caused the experience that 
they have, the illness that they have, and feel ashamed about that. Parents of 
people with psychiatric problems will worry that perhaps there was something that 
they did that caused their child to become sick, or they might wonder if there was 
something they could have done to prevent it. 
Those sorts of guilt, shame and stigma things can be really problematic for people 
and those are things that we can address really helpfully in psychiatric genetic 
counselling 
Fundamentally psychiatric genetic counselling is about helping people to better 
understand what we know from research about the causes of psychiatric disorders - 
about how genes and environment can work together to contribute to the 
development of these conditions. And it’s about providing people with support and 
counselling around that to address any guilt or shame or stigma they might be 
feeling. 
But in addition what we can also do is talk with people about strategies they might 
be able to use to protect mental health going forward. So for some people that might 
involve things like meditation, for other people perhaps spending time with a pet, 
going for walk with dog, or so on. We help people to find on an individual basis 
things that will work for them to help protect their mental health. 
So these are all things that genetic counsellors can do.” 
 
Dr. J. Austin, PhD, CCGC. February 2015. 
 
AVAILABLE FROM: https://www.youtube.com/watch?v=PqnxqMnPk_g 
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Appendix H: Causal Attribution Questionnaire (Clinical tool) 
 
Received from: (Dr. J. Austin, pers comms., 26 November 2014. © J. Austin, 2014). 
 
Please circle a number between 1 and 9 according to how much you think YOUR 
mental illness was caused by genetic factors. For example, circling 1 would indicate 
that you believe that genetic factors did not contribute at all to your mental illness, 
circling 5 would indicate that you believe that genetic factors contributed a moderate 
amount, and circling 9 would indicate that you believe your mental illness was 
caused entirely by genetic factors. 
 
Genetics did not                                    Genetics contributed              Genetics alone 
contribute at all            moderately              caused my illness 
 
  1 2 3 4 5 6 7 8 9 
 
Now, please circle a number between 1 and 9 according to how confident or sure 
you are of the answer you provided above. For example, circling 1 would indicate 
that you are not at all sure that the answer you provided is correct, and circling 9 
would indicate that you are absolutely certain that the answer provided above is 
correct. 
 
I am not   I feel somewhat           
     I am completely 
sure at all    uncertain         confident 
 
  1 2 3 4 5 6 7 8 9 
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Please circle a number between 1 and 9 according to how much you think YOUR 
mental illness was caused by your experiences (you can also think about this as 
things that happened to you, or environmental factors). For example, circling 1 
would indicate that you believe that your experiences did not contribute at all to your 
mental illness, circling 5 would indicate that you believe that your experiences 
contributed a moderate amount, and circling 9 would indicate that you believe your 
mental illness was caused entirely by your experiences. 
 
  
My experiences did not                  My experiences    My experiences alone 
contribute at all                 contributed moderately               caused my illness 
 
  1 2 3 4 5 6 7 8 9 
 
Now, please circle a number between 1 and 9 according to how confident or sure 
you are of the answer you provided above. For example, circling 1 would indicate 
that you are not at all sure that the answer you provided is correct, and circling 9 
would indicate that you are absolutely certain that the answer provided above is 
correct. 
 
I am not     I feel somewhat         I am completely 
sure at all    uncertain         confident 
 
  1 2 3 4 5 6 7 8 9 
 
 
 
